Bots, editor, reviewer, Administrators
13,951
edits
Feed:All articles/Pretty: Difference between revisions
Jump to navigation
Jump to search
no edit summary
No edit summary |
No edit summary |
||
| Line 4: | Line 4: | ||
"articles" : [ | "articles" : [ | ||
{ | { | ||
"timestamp" : "2013-08-10T02:59:37Z", | |||
"briefDesignDescription" : "Simvastatin in stable CAD", | |||
"fulltexturl" : "http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(94)90566-5/abstract", | |||
"pageid" : 1587, | |||
"pdfurl" : "", | |||
"trainingLevel" : "Student", | |||
"citation" : "Pedersen TR, <i>et al</i>. \"Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)\". <i>The Lancet</i>. 1994. 344(8934):1383-1389.", | |||
"subspecialties" : "Cardiology", | "subspecialties" : "Cardiology", | ||
"expansion" : "Scandinavian Simvastatin Survival Study", | "expansion" : "Scandinavian Simvastatin Survival Study", | ||
| Line 9: | Line 16: | ||
"published" : "1994-11-19", | "published" : "1994-11-19", | ||
"pageName" : "4S", | "pageName" : "4S", | ||
"diseases" : "Hyperlipidemia;Coronary Artery Disease", | "diseases" : "Hyperlipidemia;Coronary Artery Disease", | ||
" | "abbreviation" : "4S", | ||
"title" : "Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)", | "title" : "Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)", | ||
"pmid" : "7968073" | |||
"pmid" : "7968073 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-10-19T15:24:19Z", | |||
"briefDesignDescription" : "ISDN/hydralazine for blacks with HF", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa042934", | |||
"pageid" : 41, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa042934", | |||
"trainingLevel" : "Student", | |||
"citation" : "Taylor AL, <i>et al</i>. \"Combination of Isosorbide Dinitrate and Hydralazine in Blacks with Heart Failure\". <i>The New England Journal of Medicine</i>. 2004. 351(20):2049-2057.", | |||
"subspecialties" : "Cardiology", | "subspecialties" : "Cardiology", | ||
"expansion" : "African-American Heart Failure Trial", | "expansion" : "African-American Heart Failure Trial", | ||
| Line 27: | Line 34: | ||
"published" : "2004-11-11", | "published" : "2004-11-11", | ||
"pageName" : "A-HeFT", | "pageName" : "A-HeFT", | ||
"diseases" : "Heart Failure", | "diseases" : "Heart Failure", | ||
" | "abbreviation" : "A-HeFT", | ||
"title" : "Combination of Isosorbide Dinitrate and Hydralazine in Blacks with Heart Failure", | "title" : "Combination of Isosorbide Dinitrate and Hydralazine in Blacks with Heart Failure", | ||
"pmid" : "15533851" | |||
"pmid" : "15533851 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-06-04T17:42:35Z", | "timestamp" : "2013-06-04T17:42:35Z", | ||
"briefDesignDescription" : "Benazepril/amlodipine vs. benazepril/HCTZ in HTN", | "briefDesignDescription" : "Benazepril/amlodipine vs. benazepril/HCTZ in HTN", | ||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa0806182", | "fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa0806182", | ||
"pageid" : 1448, | "pageid" : 1448, | ||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa0806182", | "pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa0806182", | ||
"trainingLevel" : "Resident", | "trainingLevel" : "Resident", | ||
"citation" : "Jamerson K, <i>et al</i>. \"Benazepril plus Amlodipine or Hydrochlorothiazide for Hypertension in High-Risk Patients\". <i>The New England Journal of Medicine</i>. 2008. 359(23):2417-2428." | "citation" : "Jamerson K, <i>et al</i>. \"Benazepril plus Amlodipine or Hydrochlorothiazide for Hypertension in High-Risk Patients\". <i>The New England Journal of Medicine</i>. 2008. 359(23):2417-2428.", | ||
"subspecialties" : "Cardiology", | |||
"expansion" : "Avoiding Cardiovascular Events through Combination Therapy in Patients Living with Systolic Hypertension", | |||
"briefResultsDescription" : "Benazepril/amlodipine is associated with fewer CV events", | |||
"published" : "2008-12-04", | |||
"pageName" : "ACCOMPLISH", | |||
"diseases" : "Hypertension", | |||
"abbreviation" : "ACCOMPLISH", | |||
"title" : "Benazepril plus Amlodipine or Hydrochlorothiazide for Hypertension in High-Risk Patients", | |||
"pmid" : "19052124" | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-11-02T15:39:13Z", | |||
"briefDesignDescription" : "Intensive glycemic therapy in T2DM", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa0802743", | |||
"pageid" : 105, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa0802743", | |||
"trainingLevel" : "Intern", | |||
"citation" : "Gerstein HC, <i>et al</i>. \"Effects of Intensive Glucose Lowering in Type 2 Diabetes\". <i>The New England Journal of Medicine</i>. 2008. 358(24):2545-59.", | |||
"subspecialties" : "Endocrinology", | "subspecialties" : "Endocrinology", | ||
"expansion" : "Action to Control Cardiovascular Risk in Diabetes", | "expansion" : "Action to Control Cardiovascular Risk in Diabetes", | ||
| Line 63: | Line 70: | ||
"published" : "2008-06-12", | "published" : "2008-06-12", | ||
"pageName" : "ACCORD", | "pageName" : "ACCORD", | ||
"diseases" : "Diabetes Mellitus", | "diseases" : "Diabetes Mellitus", | ||
" | "abbreviation" : "ACCORD", | ||
"title" : "Effects of Intensive Glucose Lowering in Type 2 Diabetes", | "title" : "Effects of Intensive Glucose Lowering in Type 2 Diabetes", | ||
"pmid" : "18539917" | |||
"pmid" : "18539917 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-11-18T17:32:07Z", | |||
"briefDesignDescription" : "ASA/clopidogrel vs. ASA in AF", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa0901301", | |||
"pageid" : 360, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa0901301", | |||
"trainingLevel" : "Resident", | |||
"citation" : "Connolly SJ, <i>et al</i>. \"Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation\". <i>The New England Journal of Medicine</i>. 2009. 360(20):2066-78.", | |||
"subspecialties" : "Cardiology;Neurology", | "subspecialties" : "Cardiology;Neurology", | ||
"expansion" : "Atrial Fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascular Events", | "expansion" : "Atrial Fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascular Events", | ||
| Line 81: | Line 88: | ||
"published" : "2009-05-14", | "published" : "2009-05-14", | ||
"pageName" : "ACTIVE A", | "pageName" : "ACTIVE A", | ||
"diseases" : "Atrial Fibrillation;Stroke;Transient Ischemic Attack", | "diseases" : "Atrial Fibrillation;Stroke;Transient Ischemic Attack", | ||
" | "abbreviation" : "ACTIVE A", | ||
"title" : "Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation", | "title" : "Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation", | ||
"pmid" : "19336502" | |||
"pmid" : "19336502 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-08-20T14:04:09Z", | |||
"briefDesignDescription" : "ASA/clopidogrel vs. warfarin in AF", | |||
"fulltexturl" : "http://linkinghub.elsevier.com/retrieve/pii/S0140-6736(06)68845-4", | |||
"pageid" : 1438, | |||
"pdfurl" : "http://download.thelancet.com/pdfs/journals/lancet/PIIS0140673606688454.pdf", | |||
"trainingLevel" : "Intern", | |||
"citation" : "Connolly SJ, <i>et al</i>. \"Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial.\". <i>The Lancet</i>. 2006. 367(9526):1903-12.", | |||
"subspecialties" : "Cardiology;Neurology", | "subspecialties" : "Cardiology;Neurology", | ||
"expansion" : "Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events", | "expansion" : "Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events", | ||
| Line 99: | Line 106: | ||
"published" : "2006-06-10", | "published" : "2006-06-10", | ||
"pageName" : "ACTIVE W", | "pageName" : "ACTIVE W", | ||
"diseases" : "Atrial Fibrillation;Stroke;Transient Ischemic Attack", | "diseases" : "Atrial Fibrillation;Stroke;Transient Ischemic Attack", | ||
" | "abbreviation" : "ACTIVE W", | ||
"title" : "Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial.", | "title" : "Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial.", | ||
"pmid" : "16765759" | |||
"pmid" : "16765759 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-08-21T23:12:29Z", | |||
"briefDesignDescription" : "Cisatracurium in ARDS", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa1005372", | |||
"pageid" : 1119, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa1005372", | |||
"trainingLevel" : "resident", | |||
"citation" : "Papazian L, <i>et al</i>. \"Neuromuscular blockers in early acute respiratory distress syndrome\". <i>The New England Journal of Medicine</i>. 2010. 363(12):1107-1116.", | |||
"subspecialties" : "Critical Care", | "subspecialties" : "Critical Care", | ||
"expansion" : "ARDS et Curarisation Systematique", | "expansion" : "ARDS et Curarisation Systematique", | ||
| Line 117: | Line 124: | ||
"published" : "2010-09-16", | "published" : "2010-09-16", | ||
"pageName" : "ACURASYS", | "pageName" : "ACURASYS", | ||
"diseases" : "Acute Respiratory Distress Syndrome", | "diseases" : "Acute Respiratory Distress Syndrome", | ||
" | "abbreviation" : "ACURASYS", | ||
"title" : "Neuromuscular blockers in early acute respiratory distress syndrome", | "title" : "Neuromuscular blockers in early acute respiratory distress syndrome", | ||
"pmid" : "20843245" | |||
}, | |||
"pmid" : "20843245 | |||
}, | |||
{ | { | ||
"timestamp" : "2013-11-18T20:29:48Z", | |||
"briefDesignDescription" : "Intensive glycemic therapy in T2DM", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa0802987", | |||
"pageid" : 248, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa0802987", | |||
"trainingLevel" : "Intern", | |||
"citation" : "Patel A, <i>et al</i>. \"Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes\". <i>The New England Journal of Medicine</i>. 2008. 358(24):2560-2572.", | |||
"subspecialties" : "Endocrinology", | "subspecialties" : "Endocrinology", | ||
"expansion" : "Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation", | "expansion" : "Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation", | ||
| Line 135: | Line 142: | ||
"published" : "2008-06-06", | "published" : "2008-06-06", | ||
"pageName" : "ADVANCE", | "pageName" : "ADVANCE", | ||
"diseases" : "Diabetes Mellitus", | "diseases" : "Diabetes Mellitus", | ||
" | "abbreviation" : "ADVANCE", | ||
"title" : "Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes", | "title" : "Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes", | ||
"pmid" : "18539916" | |||
"pmid" : "18539916 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-10-30T11:32:38Z", | |||
"briefDesignDescription" : "Rate vs. rhythm control in AF", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa021328", | |||
"pageid" : 87, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa021328", | |||
"trainingLevel" : "Student", | |||
"citation" : "Wyse DG, <i>et al</i>. \"A Comparison of Rate Control and Rhythm Control in Patients with Atrial Fibrillation\". <i>The New England Journal of Medicine</i>. 2002. 347(23):1825-1833.", | |||
"subspecialties" : "Cardiology", | "subspecialties" : "Cardiology", | ||
"expansion" : "Atrial Fibrillation Follow-up Investigation of Rhythm Management", | "expansion" : "Atrial Fibrillation Follow-up Investigation of Rhythm Management", | ||
| Line 153: | Line 160: | ||
"published" : "2002-11-05", | "published" : "2002-11-05", | ||
"pageName" : "AFFIRM", | "pageName" : "AFFIRM", | ||
"diseases" : "Atrial Fibrillation", | "diseases" : "Atrial Fibrillation", | ||
" | "abbreviation" : "AFFIRM", | ||
"title" : "A Comparison of Rate Control and Rhythm Control in Patients with Atrial Fibrillation", | "title" : "A Comparison of Rate Control and Rhythm Control in Patients with Atrial Fibrillation", | ||
"pmid" : "12466506" | |||
"pmid" : "12466506 | |||
}, | }, | ||
{ | { | ||
"subspecialties" : "Nephrology;Cardiology", | "timestamp" : "2013-08-20T14:07:38Z", | ||
"briefDesignDescription" : "Chlorthalidone in HTN", | |||
"fulltexturl" : "http://jama.ama-assn.org/content/288/23/2981.long", | |||
"pageid" : 171, | |||
"pdfurl" : "http://jama.ama-assn.org/content/288/23/2981.full.pdf", | |||
"trainingLevel" : "Student", | |||
"citation" : "Wright JT, <i>et al</i>. \"Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs. Diuretic\". <i>Journal of the American Medical Association</i>. 2002. 288(23):2981-2997.", | |||
"subspecialties" : "Nephrology;Cardiology", | |||
"expansion" : "The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial", | "expansion" : "The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial", | ||
"briefResultsDescription" : "Chlorthalidone performs similarly to lisinopril and amlodipine", | "briefResultsDescription" : "Chlorthalidone performs similarly to lisinopril and amlodipine", | ||
"published" : "2002-12-18", | "published" : "2002-12-18", | ||
"pageName" : "ALLHAT", | "pageName" : "ALLHAT", | ||
"diseases" : "Hypertension", | "diseases" : "Hypertension", | ||
" | "abbreviation" : "ALLHAT", | ||
"title" : "Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs. Diuretic", | "title" : "Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs. Diuretic", | ||
"pmid" : "12479763" | |||
"pmid" : "12479763 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-10-20T05:07:00Z", | |||
"briefDesignDescription" : "Apixaban vs. warfarin in VTE", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa1302507", | |||
"pageid" : 1609, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa1302507", | |||
"trainingLevel" : "Intern\n}}", | |||
"citation" : "Agnelli G, <i>et al</i>. \"Oral apixaban for the treatment of acute venous thromboembolism\". <i>The New England Journal of Medicine</i>. 2013. 369(9):799-808.", | |||
"subspecialties" : "Hematology;Pulmonology", | "subspecialties" : "Hematology;Pulmonology", | ||
"expansion" : "Apixaban for the Initial Management of Pulmonary Embolism and Deep-Vein Thrombosis as First-Line Therapy", | "expansion" : "Apixaban for the Initial Management of Pulmonary Embolism and Deep-Vein Thrombosis as First-Line Therapy", | ||
| Line 189: | Line 196: | ||
"published" : "2013-07-01", | "published" : "2013-07-01", | ||
"pageName" : "AMPLIFY", | "pageName" : "AMPLIFY", | ||
"diseases" : "Venous Thromboembolism;Pulmonary Embolism;Deep Vein Thrombosis", | "diseases" : "Venous Thromboembolism;Pulmonary Embolism;Deep Vein Thrombosis", | ||
" | "abbreviation" : "AMPLIFY", | ||
"title" : "Oral apixaban for the treatment of acute venous thromboembolism", | "title" : "Oral apixaban for the treatment of acute venous thromboembolism", | ||
"pmid" : "23808982" | |||
"pmid" : "23808982 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-08-12T22:42:00Z", | "timestamp" : "2013-08-12T22:42:00Z", | ||
"briefDesignDescription" : "Apixaban after VTE treatment", | "briefDesignDescription" : "Apixaban after VTE treatment", | ||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa1207541", | "fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa1207541", | ||
"pageid" : 1245, | "pageid" : 1245, | ||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa1207541", | "pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa1207541", | ||
"trainingLevel" : "Resident", | "trainingLevel" : "Resident", | ||
"citation" : "Agnelli G, <i>et al</i>. \"Apixaban for extended treatment of venous thromboembolism\". <i>The New England Journal of Medicine</i>. 2013. 368(8):699-708." | "citation" : "Agnelli G, <i>et al</i>. \"Apixaban for extended treatment of venous thromboembolism\". <i>The New England Journal of Medicine</i>. 2013. 368(8):699-708.", | ||
"subspecialties" : "Hematology", | |||
"expansion" : "Apixaban after the Initial Management of Pulmonary Embolism and Deep Vein Thrombosis with First-Line Therapy-Extended Treatment", | |||
"briefResultsDescription" : "Apixaban reduces recurrent VTE", | |||
"published" : "2013-02-21", | |||
"pageName" : "AMPLIFY-EXT", | |||
"diseases" : "Venous Thromboembolism;Deep Vein Thrombosis;Pulmonary Embolism", | |||
"abbreviation" : "AMPLIFY-EXT", | |||
"title" : "Apixaban for extended treatment of venous thromboembolism", | |||
"pmid" : "23216615" | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-06-05T02:56:47Z", | |||
"briefDesignDescription" : "Corticosteroids in septic shock", | |||
"fulltexturl" : "http://jama.jamanetwork.com/article.aspx?articleid", | |||
"pageid" : 939, | |||
"pdfurl" : "http://jama.jamanetwork.com/data/Journals/JAMA/4844/JCE10061.pdf", | |||
"trainingLevel" : "Resident", | |||
"citation" : "Annane D, <i>et al</i>. \"Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock\". <i>Journal of the American Medical Association</i>. 2002. 288(7):862-871.", | |||
"subspecialties" : "Critical Care", | "subspecialties" : "Critical Care", | ||
"expansion" : "", | "expansion" : "", | ||
| Line 225: | Line 232: | ||
"published" : "2002-08-21", | "published" : "2002-08-21", | ||
"pageName" : "Annane Trial", | "pageName" : "Annane Trial", | ||
"diseases" : "Sepsis;Shock", | "diseases" : "Sepsis;Shock", | ||
" | "abbreviation" : "", | ||
"title" : "Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock", | "title" : "Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock", | ||
"pmid" : "12186604" | |||
"pmid" : "12186604 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-06-11T21:14:19Z", | |||
"briefDesignDescription" : "Ceftriaxone vs. norfloxacin in cirrhotics with GI bleed", | |||
"fulltexturl" : "http://www.gastrojournal.org/article/S0016-5085(06)01535-6/fulltext", | |||
"pageid" : 82, | |||
"pdfurl" : "http://www.gastrojournal.org/article/S0016-5085(06)01535-6/pdf", | |||
"trainingLevel" : "Intern", | |||
"citation" : "Fernández J, <i>et al</i>. \"Norfloxacin vs. ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage\". <i>Gastroenterology</i>. 2006. 131(4):1049-56.", | |||
"subspecialties" : "Gastroenterology;Infectious Disease", | "subspecialties" : "Gastroenterology;Infectious Disease", | ||
"expansion" : "", | "expansion" : "", | ||
| Line 243: | Line 250: | ||
"published" : "2006-10-01", | "published" : "2006-10-01", | ||
"pageName" : "Antibiotics in Cirrhosis with Hemorrhage", | "pageName" : "Antibiotics in Cirrhosis with Hemorrhage", | ||
"diseases" : "Cirrhosis;Gastrointestinal Hemorrhage", | "diseases" : "Cirrhosis;Gastrointestinal Hemorrhage", | ||
" | "abbreviation" : "", | ||
"title" : "Norfloxacin vs. ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage", | "title" : "Norfloxacin vs. ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage", | ||
"pmid" : "17030175" | |||
"pmid" : "17030175 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-06-19T04:39:10Z", | |||
"briefDesignDescription" : "Low vs. traditional volumes in ARDS", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJM200005043421801", | |||
"pageid" : 114, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJM200005043421801", | |||
"trainingLevel" : "Intern", | |||
"citation" : "Brower RG, <i>et al</i>. \"Ventilation With Lower Tidal Volumes As Compared With Traditional Tidal Volumes For Acute Lung Injury And The Acute Respiratory Distress Syndrome\". <i>The New England Journal of Medicine</i>. 2000. 342(18):1301-1308.", | |||
"subspecialties" : "Critical Care", | "subspecialties" : "Critical Care", | ||
"expansion" : "Acute Respiratory Distress Syndrome Network", | "expansion" : "Acute Respiratory Distress Syndrome Network", | ||
| Line 261: | Line 268: | ||
"published" : "2000-05-04", | "published" : "2000-05-04", | ||
"pageName" : "ARDSNet", | "pageName" : "ARDSNet", | ||
"diseases" : "Acute Respiratory Distress Syndrome", | "diseases" : "Acute Respiratory Distress Syndrome", | ||
" | "abbreviation" : "ARDSNet", | ||
"title" : "Ventilation With Lower Tidal Volumes As Compared With Traditional Tidal Volumes For Acute Lung Injury And The Acute Respiratory Distress Syndrome", | "title" : "Ventilation With Lower Tidal Volumes As Compared With Traditional Tidal Volumes For Acute Lung Injury And The Acute Respiratory Distress Syndrome", | ||
"pmid" : "10793162" | |||
"pmid" : "10793162 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-10-05T21:08:20Z", | |||
"briefDesignDescription" : "Apixaban vs. warfarin in AF", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa1107039", | |||
"pageid" : 1497, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa1107039", | |||
"trainingLevel" : "Intern", | |||
"citation" : "Granger CB, <i>et al</i>. \"Apixaban versus warfarin in patients with atrial fibrillation\". <i>The New England Journal of Medicine</i>. 2011. 365(11):981-982.", | |||
"subspecialties" : "Cardiology;Neurology", | "subspecialties" : "Cardiology;Neurology", | ||
"expansion" : "Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation", | "expansion" : "Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation", | ||
| Line 279: | Line 286: | ||
"published" : "2011-09-15", | "published" : "2011-09-15", | ||
"pageName" : "ARISTOTLE", | "pageName" : "ARISTOTLE", | ||
"diseases" : "Atrial Fibrillation;Stroke;Transient Ischemic Attack", | "diseases" : "Atrial Fibrillation;Stroke;Transient Ischemic Attack", | ||
" | "abbreviation" : "ARISTOTLE", | ||
"title" : "Apixaban versus warfarin in patients with atrial fibrillation", | "title" : "Apixaban versus warfarin in patients with atrial fibrillation", | ||
" | "pmid" : "21870978" | ||
" | }, | ||
" | { | ||
"timestamp" : "2013-08-21T13:48:06Z", | |||
"briefDesignDescription" : "Aspirin after VTE treatment", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa1210384", | |||
"pageid" : 1241, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa1210384", | |||
"trainingLevel" : "Intern", | "trainingLevel" : "Intern", | ||
"citation" : " | "citation" : "Brighton TA, <i>et al</i>. \"Low-Dose Aspirin for Preventing Recurrent Venous Thromboembolism\". <i>The New England Journal of Medicine</i>. 2012. 367(21):1979-1987.", | ||
"subspecialties" : "Hematology", | "subspecialties" : "Hematology", | ||
"expansion" : "Aspirin to Prevent Recurrent Venous Thromboembolism", | "expansion" : "Aspirin to Prevent Recurrent Venous Thromboembolism", | ||
| Line 297: | Line 304: | ||
"published" : "2012-11-04", | "published" : "2012-11-04", | ||
"pageName" : "ASPIRE", | "pageName" : "ASPIRE", | ||
"diseases" : "Venous Thromboembolism", | "diseases" : "Venous Thromboembolism", | ||
" | "abbreviation" : "ASPIRE", | ||
"title" : "Low-Dose Aspirin for Preventing Recurrent Venous Thromboembolism", | "title" : "Low-Dose Aspirin for Preventing Recurrent Venous Thromboembolism", | ||
"pmid" : "23121403" | |||
"pmid" : "23121403 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-10-20T05:13:36Z", | |||
"briefDesignDescription" : "Revascularization in RAS", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa0905368", | |||
"pageid" : 1684, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa0905368", | |||
"trainingLevel" : "Resident", | |||
"citation" : "Wheatley K, <i>et al</i>. \"Revascularization versus medical therapy for renal-artery stenosis\". <i>The New England Journal of Medicine</i>. 2009. 361(20):1953-1962.", | |||
"subspecialties" : "Nephrology", | "subspecialties" : "Nephrology", | ||
"expansion" : "Angioplasty and Stenting for Renal Artery Lesions", | "expansion" : "Angioplasty and Stenting for Renal Artery Lesions", | ||
| Line 315: | Line 322: | ||
"published" : "2009-11-12", | "published" : "2009-11-12", | ||
"pageName" : "ASTRAL", | "pageName" : "ASTRAL", | ||
"diseases" : "Renal Artery Stenosis;Hypertension", | "diseases" : "Renal Artery Stenosis;Hypertension", | ||
" | "abbreviation" : "ASTRAL", | ||
"title" : "Revascularization versus medical therapy for renal-artery stenosis", | "title" : "Revascularization versus medical therapy for renal-artery stenosis", | ||
"pmid" : "19907042" | |||
"pmid" : "19907042 | |||
}, | }, | ||
{ | { | ||
"subspecialties" : "Oncology", | "timestamp" : "2013-10-28T22:50:28Z", | ||
"briefDesignDescription" : "10y vs. 5y tamoxifen in breast cancer", | |||
"fulltexturl" : "http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3596060/", | |||
"pageid" : 1581, | |||
"pdfurl" : "http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(12)61963-1/fulltext", | |||
"trainingLevel" : "Fellow", | |||
"citation" : "Davies C, <i>et al</i>. \"Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial\". <i>The Lancet</i>. 2013. 381(9869):805-16.", | |||
"subspecialties" : "Oncology", | |||
"expansion" : "Adjuvant Tamoxifen: Longer Against Shorter", | "expansion" : "Adjuvant Tamoxifen: Longer Against Shorter", | ||
"briefResultsDescription" : "10 years of tamoxifen reduces recurrence and mortality", | "briefResultsDescription" : "10 years of tamoxifen reduces recurrence and mortality", | ||
"published" : "2013-03-09", | "published" : "2013-03-09", | ||
"pageName" : "ATLAS", | "pageName" : "ATLAS", | ||
"diseases" : "Breast Cancer", | "diseases" : "Breast Cancer", | ||
" | "abbreviation" : "ATLAS", | ||
"title" : "Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial", | "title" : "Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial", | ||
"pmid" : "23219286" | |||
"pmid" : "23219286 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-11-14T15:25:47Z", | |||
"briefDesignDescription" : "Rivaroxaban after ACS", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa1112277", | |||
"pageid" : 174, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa1112277", | |||
"trainingLevel" : "Resident\n}}", | |||
"citation" : "Mega JL, <i>et al</i>. \"Rivaroxaban in Patients with Recent Acute Coronary Syndrome\". <i>The New England Journal of Medicine</i>. 2012. 366(1):9-19.", | |||
"subspecialties" : "Cardiology", | "subspecialties" : "Cardiology", | ||
"expansion" : "Anti-Xa Therapy to Lower Cardiovascular Events in Addition to Standard Therapy in Subjects with Acute Coronary Syndrome-Thrombolysis in Myocardial Infarction 51", | "expansion" : "Anti-Xa Therapy to Lower Cardiovascular Events in Addition to Standard Therapy in Subjects with Acute Coronary Syndrome-Thrombolysis in Myocardial Infarction 51", | ||
| Line 351: | Line 358: | ||
"published" : "2012-01-05", | "published" : "2012-01-05", | ||
"pageName" : "ATLAS ACS-2, TIMI 51", | "pageName" : "ATLAS ACS-2, TIMI 51", | ||
"diseases" : "Acute Coronary Syndrome;Coronary Artery Disease", | "diseases" : "Acute Coronary Syndrome;Coronary Artery Disease", | ||
" | "abbreviation" : "ATLAS ACS 2-TIMI 51", | ||
"title" : "Rivaroxaban in Patients with Recent Acute Coronary Syndrome", | "title" : "Rivaroxaban in Patients with Recent Acute Coronary Syndrome", | ||
"pmid" : "22077192" | |||
"pmid" : "22077192 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-10-30T11:09:27Z", | "timestamp" : "2013-10-30T11:09:27Z", | ||
"briefDesignDescription" : "Apixaban vs. ASA in AF", | "briefDesignDescription" : "Apixaban vs. ASA in AF", | ||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa1007432", | "fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa1007432", | ||
"pageid" : 1718, | "pageid" : 1718, | ||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa1007432", | "pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa1007432", | ||
"trainingLevel" : "Intern\n}}", | "trainingLevel" : "Intern\n}}", | ||
"citation" : "Connolly SJ, <i>et al</i>. \"Apixaban in patients with atrial fibrillation\". <i>The New England Journal of Medicine</i>. 2011. 364(9):806-817." | "citation" : "Connolly SJ, <i>et al</i>. \"Apixaban in patients with atrial fibrillation\". <i>The New England Journal of Medicine</i>. 2011. 364(9):806-817.", | ||
"subspecialties" : "Cardiology;Neurology", | |||
"expansion" : "Apixaban Versus Acetylsalicylic Acid to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment", | |||
"briefResultsDescription" : "Apixaban better than ASA without increased bleeding in AF", | |||
"published" : "2011-03-03", | |||
"pageName" : "AVERROES", | |||
"diseases" : "Atrial Fibrillation;Stroke;Transient Ischemic Attack", | |||
"abbreviation" : "AVERROES", | |||
"title" : "Apixaban in patients with atrial fibrillation", | |||
"pmid" : "21309657" | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-06-22T12:16:42Z", | |||
"briefDesignDescription" : "CABG/PCI vs. OMT in diabetes with CAD", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa0805796", | |||
"pageid" : 1471, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa0805796", | |||
"trainingLevel" : "Resident", | |||
"citation" : "Frye RL, <i>et al</i>. \"A Randomized Trial of Therapies for Type 2 Diabetes and Coronary Artery Disease\". <i>The New England Journal of Medicine</i>. 2009. 360(24):2503-2515.", | |||
"subspecialties" : "Cardiology;Endocrinology", | "subspecialties" : "Cardiology;Endocrinology", | ||
"expansion" : "Bypass Angioplasty Revascularization Investigation 2 Diabetes", | "expansion" : "Bypass Angioplasty Revascularization Investigation 2 Diabetes", | ||
| Line 387: | Line 394: | ||
"published" : "2009-06-11", | "published" : "2009-06-11", | ||
"pageName" : "BARI 2D", | "pageName" : "BARI 2D", | ||
"diseases" : "Coronary Artery Disease;Diabetes Mellitus", | "diseases" : "Coronary Artery Disease;Diabetes Mellitus", | ||
" | "abbreviation" : "BARI 2D", | ||
"title" : "A Randomized Trial of Therapies for Type 2 Diabetes and Coronary Artery Disease", | "title" : "A Randomized Trial of Therapies for Type 2 Diabetes and Coronary Artery Disease", | ||
"pmid" : "19502645" | |||
"pmid" : "19502645 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-08-30T21:49:47Z", | |||
"briefDesignDescription" : "DMARD ± prednisone or infliximab in RA", | |||
"fulltexturl" : "http://onlinelibrary.wiley.com/doi/10.1002/art.23364/pdf", | |||
"pageid" : 77, | |||
"pdfurl" : "http://onlinelibrary.wiley.com/doi/10.1002/art.23364/pdf", | |||
"trainingLevel" : "Resident", | |||
"citation" : "Goekoop-Ruiterman YP, <i>et al</i>. \"Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis\". <i>Arthritis & Rheumatism</i>. 2005. 58(2 Suppl):S126-35.", | |||
"subspecialties" : "Rheumatology", | "subspecialties" : "Rheumatology", | ||
"expansion" : "Behandel-Strategeieën (\"treatment strategies\" in Dutch)", | "expansion" : "Behandel-Strategeieën (\"treatment strategies\" in Dutch)", | ||
| Line 405: | Line 412: | ||
"published" : "2005-11-01", | "published" : "2005-11-01", | ||
"pageName" : "BeSt", | "pageName" : "BeSt", | ||
"diseases" : "Rheumatoid Arthritis", | "diseases" : "Rheumatoid Arthritis", | ||
" | "abbreviation" : "BeSt", | ||
"title" : "Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis", | "title" : "Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis", | ||
"pmid" : "18240203" | |||
"pmid" : "18240203 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2012-06-13T05:04:26Z", | |||
"briefDesignDescription" : "CT head rules for trauma", | |||
"fulltexturl" : "http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(00)04561-X/fulltext", | |||
"pageid" : 93, | |||
"pdfurl" : "http://download.thelancet.com/pdfs/journals/lancet/PIIS014067360004561X.pdf", | |||
"trainingLevel" : "resident", | |||
"citation" : "Stiell IG, <i>et al</i>. \"The Canadian CT Head Rule for patients with minor head trauma\". <i>The Lancet</i>. 2001. 357(9266):1391-96.", | |||
"subspecialties" : "Emergency Medicine;Neurology", | "subspecialties" : "Emergency Medicine;Neurology", | ||
"expansion" : "", | "expansion" : "", | ||
| Line 423: | Line 430: | ||
"published" : "2001-05-05", | "published" : "2001-05-05", | ||
"pageName" : "Canadian CT Head Rule", | "pageName" : "Canadian CT Head Rule", | ||
"diseases" : "Trauma", | "diseases" : "Trauma", | ||
" | "abbreviation" : "", | ||
"title" : "The Canadian CT Head Rule for patients with minor head trauma", | "title" : "The Canadian CT Head Rule for patients with minor head trauma", | ||
"pmid" : "11356436" | |||
"pmid" : "11356436 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-08-27T18:42:59Z", | |||
"briefDesignDescription" : "Clopidogrel vs. aspirin in CV disease", | |||
"fulltexturl" : "http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(96)09457-3/fulltext", | |||
"pageid" : 7, | |||
"pdfurl" : "http://download.thelancet.com/pdfs/journals/lancet/PIIS0140673696094573.pdf", | |||
"trainingLevel" : "Intern", | |||
"citation" : "Gent M, <i>et al</i>. \"A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events\". <i>The Lancet</i>. 1996. 348(9038):1329-39.", | |||
"subspecialties" : "Neurology;Cardiology", | "subspecialties" : "Neurology;Cardiology", | ||
"expansion" : "Clopidogrel versus Aspirin in Patients at Risk of Ischaemic Events", | "expansion" : "Clopidogrel versus Aspirin in Patients at Risk of Ischaemic Events", | ||
| Line 441: | Line 448: | ||
"published" : "1996-11-16", | "published" : "1996-11-16", | ||
"pageName" : "CAPRIE", | "pageName" : "CAPRIE", | ||
"diseases" : "Stroke;Transient Ischemic Attack;Coronary Artery Disease", | "diseases" : "Stroke;Transient Ischemic Attack;Coronary Artery Disease", | ||
" | "abbreviation" : "CAPRIE", | ||
"title" : "A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events", | "title" : "A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events", | ||
"pmid" : "8918275" | |||
}, | |||
"pmid" : "8918275 | |||
}, | |||
{ | { | ||
"timestamp" : "2013-07-19T09:39:28Z", | |||
"briefDesignDescription" : "Ultrafiltration in decompensated HF", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa1210357", | |||
"pageid" : 1356, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa1210357", | |||
"trainingLevel" : "Resident", | |||
"citation" : "Bart BA, <i>et al</i>. \"Ultrafiltration in Decompensated Heart Failure with Cardiorenal Syndrome\". <i>The New England Journal of Medicine</i>. 2012. 367(24):2296-2304.", | |||
"subspecialties" : "Cardiology", | "subspecialties" : "Cardiology", | ||
"expansion" : "Cardiorenal Rescue Study in Acute Decompensated Heart Failure", | "expansion" : "Cardiorenal Rescue Study in Acute Decompensated Heart Failure", | ||
| Line 459: | Line 466: | ||
"published" : "2012-12-13", | "published" : "2012-12-13", | ||
"pageName" : "CARRESS-HF", | "pageName" : "CARRESS-HF", | ||
"diseases" : "Heart Failure", | "diseases" : "Heart Failure", | ||
" | "abbreviation" : "CARRESS-HF", | ||
"title" : "Ultrafiltration in Decompensated Heart Failure with Cardiorenal Syndrome", | "title" : "Ultrafiltration in Decompensated Heart Failure with Cardiorenal Syndrome", | ||
"pmid" : "23131078" | |||
"pmid" : "23131078 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-06-30T15:36:05Z", | |||
"briefDesignDescription" : "Antiarrhythmics post-MI", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJM199103213241201", | |||
"pageid" : 1110, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJM199103213241201", | |||
"trainingLevel" : "Resident", | |||
"citation" : "Echt DS, <i>et al</i>. \"Mortality and morbidity in patients receiving encainide, flecainide, or placebo\". <i>The New England Journal of Medicine</i>. 1991. 324(12):781-788.", | |||
"subspecialties" : "Cardiology", | "subspecialties" : "Cardiology", | ||
"expansion" : "Cardiac Arrhythmia Suppression Trial", | "expansion" : "Cardiac Arrhythmia Suppression Trial", | ||
| Line 477: | Line 484: | ||
"published" : "1991-03-21", | "published" : "1991-03-21", | ||
"pageName" : "CAST I", | "pageName" : "CAST I", | ||
"diseases" : "Acute Coronary Syndrome;Myocardial Infarction", | "diseases" : "Acute Coronary Syndrome;Myocardial Infarction", | ||
" | "abbreviation" : "CAST I", | ||
"title" : "Mortality and morbidity in patients receiving encainide, flecainide, or placebo", | "title" : "Mortality and morbidity in patients receiving encainide, flecainide, or placebo", | ||
"pmid" : "1900101" | |||
"pmid" : "1900101 | |||
}, | }, | ||
{ | { | ||
"subspecialties" : "Psychiatry", | "timestamp" : "2012-06-19T22:07:32Z", | ||
"briefDesignDescription" : "Antipsychotics in schizophrenia", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa051688", | |||
"pageid" : 419, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa051688", | |||
"trainingLevel" : "Resident", | |||
"citation" : "Lieberman JA, <i>et al</i>. \"Effectiveness of antipsychotic drugs in patients with chronic schizophrenia\". <i>The New England Journal of Medicine</i>. 2005. 353(12):1209-23.", | |||
"subspecialties" : "Psychiatry", | |||
"expansion" : "Clinical Antipsychotic Trials of Intervention Effectiveness", | "expansion" : "Clinical Antipsychotic Trials of Intervention Effectiveness", | ||
"briefResultsDescription" : "Olanzapine ↓discontinuations but ↑metabolic syndrome, and perphenazine ˜ atypicals", | "briefResultsDescription" : "Olanzapine ↓discontinuations but ↑metabolic syndrome, and perphenazine ˜ atypicals", | ||
"published" : "2005-09-22", | "published" : "2005-09-22", | ||
"pageName" : "CATIE", | "pageName" : "CATIE", | ||
"diseases" : "Schizophrenia", | "diseases" : "Schizophrenia", | ||
" | "abbreviation" : "CATIE", | ||
"title" : "Effectiveness of antipsychotic drugs in patients with chronic schizophrenia", | "title" : "Effectiveness of antipsychotic drugs in patients with chronic schizophrenia", | ||
"pmid" : "16172203" | |||
"pmid" : "16172203 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-08-05T13:18:59Z", | |||
"briefDesignDescription" : "ASA/clopidogrel vs. ASA in TIA/stroke", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa1215340", | |||
"pageid" : 1530, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa1215340", | |||
"trainingLevel" : "Resident", | |||
"citation" : "Wang Y, <i>et al</i>. \"Clopidogrel with aspirin in acute minor stroke or transient ischemic attack\". <i>The New England Journal of Medicine</i>. 2013. 369(1):11-19.", | |||
"subspecialties" : "Neurology", | "subspecialties" : "Neurology", | ||
"expansion" : "Clopidogrel in High-risk patients with Acute Nondisabling Cerebrovascular Events", | "expansion" : "Clopidogrel in High-risk patients with Acute Nondisabling Cerebrovascular Events", | ||
| Line 513: | Line 520: | ||
"published" : "2013-07-04", | "published" : "2013-07-04", | ||
"pageName" : "CHANCE", | "pageName" : "CHANCE", | ||
"diseases" : "Stroke;Transient Ischemic Attack", | "diseases" : "Stroke;Transient Ischemic Attack", | ||
" | "abbreviation" : "CHANCE", | ||
"title" : "Clopidogrel with aspirin in acute minor stroke or transient ischemic attack", | "title" : "Clopidogrel with aspirin in acute minor stroke or transient ischemic attack", | ||
"pmid" : "23803136" | |||
"pmid" : "23803136 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2012-05-07T01:52:13Z", | "timestamp" : "2012-05-07T01:52:13Z", | ||
"briefDesignDescription" : "EPO in CKD with anemia", | "briefDesignDescription" : "EPO in CKD with anemia", | ||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa065485", | "fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa065485", | ||
"pageid" : 422, | "pageid" : 422, | ||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa065485", | "pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa065485", | ||
"trainingLevel" : "Resident", | "trainingLevel" : "Resident", | ||
"citation" : "Singh, AK <i>et al</i>. \"Correction of Anemia with Epoetin Alfa in Chronic Kidney Disease\". <i>The New England Journal of Medicine</i>. 2006. 355(20):2085-2098." | "citation" : "Singh, AK <i>et al</i>. \"Correction of Anemia with Epoetin Alfa in Chronic Kidney Disease\". <i>The New England Journal of Medicine</i>. 2006. 355(20):2085-2098.", | ||
"subspecialties" : "Nephrology;Hematology", | |||
"expansion" : "Correction of Hemoglobin and Outcomes in Renal Insufficiency", | |||
"briefResultsDescription" : "Increased morbidity/mortality with higher hgb targets", | |||
"published" : "2006-11-16", | |||
"pageName" : "CHOIR", | |||
"diseases" : "Chronic Kidney Disease;Anemia", | |||
"abbreviation" : "CHOIR", | |||
"title" : "Correction of Anemia with Epoetin Alfa in Chronic Kidney Disease", | |||
"pmid" : "17108343" | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-08-15T18:51:46Z", | |||
"briefDesignDescription" : "PFO closure in cryptogenic stroke", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa1009639", | |||
"pageid" : 1093, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa1009639", | |||
"trainingLevel" : "Fellow", | |||
"citation" : "Furlan AJ, <i>et al</i>. \"Closure or medical therapy for cryptogenic stroke with patent foramen ovale\". <i>The New England Journal of Medicine</i>. 2012. 366(11):991-999.", | |||
"subspecialties" : "Neurology;Cardiology", | "subspecialties" : "Neurology;Cardiology", | ||
"expansion" : "Evaluation of the STARFlex Septal Closure System in Patients with a Stroke and/or Transient Ischemic Attack due to Presumed Paradoxical Embolism through a Patent Foramen Ovale", | "expansion" : "Evaluation of the STARFlex Septal Closure System in Patients with a Stroke and/or Transient Ischemic Attack due to Presumed Paradoxical Embolism through a Patent Foramen Ovale", | ||
| Line 549: | Line 556: | ||
"published" : "2012-03-15", | "published" : "2012-03-15", | ||
"pageName" : "CLOSURE I", | "pageName" : "CLOSURE I", | ||
"diseases" : "Stroke;Patent Foramen Ovale;Transient Ischemic Attack", | "diseases" : "Stroke;Patent Foramen Ovale;Transient Ischemic Attack", | ||
" | "abbreviation" : "CLOSURE I", | ||
"title" : "Closure or medical therapy for cryptogenic stroke with patent foramen ovale", | "title" : "Closure or medical therapy for cryptogenic stroke with patent foramen ovale", | ||
"pmid" : "22417252" | |||
"pmid" : "22417252 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-07-03T16:13:31Z", | |||
"briefDesignDescription" : "LMWH vs. coumadin in cancer VTE", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa025313", | |||
"pageid" : 13, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa025313", | |||
"trainingLevel" : "Intern", | |||
"citation" : "Lee AY, <i>et al</i>. \"Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer\". <i>The New England Journal of Medicine</i>. 2003. 349(2):146-53.", | |||
"subspecialties" : "Hematology;Oncology", | "subspecialties" : "Hematology;Oncology", | ||
"expansion" : "Comparison of Low Molecular Weight Heparin Versus Oral Anticoagulant Therapy for Long Term Anticoagulation in Cancer Patients With Venous Thromboembolism", | "expansion" : "Comparison of Low Molecular Weight Heparin Versus Oral Anticoagulant Therapy for Long Term Anticoagulation in Cancer Patients With Venous Thromboembolism", | ||
| Line 567: | Line 574: | ||
"published" : "2003-07-10", | "published" : "2003-07-10", | ||
"pageName" : "CLOT", | "pageName" : "CLOT", | ||
"diseases" : "Deep Vein Thrombosis;Pulmonary Embolism;Venous Thromboembolism", | "diseases" : "Deep Vein Thrombosis;Pulmonary Embolism;Venous Thromboembolism", | ||
" | "abbreviation" : "CLOT", | ||
"title" : "Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer", | "title" : "Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer", | ||
"pmid" : "12853587" | |||
"pmid" : "12853587 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2012-06-20T01:47:52Z", | |||
"briefDesignDescription" : "PPI plus clopidogrel in CAD", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa1007964", | |||
"pageid" : 313, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa1007964", | |||
"trainingLevel" : "Resident", | |||
"citation" : "Bhatt DL, <i>et al</i>. \"Clopidogrel with or without omeprazole in coronary artery disease\". <i>The New England Journal of Medicine</i>. 2010. 363(20):1909-17.", | |||
"subspecialties" : "Cardiology", | "subspecialties" : "Cardiology", | ||
"expansion" : "Clopidogrel and the Optimization of Gastrointestinal Events Trial", | "expansion" : "Clopidogrel and the Optimization of Gastrointestinal Events Trial", | ||
| Line 585: | Line 592: | ||
"published" : "2010-11-11", | "published" : "2010-11-11", | ||
"pageName" : "COGENT", | "pageName" : "COGENT", | ||
"diseases" : "Coronary Artery Disease", | "diseases" : "Coronary Artery Disease", | ||
" | "abbreviation" : "COGENT", | ||
"title" : "Clopidogrel with or without omeprazole in coronary artery disease", | "title" : "Clopidogrel with or without omeprazole in coronary artery disease", | ||
"pmid" : "20925534" | |||
"pmid" : "20925534 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-07-19T09:42:35Z", | |||
"briefDesignDescription" : "Carvedilol vs. metoprolol in HF", | |||
"fulltexturl" : "http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(03)13800-7/fulltext", | |||
"pageid" : 121, | |||
"pdfurl" : "http://download.thelancet.com/pdfs/journals/lancet/PIIS0140673603138007.pdf", | |||
"trainingLevel" : "Resident", | |||
"citation" : "Poole-Wilson PA, <i>et al</i>. \"Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial\". <i>The Lancet</i>. 2003. 362(9377):7-13.", | |||
"subspecialties" : "Cardiology", | "subspecialties" : "Cardiology", | ||
"expansion" : "Carvedilol Or Metoprolol European Trial", | "expansion" : "Carvedilol Or Metoprolol European Trial", | ||
| Line 603: | Line 610: | ||
"published" : "2003-07-05", | "published" : "2003-07-05", | ||
"pageName" : "COMET", | "pageName" : "COMET", | ||
"diseases" : "Heart Failure", | "diseases" : "Heart Failure", | ||
"abbreviation" : "COMET", | "abbreviation" : "COMET", | ||
" | "title" : "Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial", | ||
"pmid" : "12853193" | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-06-30T15:36:17Z", | |||
"briefDesignDescription" : "Metoprolol in acute MI", | |||
"fulltexturl" : "http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(05)67661-1/fulltext", | |||
"pageid" : 1451, | |||
"pdfurl" : "http://download.thelancet.com/pdfs/journals/lancet/PIIS0140673605676611.pdf", | |||
"trainingLevel" : "Student", | |||
"citation" : "Chen ZM, <i>et al</i>. \"Early intravenous then oral metoprolol in 45 852 patients with acute myocardial infarction: randomised placebo-controlled trial\". <i>The Lancet</i>. 2005. 366(9497):1622-1632.", | |||
"subspecialties" : "Cardiology", | "subspecialties" : "Cardiology", | ||
"expansion" : "ClOpidogrel and Metoprolol in Myocardial Infarction Trial / Second Chinese Cardiac Study", | "expansion" : "ClOpidogrel and Metoprolol in Myocardial Infarction Trial / Second Chinese Cardiac Study", | ||
| Line 621: | Line 628: | ||
"published" : "2005-11-05", | "published" : "2005-11-05", | ||
"pageName" : "COMMIT", | "pageName" : "COMMIT", | ||
"diseases" : "Acute Coronary Syndrome;Myocardial Infarction", | "diseases" : "Acute Coronary Syndrome;Myocardial Infarction", | ||
" | "abbreviation" : "COMMIT/CCS-2", | ||
"title" : "Early intravenous then oral metoprolol in 45 852 patients with acute myocardial infarction: randomised placebo-controlled trial", | "title" : "Early intravenous then oral metoprolol in 45 852 patients with acute myocardial infarction: randomised placebo-controlled trial", | ||
"pmid" : "16271643" | |||
"pmid" : "16271643 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-03-12T08:07:27Z", | |||
"briefDesignDescription" : "Enalapril in severe HF", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJM198706043162301", | |||
"pageid" : 18, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJM198706043162301", | |||
"trainingLevel" : "Intern", | |||
"citation" : "CONSENSUS Trial Study Group. \"Effects of enalapril on mortality in severe congestive heart failure, results of the cooperative north Scandinavian enalapril survival study\". <i>The New England Journal of Medicine</i>. 1987. 316(23):1429-35.", | |||
"subspecialties" : "Cardiology", | "subspecialties" : "Cardiology", | ||
"expansion" : "Cooperative North Scandinavian Enalapril Survival Study", | "expansion" : "Cooperative North Scandinavian Enalapril Survival Study", | ||
| Line 639: | Line 646: | ||
"published" : "1987-06-04", | "published" : "1987-06-04", | ||
"pageName" : "CONSENSUS", | "pageName" : "CONSENSUS", | ||
"diseases" : "Heart Failure", | "diseases" : "Heart Failure", | ||
" | "abbreviation" : "CONSENSUS", | ||
"title" : "Effects of enalapril on mortality in severe congestive heart failure, results of the cooperative north Scandinavian enalapril survival study", | "title" : "Effects of enalapril on mortality in severe congestive heart failure, results of the cooperative north Scandinavian enalapril survival study", | ||
"pmid" : "2883575" | |||
"pmid" : "2883575 | |||
}, | }, | ||
{ | { | ||
"subspecialties" : "Cardiology", | "timestamp" : "2013-08-23T20:51:32Z", | ||
"expansion" : "Carvedilol Prospective Randomized Cumulative Survival", | "briefDesignDescription" : "Carvedilol in HF", | ||
"fulltexturl" : "http://circ.ahajournals.org/content/106/17/2194.full", | |||
"pageid" : 42, | |||
"pdfurl" : "http://circ.ahajournals.org/content/106/17/2194.full.pdf", | |||
"trainingLevel" : "Intern", | |||
"citation" : "Packer M, <i>et al</i>. \"Effect of Carvedilol on the Morbidity of Patients With Severe Chronic Heart Failure\". <i>Circulation</i>. 2002. 106(17):2194-9.", | |||
"subspecialties" : "Cardiology", | |||
"expansion" : "Carvedilol Prospective Randomized Cumulative Survival", | |||
"briefResultsDescription" : "Carvedilol reduces mortality and HF hospitalizations in severe NYHA class III-IV HF", | "briefResultsDescription" : "Carvedilol reduces mortality and HF hospitalizations in severe NYHA class III-IV HF", | ||
"published" : "2002-10-22", | "published" : "2002-10-22", | ||
"pageName" : "COPERNICUS", | "pageName" : "COPERNICUS", | ||
"diseases" : "Heart Failure", | "diseases" : "Heart Failure", | ||
" | "abbreviation" : "COPERNICUS", | ||
"title" : "Effect of Carvedilol on the Morbidity of Patients With Severe Chronic Heart Failure", | "title" : "Effect of Carvedilol on the Morbidity of Patients With Severe Chronic Heart Failure", | ||
"pmid" : "12390947" | |||
"pmid" : "12390947 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-05-07T14:56:04Z", | |||
"briefDesignDescription" : "Rosuvastatin in ischemic HF", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa0706201", | |||
"pageid" : 524, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa0706201", | |||
"trainingLevel" : "Resident", | |||
"citation" : "Kjekshus J, <i>et al</i>. \"Rosuvastatin in Older Patients with Systolic Heart Failure\". <i>The New England Journal of Medicine</i>. 2007. 357(22):2248-61.", | |||
"subspecialties" : "Cardiology", | "subspecialties" : "Cardiology", | ||
"expansion" : "Controlled Rosuvastatin Multinational Trial in Heart Failure", | "expansion" : "Controlled Rosuvastatin Multinational Trial in Heart Failure", | ||
| Line 675: | Line 682: | ||
"published" : "2007-11-29", | "published" : "2007-11-29", | ||
"pageName" : "CORONA", | "pageName" : "CORONA", | ||
"diseases" : "Heart Failure;Hyperlipidemia", | "diseases" : "Heart Failure;Hyperlipidemia", | ||
" | "abbreviation" : "CORONA", | ||
"title" : "Rosuvastatin in Older Patients with Systolic Heart Failure", | "title" : "Rosuvastatin in Older Patients with Systolic Heart Failure", | ||
"pmid" : "17984166" | |||
"pmid" : "17984166 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-06-05T11:13:34Z", | "timestamp" : "2013-06-05T11:13:34Z", | ||
"briefDesignDescription" : "Hydrocortisone in septic shock", | "briefDesignDescription" : "Hydrocortisone in septic shock", | ||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa071366", | "fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa071366", | ||
"pageid" : 4, | "pageid" : 4, | ||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa071366", | "pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa071366", | ||
"trainingLevel" : "Student", | "trainingLevel" : "Student", | ||
"citation" : "Sprung CL, <i>et al</i>. \"Hydrocortisone therapy for patients with septic shock\". <i>New England Journal of Medicine</i>. 2008. 358(2):111-24." | "citation" : "Sprung CL, <i>et al</i>. \"Hydrocortisone therapy for patients with septic shock\". <i>New England Journal of Medicine</i>. 2008. 358(2):111-24.", | ||
"subspecialties" : "Critical Care;Endocrinology", | |||
"expansion" : "Corticosteroid Therapy of Septic Shock", | |||
"briefResultsDescription" : "Improved survival of hydrocortisone in septic shock", | |||
"published" : "2008-01-10", | |||
"pageName" : "CORTICUS", | |||
"diseases" : "Sepsis;Shock", | |||
"abbreviation" : "CORTICUS", | |||
"title" : "Hydrocortisone therapy for patients with septic shock", | |||
"pmid" : "18184957" | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-06-21T13:11:38Z", | |||
"briefDesignDescription" : "PCI vs. medical therapy in CAD", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa070829", | |||
"pageid" : 21, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa070829", | |||
"trainingLevel" : "Student", | |||
"citation" : "Boden WE, <i>et al</i>. \"Optimal medical therapy with or without PCI for stable coronary disease\". <i>The New England Journal of Medicine</i>. 2007. 356:1503-16.", | |||
"subspecialties" : "Cardiology", | "subspecialties" : "Cardiology", | ||
"expansion" : "Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation", | "expansion" : "Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation", | ||
| Line 711: | Line 718: | ||
"published" : "2007-04-12", | "published" : "2007-04-12", | ||
"pageName" : "COURAGE", | "pageName" : "COURAGE", | ||
"diseases" : "Coronary Artery Disease", | "diseases" : "Coronary Artery Disease", | ||
" | "abbreviation" : "COURAGE", | ||
"title" : "Optimal medical therapy with or without PCI for stable coronary disease", | "title" : "Optimal medical therapy with or without PCI for stable coronary disease", | ||
"pmid" : "17387127" | |||
"pmid" : "17387127 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-08-31T18:14:13Z", | |||
"briefDesignDescription" : "Tranexamic acid in trauma", | |||
"fulltexturl" : "http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2810%2960835-5/fulltext", | |||
"pageid" : 490, | |||
"pdfurl" : "http://download.thelancet.com/pdfs/journals/lancet/PIIS0140673610608355.pdf", | |||
"trainingLevel" : "resident", | |||
"citation" : "Shakur H, <i>et al</i>. \"Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage\". <i>The Lancet</i>. 2010. 376(9734):23-32.", | |||
"subspecialties" : "Emergency Medicine;Surgery", | "subspecialties" : "Emergency Medicine;Surgery", | ||
"expansion" : "Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage 2", | "expansion" : "Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage 2", | ||
| Line 729: | Line 736: | ||
"published" : "2010-07-03", | "published" : "2010-07-03", | ||
"pageName" : "CRASH-2", | "pageName" : "CRASH-2", | ||
"diseases" : "Trauma", | "diseases" : "Trauma", | ||
" | "abbreviation" : "CRASH-2", | ||
"title" : "Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage", | "title" : "Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage", | ||
"pmid" : "20554319" | |||
"pmid" : "20554319 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-08-15T18:50:20Z", | |||
"briefDesignDescription" : "Stenting vs. CEA in carotid stenosis", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa0912321", | |||
"pageid" : 492, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa0912321", | |||
"trainingLevel" : "Intern", | |||
"citation" : "Brott TG, <i>et al</i>. \"Stenting versus Endarterectomy for Treatment of Carotid-Artery Stenosis\". <i>The New England Journal of Medicine</i>. 2010. 363(1):11-23.", | |||
"subspecialties" : "Surgery;Neurology;Cardiology", | "subspecialties" : "Surgery;Neurology;Cardiology", | ||
"expansion" : "Carotid Revascularization Endarterectomy vs. Stenting Trial", | "expansion" : "Carotid Revascularization Endarterectomy vs. Stenting Trial", | ||
| Line 747: | Line 754: | ||
"published" : "2010-07-01", | "published" : "2010-07-01", | ||
"pageName" : "CREST", | "pageName" : "CREST", | ||
"diseases" : "Carotid Stenosis;Stroke;Transient Ischemic Attack", | "diseases" : "Carotid Stenosis;Stroke;Transient Ischemic Attack", | ||
" | "abbreviation" : "CREST", | ||
"title" : "Stenting versus Endarterectomy for Treatment of Carotid-Artery Stenosis", | "title" : "Stenting versus Endarterectomy for Treatment of Carotid-Artery Stenosis", | ||
"pmid" : "20505173" | |||
"pmid" : "20505173 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-08-07T13:19:01Z", | |||
"briefDesignDescription" : "Captopril in T1DM nephropathy", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJM199311113292004", | |||
"pageid" : 1591, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJM199311113292004", | |||
"trainingLevel" : "Student", | |||
"citation" : "Lewis EJ, <i>et al</i>. \"The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group.\". <i>The New England Journal of Medicine</i>. 1993. 329(20):1456-1462.", | |||
"subspecialties" : "Nephrology;Endocrinology", | "subspecialties" : "Nephrology;Endocrinology", | ||
"expansion" : "Collaborative Study Group Captopril Trial", | "expansion" : "Collaborative Study Group Captopril Trial", | ||
| Line 765: | Line 772: | ||
"published" : "1993-11-11", | "published" : "1993-11-11", | ||
"pageName" : "CSG Captopril Trial", | "pageName" : "CSG Captopril Trial", | ||
"diseases" : "Diabetic Nephropathy;Diabetes Mellitus", | "diseases" : "Diabetic Nephropathy;Diabetes Mellitus", | ||
" | "abbreviation" : "CSG Captopril Trial", | ||
"title" : "The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group.", | "title" : "The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group.", | ||
"pmid" : "8413456" | |||
}, | |||
"pmid" : "8413456 | |||
}, | |||
{ | { | ||
"timestamp" : "2013-08-27T10:36:48Z", | |||
"briefDesignDescription" : "Clopidogrel in UA/NSTEMI", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa010746", | |||
"pageid" : 921, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa010746", | |||
"trainingLevel" : "Resident", | |||
"citation" : "Yusuf S, <i>et al</i>. \"Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment Elevation\". <i>The New England Journal of Medicine</i>. 2001. 345(7):494-502.", | |||
"subspecialties" : "Cardiology", | "subspecialties" : "Cardiology", | ||
"expansion" : "Clopidogrel in Unstable Angina to Prevent Recurrent Events", | "expansion" : "Clopidogrel in Unstable Angina to Prevent Recurrent Events", | ||
| Line 783: | Line 790: | ||
"published" : "2001-08-16", | "published" : "2001-08-16", | ||
"pageName" : "CURE", | "pageName" : "CURE", | ||
"diseases" : "Acute Coronary Syndrome", | "diseases" : "Acute Coronary Syndrome", | ||
" | "abbreviation" : "CURE", | ||
"title" : "Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment Elevation", | "title" : "Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment Elevation", | ||
"pmid" : "11519503" | |||
"pmid" : "11519503 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-09-30T22:37:35Z", | |||
"briefDesignDescription" : "Scheduled daily sedation holidays in intubated patients", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJM200005183422002", | |||
"pageid" : 1554, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJM200005183422002", | |||
"trainingLevel" : "Intern", | |||
"citation" : "Kress JP, <i>et al</i>. \"Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation\". <i>The New England Journal of Medicine</i>. 2000. 342(20):1471-1477.", | |||
"subspecialties" : "Critical Care;Pulmonology", | "subspecialties" : "Critical Care;Pulmonology", | ||
"expansion" : "", | "expansion" : "", | ||
| Line 801: | Line 808: | ||
"published" : "2000-05-18", | "published" : "2000-05-18", | ||
"pageName" : "Daily ICU Sedation Holidays", | "pageName" : "Daily ICU Sedation Holidays", | ||
"diseases" : "Respiratory Failure", | "diseases" : "Respiratory Failure", | ||
" | "abbreviation" : "", | ||
"title" : "Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation", | "title" : "Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation", | ||
"pmid" : "10816184" | |||
"pmid" : "10816184 | |||
}, | }, | ||
{ | { | ||
"subspecialties" : "Cardiology;Nephrology", | "timestamp" : "2013-04-04T11:30:00Z", | ||
"briefDesignDescription" : "DASH diet in HTN", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJM199704173361601", | |||
"pageid" : 90, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJM199704173361601", | |||
"trainingLevel" : "Student", | |||
"citation" : "Appel LJ, <i>et al</i>. \"A clinical trial of the effects of dietary patterns on blood pressure\". <i>The New England Journal of Medicine</i>. 1997. 336(16):1117-1124.", | |||
"subspecialties" : "Cardiology;Nephrology", | |||
"expansion" : "Dietary Approaches to Stop Hypertension", | "expansion" : "Dietary Approaches to Stop Hypertension", | ||
"briefResultsDescription" : "DASH diet reduces SBP and DBP", | "briefResultsDescription" : "DASH diet reduces SBP and DBP", | ||
"published" : "1997-04-17", | "published" : "1997-04-17", | ||
"pageName" : "DASH", | "pageName" : "DASH", | ||
"diseases" : "Hypertension", | "diseases" : "Hypertension", | ||
" | "abbreviation" : "DASH", | ||
"title" : "A clinical trial of the effects of dietary patterns on blood pressure", | "title" : "A clinical trial of the effects of dietary patterns on blood pressure", | ||
"pmid" : "9099655" | |||
"pmid" : "9099655 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2012-09-16T11:23:12Z", | |||
"briefDesignDescription" : "Intensive glycemic therapy in T1DM", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJM199309303291401", | |||
"pageid" : 135, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJM199309303291401", | |||
"trainingLevel" : "Student", | |||
"citation" : "DCCT Research Group. \"The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus\". <i>The New England Journal of Medicine</i>. 1993. 329(14):977-986.", | |||
"subspecialties" : "Endocrinology", | "subspecialties" : "Endocrinology", | ||
"expansion" : "Diabetes Control and Complications Trial", | "expansion" : "Diabetes Control and Complications Trial", | ||
| Line 837: | Line 844: | ||
"published" : "1993-09-30", | "published" : "1993-09-30", | ||
"pageName" : "DCCT", | "pageName" : "DCCT", | ||
"diseases" : "Diabetes Mellitus", | "diseases" : "Diabetes Mellitus", | ||
" | "abbreviation" : "DCCT", | ||
"title" : "The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus", | "title" : "The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus", | ||
"pmid" : "8366922" | |||
"pmid" : "8366922 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-03-12T08:13:55Z", | "timestamp" : "2013-03-12T08:13:55Z", | ||
"briefDesignDescription" : "ICD vs. medical therapy in HF", | "briefDesignDescription" : "ICD vs. medical therapy in HF", | ||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa033088", | "fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa033088", | ||
"pageid" : 84, | "pageid" : 84, | ||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa033088", | "pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa033088", | ||
"trainingLevel" : "Resident", | "trainingLevel" : "Resident", | ||
"citation" : "Kadish A, <i>et al</i>. \"Prophylactic Defibrillator Implantation in Patients with Nonischemic Dilated Cardiomyopathy\". <i>The New England Journal of Medicine</i>. 2004. 350(21):2151-2158." | "citation" : "Kadish A, <i>et al</i>. \"Prophylactic Defibrillator Implantation in Patients with Nonischemic Dilated Cardiomyopathy\". <i>The New England Journal of Medicine</i>. 2004. 350(21):2151-2158.", | ||
"subspecialties" : "Cardiology", | |||
"expansion" : "Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation", | |||
"briefResultsDescription" : "ICD reduced risk of arrhythmogenic sudden death, but not overall mortality", | |||
"published" : "2004-05-20", | |||
"pageName" : "DEFINITE", | |||
"diseases" : "Heart Failure", | |||
"abbreviation" : "DEFINITE", | |||
"title" : "Prophylactic Defibrillator Implantation in Patients with Nonischemic Dilated Cardiomyopathy", | |||
"pmid" : "15152060" | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-10-24T01:13:09Z", | |||
"briefDesignDescription" : "Digoxin in HF", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJM199702203360801", | |||
"pageid" : 89, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJM199702203360801", | |||
"trainingLevel" : "Resident", | |||
"citation" : "Gorlin R, <i>et al</i>. \"The effect of digoxin on mortality and morbidity in patients with heart failure\". <i>The New England Journal of Medicine</i>. 1997. 336(8):525-533.", | |||
"subspecialties" : "Cardiology", | "subspecialties" : "Cardiology", | ||
"expansion" : "Digitalis Investigation Group", | "expansion" : "Digitalis Investigation Group", | ||
| Line 873: | Line 880: | ||
"published" : "1997-02-20", | "published" : "1997-02-20", | ||
"pageName" : "DIG", | "pageName" : "DIG", | ||
"diseases" : "Heart Failure", | "diseases" : "Heart Failure", | ||
" | "abbreviation" : "DIG", | ||
"title" : "The effect of digoxin on mortality and morbidity in patients with heart failure", | "title" : "The effect of digoxin on mortality and morbidity in patients with heart failure", | ||
"pmid" : "9036306" | |||
"pmid" : "9036306 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-07-08T18:55:38Z", | |||
"briefDesignDescription" : "Diuretic dosing in acute HF", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa1005419", | |||
"pageid" : 1457, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa1005419", | |||
"trainingLevel" : "Intern", | |||
"citation" : "Felker GM, <i>et al</i>. \"Diuretic strategies in patients with acute decompensated heart failure\". <i>The New England Journal of Medicine</i>. 2011. 364(9):797-805.", | |||
"subspecialties" : "Cardiology", | "subspecialties" : "Cardiology", | ||
"expansion" : "Diuretic Optimization Strategies Evaluation", | "expansion" : "Diuretic Optimization Strategies Evaluation", | ||
| Line 891: | Line 898: | ||
"published" : "2011-03-03", | "published" : "2011-03-03", | ||
"pageName" : "DOSE", | "pageName" : "DOSE", | ||
"diseases" : "Heart Failure", | "diseases" : "Heart Failure", | ||
" | "abbreviation" : "DOSE", | ||
"title" : "Diuretic strategies in patients with acute decompensated heart failure", | "title" : "Diuretic strategies in patients with acute decompensated heart failure", | ||
"pmid" : "21366472" | |||
"pmid" : "21366472 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-07-29T21:18:41Z", | |||
"briefDesignDescription" : "Duct tape vs. cryotherapy for warts", | |||
"fulltexturl" : "", | |||
"pageid" : 1579, | |||
"pdfurl" : "http://archpedi.jamanetwork.com/data/Journals/PEDS/5052/POA20075.pdf", | |||
"trainingLevel" : "Student", | |||
"citation" : "Focht DR, <i>et al</i>. \"The efficacy of duct tape vs cryotherapy in the treatment of verruca vulgaris (the common wart)\". <i>Archives of Pediatric and Adolescent Medicine</i>. 2002. 156:971-974.", | |||
"subspecialties" : "Pediatrics;Dermatology", | "subspecialties" : "Pediatrics;Dermatology", | ||
"expansion" : "", | "expansion" : "", | ||
| Line 909: | Line 916: | ||
"published" : "2002-10-01", | "published" : "2002-10-01", | ||
"pageName" : "Duct Tape for Treatment of the Common Wart", | "pageName" : "Duct Tape for Treatment of the Common Wart", | ||
"diseases" : "Warts", | "diseases" : "Warts", | ||
" | "abbreviation" : "", | ||
"title" : "The efficacy of duct tape vs cryotherapy in the treatment of verruca vulgaris (the common wart)", | "title" : "The efficacy of duct tape vs cryotherapy in the treatment of verruca vulgaris (the common wart)", | ||
"pmid" : "12361440" | |||
"pmid" : "12361440 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-08-16T00:33:17Z", | |||
"briefDesignDescription" : "Palliative care in NSCLC", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa1000678", | |||
"pageid" : 466, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa1000678", | |||
"trainingLevel" : "Intern", | |||
"citation" : "Temel, JS <i>et al</i>. \"Early Palliative Care for Patients with Metastatic Non-Small-Cell Lung Cancer\". <i>The New England Journal of Medicine</i>. 2010. 363(8):733-742.", | |||
"subspecialties" : "Oncology;Palliative Care", | "subspecialties" : "Oncology;Palliative Care", | ||
"expansion" : null, | "expansion" : null, | ||
| Line 927: | Line 934: | ||
"published" : "2010-08-19", | "published" : "2010-08-19", | ||
"pageName" : "Early Palliative Care", | "pageName" : "Early Palliative Care", | ||
"diseases" : "Lung Cancer", | "diseases" : "Lung Cancer", | ||
" | "abbreviation" : null, | ||
"title" : "Early Palliative Care for Patients with Metastatic Non-Small-Cell Lung Cancer", | "title" : "Early Palliative Care for Patients with Metastatic Non-Small-Cell Lung Cancer", | ||
" | "pmid" : "20818875" | ||
" | }, | ||
" | { | ||
"timestamp" : "2013-06-17T12:56:29Z", | |||
"briefDesignDescription" : "Alteplase 3-4.5h after stroke", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa0804656", | |||
"pageid" : 115, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa0804656", | |||
"trainingLevel" : "Intern", | "trainingLevel" : "Intern", | ||
"citation" : " | "citation" : "Hacke W, <i>et al</i>. \"Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke\". <i>The New England Journal of Medicine</i>. 2008. 359(13):1317-1329.", | ||
"subspecialties" : "Neurology", | "subspecialties" : "Neurology", | ||
"expansion" : "European Cooperative Acute Stroke Study III", | "expansion" : "European Cooperative Acute Stroke Study III", | ||
| Line 945: | Line 952: | ||
"published" : "2008-09-25", | "published" : "2008-09-25", | ||
"pageName" : "ECASS III", | "pageName" : "ECASS III", | ||
"diseases" : "Stroke", | "diseases" : "Stroke", | ||
" | "abbreviation" : "ECASS III", | ||
"title" : "Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke", | "title" : "Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke", | ||
"pmid" : "18815396" | |||
"pmid" : "18815396 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-03-12T08:18:42Z", | |||
"briefDesignDescription" : "Intensive glycemic therapy in T1DM", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa052187", | |||
"pageid" : 136, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa052187", | |||
"trainingLevel" : "intern", | |||
"citation" : "Nathan DM, <i>et al</i>. \"Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes\". <i>The New England Journal of Medicine</i>. 2005. 353(25):2643-2653.", | |||
"subspecialties" : "Endocrinology", | "subspecialties" : "Endocrinology", | ||
"expansion" : "Epidemiology of Diabetes Interventions and Complications", | "expansion" : "Epidemiology of Diabetes Interventions and Complications", | ||
| Line 963: | Line 970: | ||
"published" : "2005-12-22", | "published" : "2005-12-22", | ||
"pageName" : "EDIC", | "pageName" : "EDIC", | ||
"diseases" : "Diabetes Mellitus", | "diseases" : "Diabetes Mellitus", | ||
" | "abbreviation" : "EDIC", | ||
"title" : "Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes", | "title" : "Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes", | ||
"pmid" : "16371630" | |||
"pmid" : "16371630 | |||
}, | }, | ||
{ | { | ||
"subspecialties" : "Hematology;Pulmonology", | "timestamp" : "2013-08-13T15:13:42Z", | ||
"briefDesignDescription" : "Rivaroxaban vs. warfarin in PE", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa1113572", | |||
"pageid" : 1519, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa1113572", | |||
"trainingLevel" : "Student", | |||
"citation" : "Büller HR, <i>et al</i>. \"Oral rivaroxaban for the treatment of symptomatic pulmonary embolism\". <i>The New England Journal of Medicine</i>. 2012. 366(14):1287-1297.", | |||
"subspecialties" : "Hematology;Pulmonology", | |||
"expansion" : "", | "expansion" : "", | ||
"briefResultsDescription" : "Rivaroxaban is noninferior to warfarin in PE treatment", | "briefResultsDescription" : "Rivaroxaban is noninferior to warfarin in PE treatment", | ||
"published" : "2012-04-05", | "published" : "2012-04-05", | ||
"pageName" : "EINSTEIN-PE", | "pageName" : "EINSTEIN-PE", | ||
"diseases" : "Pulmonary Embolism;Venous Thromboembolism", | "diseases" : "Pulmonary Embolism;Venous Thromboembolism", | ||
" | "abbreviation" : "EINSTEIN-PE", | ||
"title" : "Oral rivaroxaban for the treatment of symptomatic pulmonary embolism", | "title" : "Oral rivaroxaban for the treatment of symptomatic pulmonary embolism", | ||
"pmid" : "22449293" | |||
"pmid" : "22449293 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-06-27T17:49:25Z", | |||
"briefDesignDescription" : "T-DM1 in metastatic breast cancer", | |||
"fulltexturl" : "http://www.nejm.org/doi/abs/10.1056/NEJMoa1209124", | |||
"pageid" : 1257, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa1209124", | |||
"trainingLevel" : "fellow", | |||
"citation" : "Verma S, <i>et al</i>. \"Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer\". <i>The New England Journal of Medicine</i>. 2012. 367(19):1783-1791.", | |||
"subspecialties" : "Oncology", | "subspecialties" : "Oncology", | ||
"expansion" : "Emtansine vs. Capecitabine+Lapatinib in Patients with HER2-Positive Locally Advanced or Metastatic Breast Cancer", | "expansion" : "Emtansine vs. Capecitabine+Lapatinib in Patients with HER2-Positive Locally Advanced or Metastatic Breast Cancer", | ||
| Line 999: | Line 1,006: | ||
"published" : "2012-11-08", | "published" : "2012-11-08", | ||
"pageName" : "EMILIA", | "pageName" : "EMILIA", | ||
"diseases" : "Breast Cancer", | "diseases" : "Breast Cancer", | ||
" | "abbreviation" : "EMILIA", | ||
"title" : "Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer", | "title" : "Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer", | ||
"pmid" : "23020162" | |||
"pmid" : "23020162 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-06-06T18:39:48Z", | "timestamp" : "2013-06-06T18:39:48Z", | ||
"briefDesignDescription" : "Eplerenone in HF", | "briefDesignDescription" : "Eplerenone in HF", | ||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa1009492", | "fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa1009492", | ||
"pageid" : 120, | "pageid" : 120, | ||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa1009492", | "pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa1009492", | ||
"trainingLevel" : "Resident", | "trainingLevel" : "Resident", | ||
"citation" : "Zannad F, <i>et al</i>. \"Eplerenone in patients with systolic heart failure and mild symptoms\". <i>The New England Journal of Medicine</i>. 2011. 364(1):11-21." | "citation" : "Zannad F, <i>et al</i>. \"Eplerenone in patients with systolic heart failure and mild symptoms\". <i>The New England Journal of Medicine</i>. 2011. 364(1):11-21.", | ||
"subspecialties" : "Cardiology", | |||
"expansion" : "Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure", | |||
"briefResultsDescription" : "Eplerenone reduces CV deaths and CHF hospitalizations", | |||
"published" : "2011-01-06", | |||
"pageName" : "EMPHASIS-HF", | |||
"diseases" : "Heart Failure", | |||
"abbreviation" : "EMPHASIS-HF", | |||
"title" : "Eplerenone in patients with systolic heart failure and mild symptoms", | |||
"pmid" : "21073363" | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-06-30T15:36:36Z", | |||
"briefDesignDescription" : "Eplerenone post-MI with HF", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa030207", | |||
"pageid" : 16, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa030207", | |||
"trainingLevel" : "Resident", | |||
"citation" : "Pitt B, <i>et al</i>. \"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction\". <i>The New England Journal of Medicine</i>. 2003. 348(14):1309-21.", | |||
"subspecialties" : "Cardiology", | "subspecialties" : "Cardiology", | ||
"expansion" : "Eplerenone Post–Acute Myocardial Infarction Heart Failure Efficacy and Survival Study", | "expansion" : "Eplerenone Post–Acute Myocardial Infarction Heart Failure Efficacy and Survival Study", | ||
| Line 1,035: | Line 1,042: | ||
"published" : "2003-04-03", | "published" : "2003-04-03", | ||
"pageName" : "EPHESUS", | "pageName" : "EPHESUS", | ||
"diseases" : "Heart Failure;Acute Coronary Syndrome;Myocardial Infarction", | "diseases" : "Heart Failure;Acute Coronary Syndrome;Myocardial Infarction", | ||
" | "abbreviation" : "EPHESUS", | ||
"title" : "Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction", | "title" : "Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction", | ||
"pmid" : "12668699" | |||
"pmid" : "12668699 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-07-08T17:33:52Z", | |||
"briefDesignDescription" : "PA catheters in acute HF management", | |||
"fulltexturl" : null, | |||
"pageid" : 1407, | |||
"pdfurl" : "http://jama.jamanetwork.com/data/Journals/JAMA/4994/JOC50108.pdf", | |||
"trainingLevel" : "Resident", | |||
"citation" : "Binanay C, <i>et al</i>. \"Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness\". <i>JAMA</i>. 2005. 294(13):1625-1633.", | |||
"subspecialties" : "Cardiology;Critical Care", | "subspecialties" : "Cardiology;Critical Care", | ||
"expansion" : "Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness", | "expansion" : "Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness", | ||
| Line 1,053: | Line 1,060: | ||
"published" : "2005-10-05", | "published" : "2005-10-05", | ||
"pageName" : "ESCAPE", | "pageName" : "ESCAPE", | ||
"diseases" : "Heart Failure", | "diseases" : "Heart Failure", | ||
" | "abbreviation" : "ESCAPE", | ||
"title" : "Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness", | "title" : "Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness", | ||
"pmid" : "16204662" | |||
"pmid" : "16204662 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-05-26T11:06:34Z", | |||
"briefDesignDescription" : "LMWH vs. UFH in UA/NSTEMI", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJM199708143370702", | |||
"pageid" : 1443, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJM199708143370702", | |||
"trainingLevel" : "Intern", | |||
"citation" : "Cohen M, <i>et al</i>. \"A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Unstable Coronary Artery Disease\". <i>The New England Journal of Medicine</i>. 1997. 337(7):447-452.", | |||
"subspecialties" : "Cardiology", | "subspecialties" : "Cardiology", | ||
"expansion" : "Efficacy and Safety of Subcutaneous Enoxaparin in Non–Q-Wave Coronary Events Study Group", | "expansion" : "Efficacy and Safety of Subcutaneous Enoxaparin in Non–Q-Wave Coronary Events Study Group", | ||
| Line 1,071: | Line 1,078: | ||
"published" : "1997-08-14", | "published" : "1997-08-14", | ||
"pageName" : "ESSENCE", | "pageName" : "ESSENCE", | ||
"diseases" : "Acute Coronary Syndrome", | "diseases" : "Acute Coronary Syndrome", | ||
" | "abbreviation" : "ESSENCE", | ||
"title" : "A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Unstable Coronary Artery Disease", | "title" : "A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Unstable Coronary Artery Disease", | ||
"pmid" : "9250846" | |||
"pmid" : "9250846 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-03-12T08:23:06Z", | |||
"briefDesignDescription" : "Dexamethasone in meningitis", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa021334", | |||
"pageid" : 306, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa021334", | |||
"trainingLevel" : "Resident", | |||
"citation" : "de Gans JD, <i>et al</i>. \"Dexamethasone in Adults with Bacterial Meningitis\". <i>The New England Journal of Medicine</i>. 2002. 347(20):1549-1556.", | |||
"subspecialties" : "Infectious Disease;Neurology", | "subspecialties" : "Infectious Disease;Neurology", | ||
"expansion" : "European Dexamethasone Study", | "expansion" : "European Dexamethasone Study", | ||
| Line 1,089: | Line 1,096: | ||
"published" : "2002-11-14", | "published" : "2002-11-14", | ||
"pageName" : "European Dexamethasone Study", | "pageName" : "European Dexamethasone Study", | ||
"diseases" : "Meningitis", | "diseases" : "Meningitis", | ||
" | "abbreviation" : "EDS", | ||
"title" : "Dexamethasone in Adults with Bacterial Meningitis", | "title" : "Dexamethasone in Adults with Bacterial Meningitis", | ||
" | "pmid" : "12432041" | ||
"pdfurl" : "http:// | }, | ||
{ | |||
"timestamp" : "2013-06-19T14:58:18Z", | |||
"briefDesignDescription" : "Tolvaptan in HF", | |||
"fulltexturl" : null, | |||
"pageid" : 1345, | |||
"pdfurl" : "http://jama.jamanetwork.com/data/Journals/JAMA/5131/joc70029_1319_1331.pdf", | |||
"trainingLevel" : "Resident", | "trainingLevel" : "Resident", | ||
"citation" : " | "citation" : "Konstam MA, <i>et al</i>. \"The Effects of Oral Tolvaptan in Patients Hospitalized for Worsening Heart Failure\". <i>The Journal of the American Medical Association</i>. 2007. 297(12):1319-1331.", | ||
"subspecialties" : "Cardiology", | "subspecialties" : "Cardiology", | ||
"expansion" : "Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan", | "expansion" : "Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan", | ||
| Line 1,107: | Line 1,114: | ||
"published" : "2007-03-28", | "published" : "2007-03-28", | ||
"pageName" : "EVEREST-Outcomes", | "pageName" : "EVEREST-Outcomes", | ||
"diseases" : "Heart Failure", | "diseases" : "Heart Failure", | ||
" | "abbreviation" : "EVEREST", | ||
"title" : "The Effects of Oral Tolvaptan in Patients Hospitalized for Worsening Heart Failure", | "title" : "The Effects of Oral Tolvaptan in Patients Hospitalized for Worsening Heart Failure", | ||
"pmid" : "17384437" | |||
"pmid" : "17384437 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-10-13T17:30:50Z", | |||
"briefDesignDescription" : "Omalizumab in severe allergic asthma", | |||
"fulltexturl" : null, | |||
"pageid" : 1434, | |||
"pdfurl" : "http://annals.org/data/Journals/AIM/20231/0000605-201105030-00002.pdf", | |||
"trainingLevel" : "Fellow", | |||
"citation" : "Hanania, NA <i>et al</i>. \"Omalizumab in Severe Allergic Asthma Inadequately Controlled With Standard Therapy: A Randomized Trial\". <i>Annals of Internal Medicine</i>. 2011. 154(9):573-582.", | |||
"subspecialties" : "Allergy and Immunology;Pulmonology;Pediatrics", | "subspecialties" : "Allergy and Immunology;Pulmonology;Pediatrics", | ||
"expansion" : "A Study of Omalizumab/Xolair in Subjects With Moderate to Severe Persistent Asthma", | "expansion" : "A Study of Omalizumab/Xolair in Subjects With Moderate to Severe Persistent Asthma", | ||
| Line 1,125: | Line 1,132: | ||
"published" : "2011-05-03", | "published" : "2011-05-03", | ||
"pageName" : "EXTRA", | "pageName" : "EXTRA", | ||
"diseases" : "Asthma", | "diseases" : "Asthma", | ||
" | "abbreviation" : "EXTRA", | ||
"title" : "Omalizumab in Severe Allergic Asthma Inadequately Controlled With Standard Therapy: A Randomized Trial", | "title" : "Omalizumab in Severe Allergic Asthma Inadequately Controlled With Standard Therapy: A Randomized Trial", | ||
"pmid" : "21536936" | |||
"pmid" : "21536936 | |||
}, | }, | ||
{ | { | ||
"subspecialties" : "Critical Care", | "timestamp" : "2013-06-18T14:58:27Z", | ||
"briefDesignDescription" : "Fluid management in ARDS", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa062200", | |||
"pageid" : 24, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa062200", | |||
"trainingLevel" : "Resident\n}}", | |||
"citation" : "Wiedemann HP, <i>et al</i>. \"Comparison of two fluid-management strategies in acute lung injury\". <i>The New England Journal of Medicine</i>. 2006. 354(24):2564-75.", | |||
"subspecialties" : "Critical Care", | |||
"expansion" : "Fluids and Catheters Treatment Trial", | "expansion" : "Fluids and Catheters Treatment Trial", | ||
"briefResultsDescription" : "Mortality benefit of conservative fluid management in ALI/ARDS", | "briefResultsDescription" : "Mortality benefit of conservative fluid management in ALI/ARDS", | ||
"published" : "2006-06-15", | "published" : "2006-06-15", | ||
"pageName" : "FACTT", | "pageName" : "FACTT", | ||
"diseases" : "Acute Respiratory Distress Syndrome", | "diseases" : "Acute Respiratory Distress Syndrome", | ||
" | "abbreviation" : "FACTT", | ||
"title" : "Comparison of two fluid-management strategies in acute lung injury", | "title" : "Comparison of two fluid-management strategies in acute lung injury", | ||
"pmid" : "16714767" | |||
"pmid" : "16714767 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-02-20T06:44:13Z", | |||
"briefDesignDescription" : "FFR-guided PCI in stable CAD", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa0807611", | |||
"pageid" : 998, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa0807611", | |||
"trainingLevel" : "resident", | |||
"citation" : "Tonino PAL, <i>et al</i>. \"Fractional Flow Reserve versus Angiography for Guiding Percutaneous Coronary Intervention\". <i>The New England Journal of Medicine</i>. 2009. 360(3):213-224.", | |||
"subspecialties" : "Cardiology", | "subspecialties" : "Cardiology", | ||
"expansion" : "Fractional Flow Reserve versus Angiography for Multivessel Evaluation", | "expansion" : "Fractional Flow Reserve versus Angiography for Multivessel Evaluation", | ||
| Line 1,161: | Line 1,168: | ||
"published" : "2009-01-15", | "published" : "2009-01-15", | ||
"pageName" : "FAME", | "pageName" : "FAME", | ||
"diseases" : "Coronary Artery Disease", | "diseases" : "Coronary Artery Disease", | ||
" | "abbreviation" : "FAME", | ||
"title" : "Fractional Flow Reserve versus Angiography for Guiding Percutaneous Coronary Intervention", | "title" : "Fractional Flow Reserve versus Angiography for Guiding Percutaneous Coronary Intervention", | ||
"pmid" : "19144937" | |||
"pmid" : "19144937 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-08-21T13:47:09Z", | "timestamp" : "2013-08-21T13:47:09Z", | ||
"briefDesignDescription" : "FFR-guided PCI vs. OMT in CAD", | "briefDesignDescription" : "FFR-guided PCI vs. OMT in CAD", | ||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa1205361", | "fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa1205361", | ||
"pageid" : 1003, | "pageid" : 1003, | ||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa1205361", | "pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa1205361", | ||
"trainingLevel" : "Resident", | "trainingLevel" : "Resident", | ||
"citation" : "De Bruyne B, <i>et al</i>. \"Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease\". <i>The New England Journal of Medicine</i>. 2012. 367(11):991-1001." | "citation" : "De Bruyne B, <i>et al</i>. \"Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease\". <i>The New England Journal of Medicine</i>. 2012. 367(11):991-1001.", | ||
"subspecialties" : "Cardiology", | |||
"expansion" : "FFR vs. Angiographyfor Multivessel Evaluation 2", | |||
"briefResultsDescription" : "FFR-guided PCI reduces urgent revascularization", | |||
"published" : "2012-09-13", | |||
"pageName" : "FAME 2", | |||
"diseases" : "Coronary Artery Disease", | |||
"abbreviation" : "FAME 2", | |||
"title" : "Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease", | |||
"pmid" : "22924638" | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-10-07T20:50:13Z", | |||
"briefDesignDescription" : "Fidaxomicin in C. difficile", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa0910812", | |||
"pageid" : 255, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa0910812", | |||
"trainingLevel" : "Resident", | |||
"citation" : "Louie TJ, <i>et al</i>. \"Fidaxomicin versus Vancomycin for Clostridium difficile Infection\". <i>The New England Journal of Medicine</i>. 2011. 365(5):422-431.", | |||
"subspecialties" : "Infectious Disease;Gastroenterology", | "subspecialties" : "Infectious Disease;Gastroenterology", | ||
"expansion" : null, | "expansion" : null, | ||
| Line 1,197: | Line 1,204: | ||
"published" : "2011-02-03", | "published" : "2011-02-03", | ||
"pageName" : "Fidaxomicin in C. difficile Diarrhea", | "pageName" : "Fidaxomicin in C. difficile Diarrhea", | ||
"diseases" : "Clostridium difficile", | "diseases" : "Clostridium difficile", | ||
" | "abbreviation" : null, | ||
"title" : "Fidaxomicin versus Vancomycin for Clostridium difficile Infection", | "title" : "Fidaxomicin versus Vancomycin for Clostridium difficile Infection", | ||
"pmid" : "21288078" | |||
"pmid" : "21288078 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-10-05T21:06:06Z", | |||
"briefDesignDescription" : "Risk factors for GI bleeds in ICU patients", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJM199402103300601", | |||
"pageid" : 391, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJM199402103300601", | |||
"trainingLevel" : "Intern", | |||
"citation" : "Cook DJ, <i>et al</i>. \"Risk factors for gastrointestinal bleeding in critically ill patients\". <i>The New England Journal of Medicine</i>. 1994. 330(6):337-381.", | |||
"subspecialties" : "Critical Care;Gastroenterology", | "subspecialties" : "Critical Care;Gastroenterology", | ||
"expansion" : null, | "expansion" : null, | ||
| Line 1,215: | Line 1,222: | ||
"published" : "1994-02-10", | "published" : "1994-02-10", | ||
"pageName" : "GI bleeding in ICU patients", | "pageName" : "GI bleeding in ICU patients", | ||
"diseases" : "Gastrointestinal Hemorrhage", | "diseases" : "Gastrointestinal Hemorrhage", | ||
" | "abbreviation" : null, | ||
"title" : "Risk factors for gastrointestinal bleeding in critically ill patients", | "title" : "Risk factors for gastrointestinal bleeding in critically ill patients", | ||
"pmid" : "8284001" | |||
"pmid" : "8284001 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-06-30T15:37:01Z", | |||
"briefDesignDescription" : "Lisinopril in acute MI", | |||
"fulltexturl" : "http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2894%2990232-1/abstract", | |||
"pageid" : 258, | |||
"pdfurl" : "", | |||
"trainingLevel" : "Resident", | |||
"citation" : "GISSI-3 Group. \"Effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction\". <i>The Lancet</i>. 1994. 343(8906):1115-22.", | |||
"subspecialties" : "Cardiology", | "subspecialties" : "Cardiology", | ||
"expansion" : "Gruppo Italiano per lo Studio della Sopravvivenza nell'infarto Miocardico", | "expansion" : "Gruppo Italiano per lo Studio della Sopravvivenza nell'infarto Miocardico", | ||
| Line 1,233: | Line 1,240: | ||
"published" : "1994-05-07", | "published" : "1994-05-07", | ||
"pageName" : "GISSI-3", | "pageName" : "GISSI-3", | ||
"diseases" : "Acute Coronary Syndrome;Heart Failure;Myocardial Infarction", | "diseases" : "Acute Coronary Syndrome;Heart Failure;Myocardial Infarction", | ||
" | "abbreviation" : "GISSI-3", | ||
"title" : "Effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction", | "title" : "Effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction", | ||
"pmid" : "7910229" | |||
"pmid" : "7910229 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-04-13T07:41:04Z", | |||
"briefDesignDescription" : "Hypothermia for cardiac arrest", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/nejmoa012689", | |||
"pageid" : 410, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/nejmoa012689", | |||
"trainingLevel" : "Resident", | |||
"citation" : "Holzer M, <i>et al</i>. \"Mild Therapeutic Hypothermia to Improve the Neurologic Outcome After Cardiac Arrest\". <i>The New England Journal of Medicine</i>. 2002. 346(8):549-556.", | |||
"subspecialties" : "Critical Care;Neurology;Cardiology", | "subspecialties" : "Critical Care;Neurology;Cardiology", | ||
"expansion" : "Hypothermia After Cardiac Arrest", | "expansion" : "Hypothermia After Cardiac Arrest", | ||
| Line 1,251: | Line 1,258: | ||
"published" : "2002-02-21", | "published" : "2002-02-21", | ||
"pageName" : "HACA", | "pageName" : "HACA", | ||
"diseases" : "Cardiac Arrest", | "diseases" : "Cardiac Arrest", | ||
" | "abbreviation" : "HACA", | ||
"title" : "Mild Therapeutic Hypothermia to Improve the Neurologic Outcome After Cardiac Arrest", | "title" : "Mild Therapeutic Hypothermia to Improve the Neurologic Outcome After Cardiac Arrest", | ||
" | "pmid" : "11856793" | ||
" | }, | ||
" | { | ||
"timestamp" : "2013-10-09T17:11:02Z", | |||
"briefDesignDescription" : "Trastuzumab in breast cancer", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa052306", | |||
"pageid" : 440, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa052306", | |||
"trainingLevel" : "Resident", | "trainingLevel" : "Resident", | ||
"citation" : " | "citation" : "Piccart-Gebhart MJ, <i>et al</i>. \"Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer\". <i>The New England Journal of Medicine</i>. 2005. 353(16):1659-72.", | ||
"subspecialties" : "Oncology", | "subspecialties" : "Oncology", | ||
"expansion" : "Herceptin Adjuvant Trial", | "expansion" : "Herceptin Adjuvant Trial", | ||
| Line 1,269: | Line 1,276: | ||
"published" : "2005-10-20", | "published" : "2005-10-20", | ||
"pageName" : "HERA", | "pageName" : "HERA", | ||
"diseases" : "Breast Cancer", | "diseases" : "Breast Cancer", | ||
" | "abbreviation" : "HERA", | ||
"title" : "Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer", | "title" : "Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer", | ||
"pmid" : "16236737" | |||
"pmid" : "16236737 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-08-15T18:50:04Z", | |||
"briefDesignDescription" : "Ramipril in patients with high CV risk", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJM200001203420301", | |||
"pageid" : 1165, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJM200001203420301", | |||
"trainingLevel" : "intern", | |||
"citation" : "Yusuf S, <i>et al</i>. \"Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients\". <i>The New England Journal of Medicine</i>. 2000. 342(3):145-153.", | |||
"subspecialties" : "Cardiology;Neurology", | "subspecialties" : "Cardiology;Neurology", | ||
"expansion" : "Heart Outcomes Prevention Evaluation", | "expansion" : "Heart Outcomes Prevention Evaluation", | ||
| Line 1,287: | Line 1,294: | ||
"published" : "2000-01-20", | "published" : "2000-01-20", | ||
"pageName" : "HOPE", | "pageName" : "HOPE", | ||
"diseases" : "Coronary Artery Disease;Stroke;Transient Ischemic Attack", | "diseases" : "Coronary Artery Disease;Stroke;Transient Ischemic Attack", | ||
" | "abbreviation" : "HOPE", | ||
"title" : "Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients", | "title" : "Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients", | ||
"pmid" : "10639539" | |||
"pmid" : "10639539 | |||
}, | }, | ||
{ | { | ||
"subspecialties" : "Infectious Disease", | "timestamp" : "2013-03-05T21:36:12Z", | ||
"briefDesignDescription" : "Early ART in HIV", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa1105243", | |||
"pageid" : 1010, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa1105243", | |||
"trainingLevel" : "Resident", | |||
"citation" : "Cohen MS, <i>et al</i>. \"Prevention of HIV-1 Infection with Early Antiretroviral Therapy\". <i>The New England Journal of Medicine</i>. 2011. 365(6):493-505.", | |||
"subspecialties" : "Infectious Disease", | |||
"expansion" : "HIV Prevention Trials Network 052 Study", | "expansion" : "HIV Prevention Trials Network 052 Study", | ||
"briefResultsDescription" : "Reduced morbidity and HIV transmission", | "briefResultsDescription" : "Reduced morbidity and HIV transmission", | ||
"published" : "2011-08-11", | "published" : "2011-08-11", | ||
"pageName" : "HPTN 052", | "pageName" : "HPTN 052", | ||
"diseases" : "HIV", | "diseases" : "HIV", | ||
" | "abbreviation" : "HPTN 052", | ||
"title" : "Prevention of HIV-1 Infection with Early Antiretroviral Therapy", | "title" : "Prevention of HIV-1 Infection with Early Antiretroviral Therapy", | ||
"pmid" : "21767103" | |||
"pmid" : "21767103 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-07-08T18:55:53Z", | |||
"briefDesignDescription" : "IABP in MI and cardiogenic shock", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa1208410", | |||
"pageid" : 1065, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa1208410", | |||
"trainingLevel" : "Fellow", | |||
"citation" : "Thiele H, <i>et al</i>. \"Intraaortic Balloon Support for Myocardial Infarction with Cardiogenic Shock\". <i>The New England Journal of Medicine</i>. 2012. 367(14):1287-1296.", | |||
"subspecialties" : "Cardiology;Critical Care", | "subspecialties" : "Cardiology;Critical Care", | ||
"expansion" : "Intraaortic Balloon Pump in Cardiogenic Shock II", | "expansion" : "Intraaortic Balloon Pump in Cardiogenic Shock II", | ||
| Line 1,323: | Line 1,330: | ||
"published" : "2012-10-10", | "published" : "2012-10-10", | ||
"pageName" : "IABP-SHOCK II", | "pageName" : "IABP-SHOCK II", | ||
"diseases" : "Acute Coronary Syndrome;Heart Failure;Shock;Myocardial Infarction", | "diseases" : "Acute Coronary Syndrome;Heart Failure;Shock;Myocardial Infarction", | ||
" | "abbreviation" : "IABP-SHOCK II", | ||
"title" : "Intraaortic Balloon Support for Myocardial Infarction with Cardiogenic Shock", | "title" : "Intraaortic Balloon Support for Myocardial Infarction with Cardiogenic Shock", | ||
"pmid" : "22920912" | |||
"pmid" : "22920912 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-03-05T21:36:40Z", | "timestamp" : "2013-03-05T21:36:40Z", | ||
"briefDesignDescription" : "Early vs. late dialysis in CKD", | "briefDesignDescription" : "Early vs. late dialysis in CKD", | ||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa1000552", | "fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa1000552", | ||
"pageid" : 1020, | "pageid" : 1020, | ||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa1000552", | "pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa1000552", | ||
"trainingLevel" : "Resident", | "trainingLevel" : "Resident", | ||
"citation" : "Cooper BA, <i>et al</i>. \"A Randomized, Controlled Trial of Early versus Late Initiation of Dialysis\". <i>The New England Journal of Medicine</i>. 2010. 363(7):609-619." | "citation" : "Cooper BA, <i>et al</i>. \"A Randomized, Controlled Trial of Early versus Late Initiation of Dialysis\". <i>The New England Journal of Medicine</i>. 2010. 363(7):609-619.", | ||
"subspecialties" : "Nephrology", | |||
"expansion" : "Initiating Dialysis Early and Late", | |||
"briefResultsDescription" : "No difference in survival or clinical outcomes", | |||
"published" : "2010-08-12", | |||
"pageName" : "IDEAL", | |||
"diseases" : "Chronic Kidney Disease", | |||
"abbreviation" : "IDEAL", | |||
"title" : "A Randomized, Controlled Trial of Early versus Late Initiation of Dialysis", | |||
"pmid" : "20581422" | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-09-26T11:10:32Z", | |||
"briefDesignDescription" : "ART in primary HIV prevention", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa1011205", | |||
"pageid" : 1100, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa1011205", | |||
"trainingLevel" : "intern", | |||
"citation" : "Grant RM, <i>et al</i>. \"Preexposure chemoprophylaxis for HIV prevention in men who have sex with men\". <i>The New England Journal of Medicine</i>. 2010. 363(27):2587-2599.", | |||
"subspecialties" : "Infectious Disease", | "subspecialties" : "Infectious Disease", | ||
"expansion" : "Iniciativa Profilaxis Pre Exposicion (\"Preexposure Prophylaxis Initiative\")", | "expansion" : "Iniciativa Profilaxis Pre Exposicion (\"Preexposure Prophylaxis Initiative\")", | ||
| Line 1,359: | Line 1,366: | ||
"published" : "2010-12-30", | "published" : "2010-12-30", | ||
"pageName" : "IPrEx", | "pageName" : "IPrEx", | ||
"diseases" : "HIV", | "diseases" : "HIV", | ||
" | "abbreviation" : "iPrEx", | ||
"title" : "Preexposure chemoprophylaxis for HIV prevention in men who have sex with men", | "title" : "Preexposure chemoprophylaxis for HIV prevention in men who have sex with men", | ||
"pmid" : "21091279" | |||
"pmid" : "21091279 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-08-07T13:43:06Z", | |||
"briefDesignDescription" : "Imatinib vs. IFNα/cytarabine in CML", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa022457", | |||
"pageid" : 1076, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa022457", | |||
"trainingLevel" : "Student", | |||
"citation" : "O'Brien SG, <i>et al</i>. \"Imatinib Compared with Interferon and Low-Dose Cytarabine for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia\". <i>The New England Journal of Medicine</i>. 2003. 384(11):994-1004.", | |||
"subspecialties" : "Hematology;Oncology", | "subspecialties" : "Hematology;Oncology", | ||
"expansion" : "International Randomized Study of Interferon and STI571", | "expansion" : "International Randomized Study of Interferon and STI571", | ||
| Line 1,377: | Line 1,384: | ||
"published" : "2003-03-13", | "published" : "2003-03-13", | ||
"pageName" : "IRIS", | "pageName" : "IRIS", | ||
"diseases" : "Chronic Myeloid Leukemia", | "diseases" : "Chronic Myeloid Leukemia", | ||
" | "abbreviation" : "IRIS", | ||
"title" : "Imatinib Compared with Interferon and Low-Dose Cytarabine for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia", | "title" : "Imatinib Compared with Interferon and Low-Dose Cytarabine for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia", | ||
"pmid" : "12637609" | |||
"pmid" : "12637609 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-06-30T15:37:36Z", | |||
"briefDesignDescription" : "Aspirin ± streptokinase in acute MI", | |||
"fulltexturl" : "http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(88)92833-4/abstract", | |||
"pageid" : 133, | |||
"pdfurl" : "", | |||
"trainingLevel" : "Resident", | |||
"citation" : "ISIS-2 Collaborative Group. \"Randomised Trial of Intravenous Streptokinase, Oral Aspirin, Both, or Neither among 17187 Cases of Suspected Acute Myocardial Infarction\". <i>The Lancet</i>. 1988. 332(8607):349-360.", | |||
"subspecialties" : "Cardiology", | "subspecialties" : "Cardiology", | ||
"expansion" : "Second International Study of Infarct Survival", | "expansion" : "Second International Study of Infarct Survival", | ||
| Line 1,395: | Line 1,402: | ||
"published" : "1988-08-13", | "published" : "1988-08-13", | ||
"pageName" : "ISIS-2", | "pageName" : "ISIS-2", | ||
"diseases" : "Acute Coronary Syndrome;Myocardial Infarction", | "diseases" : "Acute Coronary Syndrome;Myocardial Infarction", | ||
" | "abbreviation" : "ISIS-2", | ||
"title" : "Randomised Trial of Intravenous Streptokinase, Oral Aspirin, Both, or Neither among 17187 Cases of Suspected Acute Myocardial Infarction", | "title" : "Randomised Trial of Intravenous Streptokinase, Oral Aspirin, Both, or Neither among 17187 Cases of Suspected Acute Myocardial Infarction", | ||
"pmid" : "2899772" | |||
"pmid" : "2899772 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-03-23T23:33:42Z", | |||
"briefDesignDescription" : "Aspirin in acute ischemic stroke", | |||
"fulltexturl" : "http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(97)04011-7/fulltext", | |||
"pageid" : 132, | |||
"pdfurl" : "http://download.thelancet.com/pdfs/journals/lancet/PIIS0140673697040117.pdf", | |||
"trainingLevel" : "Intern", | |||
"citation" : "IST Collaborative Group. \"The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke\". <i>The Lancet</i>. 1997. 349(9065):1569-1581.", | |||
"subspecialties" : "Neurology", | "subspecialties" : "Neurology", | ||
"expansion" : "International Stroke Trial", | "expansion" : "International Stroke Trial", | ||
| Line 1,413: | Line 1,420: | ||
"published" : "1997-05-31", | "published" : "1997-05-31", | ||
"pageName" : "IST", | "pageName" : "IST", | ||
"diseases" : "Stroke", | "diseases" : "Stroke", | ||
" | "abbreviation" : "IST", | ||
"title" : "The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke", | "title" : "The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke", | ||
"pmid" : "9174558" | |||
}, | |||
"pmid" : "9174558 | |||
}, | |||
{ | { | ||
"timestamp" : "2013-08-15T18:49:48Z", | |||
"briefDesignDescription" : "Rosuvastatin for primary CV prevention", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa0807646", | |||
"pageid" : 445, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa0807646", | |||
"trainingLevel" : "resident", | |||
"citation" : "Ridker PM, <i>et al</i>. \"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein\". <i>The New England Journal of Medicine</i>. 2008. 359(21):2195-2207.", | |||
"subspecialties" : "Cardiology", | "subspecialties" : "Cardiology", | ||
"expansion" : "Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin", | "expansion" : "Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin", | ||
| Line 1,431: | Line 1,438: | ||
"published" : "2008-11-20", | "published" : "2008-11-20", | ||
"pageName" : "JUPITER", | "pageName" : "JUPITER", | ||
"diseases" : "Hyperlipidemia;Coronary Artery Disease;Stroke;Transient Ischemic Attack", | "diseases" : "Hyperlipidemia;Coronary Artery Disease;Stroke;Transient Ischemic Attack", | ||
" | "abbreviation" : "JUPITER", | ||
"title" : "Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein", | "title" : "Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein", | ||
"pmid" : "18997196" | |||
"pmid" : "18997196 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-07-07T09:48:01Z", | |||
"briefDesignDescription" : "Intensive glycemic therapy in SICU", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa011300", | |||
"pageid" : 139, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa011300", | |||
"trainingLevel" : "Resident", | |||
"citation" : "Van den Berghe G, <i>et al</i>. \"Intensive Insulin Therapy in Critically Ill Patients\". <i>The New England Journal of Medicine</i>. 2001. 345(19):1359-1367.", | |||
"subspecialties" : "Critical Care;Endocrinology", | "subspecialties" : "Critical Care;Endocrinology", | ||
"expansion" : "", | "expansion" : "", | ||
| Line 1,449: | Line 1,456: | ||
"published" : "2001-11-08", | "published" : "2001-11-08", | ||
"pageName" : "Leuven Surgical Trial", | "pageName" : "Leuven Surgical Trial", | ||
"diseases" : "Stress Hyperglycemia", | "diseases" : "Stress Hyperglycemia", | ||
" | "abbreviation" : "Leuven Surgical Trial", | ||
"title" : "Intensive Insulin Therapy in Critically Ill Patients", | "title" : "Intensive Insulin Therapy in Critically Ill Patients", | ||
"pmid" : "11794168" | |||
"pmid" : "11794168 | |||
}, | }, | ||
{ | { | ||
"subspecialties" : "Cardiology", | "timestamp" : "2013-10-20T05:06:48Z", | ||
"briefDesignDescription" : "Colchicine for stable CAD", | |||
"fulltexturl" : "http://www.sciencedirect.com/science/article/pii/S0735109712054782", | |||
"pageid" : 1583, | |||
"pdfurl" : null, | |||
"trainingLevel" : "Resident\n}}\n<!-- \nThe journal website has an equal sign as part of the URL, have to leave the sciencedirect version up for now until we can get the equal sign to be handled by our bot: http://content.onlinejacc.org/article.aspx?articleid", | |||
"citation" : "Nidorf SM, <i>et al</i>. \"Low-dose colchicine for secondary prevention of cardiovascular disease\". <i>Journal of the American College of Cardiology</i>. 2013. 61(4):404-410.", | |||
"subspecialties" : "Cardiology", | |||
"expansion" : "Low-Dose Colchicine", | "expansion" : "Low-Dose Colchicine", | ||
"briefResultsDescription" : "Colcicine may reduce complications in stable CAD", | "briefResultsDescription" : "Colcicine may reduce complications in stable CAD", | ||
"published" : "2013-01-29", | "published" : "2013-01-29", | ||
"pageName" : "LoDoCo", | "pageName" : "LoDoCo", | ||
"diseases" : "Coronary Artery Disease", | "diseases" : "Coronary Artery Disease", | ||
" | "abbreviation" : "LoDoCo", | ||
"title" : "Low-dose colchicine for secondary prevention of cardiovascular disease", | "title" : "Low-dose colchicine for secondary prevention of cardiovascular disease", | ||
"pmid" : "23265346" | |||
"pmid" : "23265346 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-09-18T11:13:42Z", | |||
"briefDesignDescription" : "Weight loss and exercise in T2DM", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa1212914", | |||
"pageid" : 1546, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa1212914", | |||
"trainingLevel" : "Intern", | |||
"citation" : "Wing RR, <i>et al</i>. \"Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes\". <i>The New England Journal of Medicine</i>. 2013. 369(2):145-154.", | |||
"subspecialties" : "Endocrinology;Cardiology", | "subspecialties" : "Endocrinology;Cardiology", | ||
"expansion" : "Look Action for HEAlth in Diabetes", | "expansion" : "Look Action for HEAlth in Diabetes", | ||
| Line 1,485: | Line 1,492: | ||
"published" : "2013-07-11", | "published" : "2013-07-11", | ||
"pageName" : "Look AHEAD", | "pageName" : "Look AHEAD", | ||
"diseases" : "Diabetes Mellitus;Cardiovascular Disease", | "diseases" : "Diabetes Mellitus;Cardiovascular Disease", | ||
" | "abbreviation" : "Look AHEAD", | ||
"title" : "Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes", | "title" : "Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes", | ||
"pmid" : "23796131" | |||
"pmid" : "23796131 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-07-04T09:24:31Z", | "timestamp" : "2013-07-04T09:24:31Z", | ||
"briefDesignDescription" : "ICD in post-MI patients with HF", | "briefDesignDescription" : "ICD in post-MI patients with HF", | ||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa013474", | "fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa013474", | ||
"pageid" : 385, | "pageid" : 385, | ||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa013474", | "pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa013474", | ||
"trainingLevel" : "Resident", | "trainingLevel" : "Resident", | ||
"citation" : "Moss AJ, <i>et al</i>. \"Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection Fraction\". <i>The New England Journal of Medicine</i>. 2002. 346(12):877-883." | "citation" : "Moss AJ, <i>et al</i>. \"Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection Fraction\". <i>The New England Journal of Medicine</i>. 2002. 346(12):877-883.", | ||
"subspecialties" : "Cardiology", | |||
"expansion" : "Multicenter Automatic Defibrillator Implantation Trial II", | |||
"briefResultsDescription" : "ICD improves survival in post-MI patients with LVEF≤30%", | |||
"published" : "2002-03-21", | |||
"pageName" : "MADIT-II", | |||
"diseases" : "Heart Failure;Acute Coronary Syndrome;Myocardial Infarction", | |||
"abbreviation" : "MADIT-II", | |||
"title" : "Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection Fraction", | |||
"pmid" : "11907286" | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-11-21T21:03:58Z", | |||
"briefDesignDescription" : "Rivaroxaban vs. LMWH for VTE prophylaxis", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa1111096", | |||
"pageid" : 1272, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa1111096", | |||
"trainingLevel" : "Resident\n}}", | |||
"citation" : "Cohen AT, <i>et al</i>. \"Rivaroxaban for thromboprophylaxis in acutely ill medical patients\". <i>The New England Journal of Medicine</i>. 2013. 368(6):513-523.", | |||
"subspecialties" : "Hematology", | "subspecialties" : "Hematology", | ||
"expansion" : "Multicenter, Randomized, Parallel Group Efficacy and Safety Study for the Prevention of Venous Thromboembolism in Hospitalized Acutely Ill Medical Patients Comparing Rivaroxaban with Enoxaparin", | "expansion" : "Multicenter, Randomized, Parallel Group Efficacy and Safety Study for the Prevention of Venous Thromboembolism in Hospitalized Acutely Ill Medical Patients Comparing Rivaroxaban with Enoxaparin", | ||
| Line 1,521: | Line 1,528: | ||
"published" : "2013-02-07", | "published" : "2013-02-07", | ||
"pageName" : "MAGELLAN", | "pageName" : "MAGELLAN", | ||
"diseases" : "Venous Thromboembolism;Deep Vein Thrombosis;Pulmonary Embolism", | "diseases" : "Venous Thromboembolism;Deep Vein Thrombosis;Pulmonary Embolism", | ||
" | "abbreviation" : "MAGELLAN", | ||
"title" : "Rivaroxaban for thromboprophylaxis in acutely ill medical patients", | "title" : "Rivaroxaban for thromboprophylaxis in acutely ill medical patients", | ||
"pmid" : "23388003" | |||
"pmid" : "23388003 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-07-08T23:04:34Z", | |||
"briefDesignDescription" : "ASA/clopidogrel vs. clopidogrel in stroke", | |||
"fulltexturl" : "http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(04)16721-4/fulltext", | |||
"pageid" : 1125, | |||
"pdfurl" : "http://download.thelancet.com/pdfs/journals/lancet/PIIS0140673604167214.pdf", | |||
"trainingLevel" : "student", | |||
"citation" : "Diener HC, <i>et al</i>. \"Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial\". <i>The Lancet</i>. 2004. 364(9431):331-337.", | |||
"subspecialties" : "Neurology", | "subspecialties" : "Neurology", | ||
"expansion" : "Management of Atherothrombosis with Clopidogrel in High-risk patients", | "expansion" : "Management of Atherothrombosis with Clopidogrel in High-risk patients", | ||
| Line 1,539: | Line 1,546: | ||
"published" : "2004-07-24", | "published" : "2004-07-24", | ||
"pageName" : "MATCH", | "pageName" : "MATCH", | ||
"diseases" : "Stroke", | "diseases" : "Stroke", | ||
" | "abbreviation" : "MATCH", | ||
"title" : "Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial", | "title" : "Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial", | ||
"pmid" : "15276392" | |||
"pmid" : "15276392 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-08-02T19:02:32Z", | |||
"briefDesignDescription" : "Metoprolol in HF", | |||
"fulltexturl" : "http://linkinghub.elsevier.com/retrieve/pii/S0140673699044402", | |||
"pageid" : 130, | |||
"pdfurl" : "", | |||
"trainingLevel" : "Resident", | |||
"citation" : "Fagerberg B, <i>et al</i>. \"Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure\". <i>The Lancet</i>. 1999. 353(9169):2001-7.", | |||
"subspecialties" : "Cardiology", | "subspecialties" : "Cardiology", | ||
"expansion" : "Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure", | "expansion" : "Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure", | ||
| Line 1,557: | Line 1,564: | ||
"published" : "1999-06-12", | "published" : "1999-06-12", | ||
"pageName" : "MERIT-HF", | "pageName" : "MERIT-HF", | ||
"diseases" : "Heart Failure", | "diseases" : "Heart Failure", | ||
" | "abbreviation" : "MERIT-HF", | ||
"title" : "Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure", | "title" : "Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure", | ||
"pmid" : "10376614" | |||
"pmid" : "10376614 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-10-20T05:06:34Z", | |||
"briefDesignDescription" : "Surgery vs. PT in OA with meniscal tear", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa1301408", | |||
"pageid" : 1429, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa1301408", | |||
"trainingLevel" : "Student\n}}", | |||
"citation" : "Katz JN, <i>et al</i>. \"Surgery versus Physical Therapy for a Meniscal Tear and Osteoarthritis\". <i>The New England Journal of Medicine</i>. 2013. 368(18):1675-1684.", | |||
"subspecialties" : "Surgery;Physical Medicine and Rehabilitation", | "subspecialties" : "Surgery;Physical Medicine and Rehabilitation", | ||
"expansion" : "Meniscal Tear in Osteoarthritis Research", | "expansion" : "Meniscal Tear in Osteoarthritis Research", | ||
| Line 1,575: | Line 1,582: | ||
"published" : "2013-05-02", | "published" : "2013-05-02", | ||
"pageName" : "METEOR", | "pageName" : "METEOR", | ||
"diseases" : "Meniscal Tear;Osteoarthritis", | "diseases" : "Meniscal Tear;Osteoarthritis", | ||
" | "abbreviation" : "METEOR", | ||
"title" : "Surgery versus Physical Therapy for a Meniscal Tear and Osteoarthritis", | "title" : "Surgery versus Physical Therapy for a Meniscal Tear and Osteoarthritis", | ||
"pmid" : "23506518" | |||
}, | |||
"pmid" : "23506518 | |||
}, | |||
{ | { | ||
"timestamp" : "2013-07-19T09:19:31Z", | |||
"briefDesignDescription" : "Atorvastatin in UA/NSTEMI", | |||
"fulltexturl" : "http://jama.ama-assn.org/content/285/13/1711.long", | |||
"pageid" : 432, | |||
"pdfurl" : "http://jama.ama-assn.org/content/285/13/1711.full.pdf", | |||
"trainingLevel" : "Resident", | |||
"citation" : "Schwartz GG, <i>et al</i>. \"Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes\". <i>Journal of the American Medical Association</i>. 2001. 285(13):1711-1718.", | |||
"subspecialties" : "Cardiology", | "subspecialties" : "Cardiology", | ||
"expansion" : "Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering", | "expansion" : "Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering", | ||
| Line 1,593: | Line 1,600: | ||
"published" : "2001-04-04", | "published" : "2001-04-04", | ||
"pageName" : "MIRACL", | "pageName" : "MIRACL", | ||
"diseases" : "Coronary Artery Disease;Acute Coronary Syndrome;Hyperlipidemia", | "diseases" : "Coronary Artery Disease;Acute Coronary Syndrome;Hyperlipidemia", | ||
" | "abbreviation" : "MIRACL", | ||
"title" : "Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes", | "title" : "Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes", | ||
"pmid" : "11277825" | |||
"pmid" : "11277825 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-09-30T17:15:04Z", | |||
"briefDesignDescription" : "Arthoscopy in knee OA", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa013259", | |||
"pageid" : 1055, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa013259", | |||
"trainingLevel" : "Resident", | |||
"citation" : "Moseley JB, <i>et al</i>. \"A controlled trial of arthroscopic surgery for osteoarthritis of the knee\". <i>The New England Journal of Medicine</i>. 2002. 347(2):81-88.", | |||
"subspecialties" : "Surgery;Physical Medicine and Rehabilitation", | "subspecialties" : "Surgery;Physical Medicine and Rehabilitation", | ||
"expansion" : "", | "expansion" : "", | ||
| Line 1,611: | Line 1,618: | ||
"published" : "2002-07-11", | "published" : "2002-07-11", | ||
"pageName" : "Moseley Trial", | "pageName" : "Moseley Trial", | ||
"diseases" : "Osteoarthritis", | "diseases" : "Osteoarthritis", | ||
" | "abbreviation" : "", | ||
"title" : "A controlled trial of arthroscopic surgery for osteoarthritis of the knee", | "title" : "A controlled trial of arthroscopic surgery for osteoarthritis of the knee", | ||
"pmid" : "12110735" | |||
"pmid" : "12110735 | |||
}, | }, | ||
{ | { | ||
"subspecialties" : "Surgery;Neurology", | "timestamp" : "2013-04-16T20:36:00Z", | ||
"briefDesignDescription" : "CEA in symptomatic carotid stenosis", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJM199811123392002", | |||
"pageid" : 128, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJM199811123392002", | |||
"trainingLevel" : "Intern", | |||
"citation" : "Barnett HJ, <i>et al</i>. \"Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis\". <i>The New England Journal of Medicine</i>. 1998. 339(20):1415-25.", | |||
"subspecialties" : "Surgery;Neurology", | |||
"expansion" : "North American Symptomatic Carotid Endarterectomy Trial", | "expansion" : "North American Symptomatic Carotid Endarterectomy Trial", | ||
"briefResultsDescription" : "CEA reduces the risk of death or stroke in symptomatic 50-69% carotid stenosis", | "briefResultsDescription" : "CEA reduces the risk of death or stroke in symptomatic 50-69% carotid stenosis", | ||
"published" : "1998-11-12", | "published" : "1998-11-12", | ||
"pageName" : "NASCET", | "pageName" : "NASCET", | ||
"diseases" : "Carotid Stenosis;Stroke", | "diseases" : "Carotid Stenosis;Stroke", | ||
" | "abbreviation" : "NASCET", | ||
"title" : "Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis", | "title" : "Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis", | ||
"pmid" : "9811916" | |||
"pmid" : "9811916 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-07-01T16:53:38Z", | |||
"briefDesignDescription" : "Dialysis prescriptions in ESRD", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJM198111123052003", | |||
"pageid" : 504, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJM198111123052003", | |||
"trainingLevel" : "Fellow", | |||
"citation" : "Lowrie EG, <i>et al</i>. \"Effect of the hemodialysis prescription of patient morbidity: report from the National Cooperative Dialysis Study\". <i>The New England Journal of Medicine</i>. 1981. 305(20):1176-1181.", | |||
"subspecialties" : "Nephrology", | "subspecialties" : "Nephrology", | ||
"expansion" : "The National Cooperative Dialysis Study", | "expansion" : "The National Cooperative Dialysis Study", | ||
| Line 1,647: | Line 1,654: | ||
"published" : "1981-11-12", | "published" : "1981-11-12", | ||
"pageName" : "NCDS", | "pageName" : "NCDS", | ||
"diseases" : "Chronic Kidney Disease", | "diseases" : "Chronic Kidney Disease", | ||
" | "abbreviation" : "NCDS", | ||
"title" : "Effect of the hemodialysis prescription of patient morbidity: report from the National Cooperative Dialysis Study", | "title" : "Effect of the hemodialysis prescription of patient morbidity: report from the National Cooperative Dialysis Study", | ||
"pmid" : "7027040" | |||
"pmid" : "7027040 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-08-27T13:27:24Z", | "timestamp" : "2013-08-27T13:27:24Z", | ||
"briefDesignDescription" : "Lung volume reduction in COPD", | "briefDesignDescription" : "Lung volume reduction in COPD", | ||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa030287", | "fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa030287", | ||
"pageid" : 1604, | "pageid" : 1604, | ||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa030287", | "pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa030287", | ||
"trainingLevel" : "Resident", | "trainingLevel" : "Resident", | ||
"citation" : "Fishman A, <i>et al</i>. \"A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema\". <i>The New England Journal of Medicine</i>. 2003. 348(21):2059-2073." | "citation" : "Fishman A, <i>et al</i>. \"A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema\". <i>The New England Journal of Medicine</i>. 2003. 348(21):2059-2073.", | ||
"subspecialties" : "Surgery;Pulmonology", | |||
"expansion" : "National Emphysema Treatment Trial", | |||
"briefResultsDescription" : "LVRS benefits apical emphysema and those with low exercise function", | |||
"published" : "2003-05-22", | |||
"pageName" : "NETT", | |||
"diseases" : "Chronic Obstructive Pulmonary Disease;Emphysema", | |||
"abbreviation" : "NETT", | |||
"title" : "A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema", | |||
"pmid" : "12759479" | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-10-21T06:31:19Z", | |||
"briefDesignDescription" : "Intensive glycemic therapy in ICU", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa0810625", | |||
"pageid" : 26, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa0810625", | |||
"trainingLevel" : "Intern", | |||
"citation" : "Finfer S, <i>et al</i>. \"Intensive versus conventional glucose control in critically ill patients\". <i>The New England Journal of Medicine</i>. 2009. 360(13):1283-1297.", | |||
"subspecialties" : "Critical Care;Endocrinology", | "subspecialties" : "Critical Care;Endocrinology", | ||
"expansion" : "Normoglycemia in Intensive Care Evaluation and Surviving Using Glucose Algorithm Regulation", | "expansion" : "Normoglycemia in Intensive Care Evaluation and Surviving Using Glucose Algorithm Regulation", | ||
| Line 1,683: | Line 1,690: | ||
"published" : "2009-03-26", | "published" : "2009-03-26", | ||
"pageName" : "NICE-SUGAR", | "pageName" : "NICE-SUGAR", | ||
"diseases" : "Stress Hyperglycemia", | "diseases" : "Stress Hyperglycemia", | ||
" | "abbreviation" : "NICE-SUGAR", | ||
"title" : "Intensive versus conventional glucose control in critically ill patients", | "title" : "Intensive versus conventional glucose control in critically ill patients", | ||
"pmid" : "19318384" | |||
"pmid" : "19318384 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-06-17T12:56:04Z", | |||
"briefDesignDescription" : "tPA in ischemic stroke", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJM199512143332401", | |||
"pageid" : 131, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJM199512143332401", | |||
"trainingLevel" : "MedicalStudent", | |||
"citation" : "Marler JR, <i>et al</i>. \"Tissue Plasminogen Activator for Acute Ischemic Stroke\". <i>The New England Journal of Medicine</i>. 1995. 333(24):1581-1587.", | |||
"subspecialties" : "Neurology;Critical Care", | "subspecialties" : "Neurology;Critical Care", | ||
"expansion" : "National Institute of Neurological Disorders and Stroke rt-PA Stroke Study", | "expansion" : "National Institute of Neurological Disorders and Stroke rt-PA Stroke Study", | ||
| Line 1,701: | Line 1,708: | ||
"published" : "1995-12-14", | "published" : "1995-12-14", | ||
"pageName" : "NINDS", | "pageName" : "NINDS", | ||
"diseases" : "Stroke", | "diseases" : "Stroke", | ||
" | "abbreviation" : "NINDS", | ||
"title" : "Tissue Plasminogen Activator for Acute Ischemic Stroke", | "title" : "Tissue Plasminogen Activator for Acute Ischemic Stroke", | ||
"pmid" : "7477192" | |||
"pmid" : "7477192 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-07-28T16:36:17Z", | |||
"briefDesignDescription" : "CT vs. CXR in lung cancer screening", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa1102873", | |||
"pageid" : 980, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa1102873", | |||
"trainingLevel" : "Resident", | |||
"citation" : "Berg CD, <i>et al</i>. \"Reduced lung cancer mortality with low-dose computed tomographic screening\". <i>The New England Journal of Medicine</i>. 2011. 365(5):395-409.", | |||
"subspecialties" : "Pulmonology;Oncology", | "subspecialties" : "Pulmonology;Oncology", | ||
"expansion" : "National Lung Screening Trial", | "expansion" : "National Lung Screening Trial", | ||
| Line 1,719: | Line 1,726: | ||
"published" : "2011-08-04", | "published" : "2011-08-04", | ||
"pageName" : "NLST", | "pageName" : "NLST", | ||
"diseases" : "Lung Cancer", | "diseases" : "Lung Cancer", | ||
" | "abbreviation" : "NLST", | ||
"title" : "Reduced lung cancer mortality with low-dose computed tomographic screening", | "title" : "Reduced lung cancer mortality with low-dose computed tomographic screening", | ||
"pmid" : "21714641" | |||
"pmid" : "21714641 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-03-12T08:34:38Z", | |||
"briefDesignDescription" : "Sentinel LN biopsy in breast cancer", | |||
"fulltexturl" : "http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3041644/", | |||
"pageid" : 1167, | |||
"pdfurl" : "http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3041644/pdf/nihms-250175.pdf", | |||
"trainingLevel" : "Student", | |||
"citation" : "Krag DN, <i>et al</i>. \"Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial\". <i>Lancet Oncology</i>. 2010. 11(10):927-933.", | |||
"subspecialties" : "Oncology", | "subspecialties" : "Oncology", | ||
"expansion" : "National Surgical Adjuvant Breast and Bowel Project Trial B-32", | "expansion" : "National Surgical Adjuvant Breast and Bowel Project Trial B-32", | ||
| Line 1,737: | Line 1,744: | ||
"published" : "2010-10-01", | "published" : "2010-10-01", | ||
"pageName" : "NSABP B-32", | "pageName" : "NSABP B-32", | ||
"diseases" : "Breast Cancer", | "diseases" : "Breast Cancer", | ||
"abbreviation" : "NSABP B-32", | "abbreviation" : "NSABP B-32", | ||
" | "title" : "Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial", | ||
"pmid" : "20863759" | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-08-25T18:37:31Z", | |||
"briefDesignDescription" : "Tamoxifen in breast cancer prevention", | |||
"fulltexturl" : "http://jnci.oxfordjournals.org/content/90/18/1371.long", | |||
"pageid" : 1049, | |||
"pdfurl" : "http://jnci.oxfordjournals.org/content/90/18/1371.full.pdf+html", | |||
"trainingLevel" : "resident\n}}", | |||
"citation" : "Fisher B, <i>et al</i>. \"Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study\". <i>Journal of the National Cancer Institute</i>. 1998. 90(18):1371-1388.", | |||
"subspecialties" : "Oncology", | "subspecialties" : "Oncology", | ||
"expansion" : "National Surgical Adjuvant Breast and Bowel Project, Prevention-1", | "expansion" : "National Surgical Adjuvant Breast and Bowel Project, Prevention-1", | ||
| Line 1,755: | Line 1,762: | ||
"published" : "1998-09-16", | "published" : "1998-09-16", | ||
"pageName" : "NSABP P-1", | "pageName" : "NSABP P-1", | ||
"diseases" : "Breast Cancer", | "diseases" : "Breast Cancer", | ||
" | "abbreviation" : "NSABP P-1", | ||
"title" : "Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study", | "title" : "Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study", | ||
"pmid" : "9747868" | |||
"pmid" : "9747868 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2012-04-26T00:18:57Z", | |||
"briefDesignDescription" : "IV PPI for GI bleeds", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJM200008033430501", | |||
"pageid" : 247, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJM200008033430501", | |||
"trainingLevel" : "Resident", | |||
"citation" : "Lau JYW, <i>et al</i>. \"Effect of Intravenous Omeprazole on Recurrent Bleeding after Endoscopic Treatment of Bleeding Peptic Ulcer\". <i>The New England Journal of Medicine</i>. 2000. 343(5):310-316.", | |||
"subspecialties" : "Gastroenterology", | "subspecialties" : "Gastroenterology", | ||
"expansion" : null, | "expansion" : null, | ||
| Line 1,773: | Line 1,780: | ||
"published" : "2000-08-03", | "published" : "2000-08-03", | ||
"pageName" : "Omeprazole in Peptic Ulcer Bleeding", | "pageName" : "Omeprazole in Peptic Ulcer Bleeding", | ||
"diseases" : "Gastrointestinal Hemorrhage", | "diseases" : "Gastrointestinal Hemorrhage", | ||
" | "abbreviation" : null, | ||
"title" : "Effect of Intravenous Omeprazole on Recurrent Bleeding after Endoscopic Treatment of Bleeding Peptic Ulcer", | "title" : "Effect of Intravenous Omeprazole on Recurrent Bleeding after Endoscopic Treatment of Bleeding Peptic Ulcer", | ||
"pmid" : "10922420" | |||
"pmid" : "10922420 | |||
}, | }, | ||
{ | { | ||
"subspecialties" : "Critical Care;Pulmonology", | "timestamp" : "2013-10-20T05:06:18Z", | ||
"expansion" : "Oscillation for Acute Respiratory Distress Syndrome Treated Early", | "briefDesignDescription" : "High-frequency oscillatory vent in early ARDS", | ||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa1215554", | |||
"pageid" : 1254, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa1215554", | |||
"trainingLevel" : "Resident\n}}", | |||
"citation" : "Ferguson ND, <i>et al</i>. \"High-Frequency Oscillation in Early Acute Respiratory Distress Syndrome\". <i>The New England Journal of Medicine</i>. 2013. 368(9):795-805.", | |||
"subspecialties" : "Critical Care;Pulmonology", | |||
"expansion" : "Oscillation for Acute Respiratory Distress Syndrome Treated Early", | |||
"briefResultsDescription" : "High-frequency oscillatory vent may harm in early ARDS", | "briefResultsDescription" : "High-frequency oscillatory vent may harm in early ARDS", | ||
"published" : "2013-02-28", | "published" : "2013-02-28", | ||
"pageName" : "OSCILLATE", | "pageName" : "OSCILLATE", | ||
"diseases" : "Acute Respiratory Distress Syndrome", | "diseases" : "Acute Respiratory Distress Syndrome", | ||
" | "abbreviation" : "Oscillate", | ||
"title" : "High-Frequency Oscillation in Early Acute Respiratory Distress Syndrome", | "title" : "High-Frequency Oscillation in Early Acute Respiratory Distress Syndrome", | ||
"pmid" : "23339639" | |||
"pmid" : "23339639 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2012-11-11T16:21:51Z", | |||
"briefDesignDescription" : "Step-up approach to pancreatitis", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa0908821", | |||
"pageid" : 398, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa0908821", | |||
"trainingLevel" : "Fellow", | |||
"citation" : "van Santvoort HC, <i>et al</i>. \"A Step-up Approach or Open Necrosectomy for Necrotizing Pancreatitis\". <i>The New England Journal of Medicine</i>. 2010. 362(16):1491-502.", | |||
"subspecialties" : "Surgery;Gastroenterology", | "subspecialties" : "Surgery;Gastroenterology", | ||
"expansion" : "Minimally Invasive Step Up Approach versus Maximal Necrosectomy in Patients with Acute Necrotising Pancreatitis", | "expansion" : "Minimally Invasive Step Up Approach versus Maximal Necrosectomy in Patients with Acute Necrotising Pancreatitis", | ||
| Line 1,809: | Line 1,816: | ||
"published" : "2010-04-22", | "published" : "2010-04-22", | ||
"pageName" : "PANTER", | "pageName" : "PANTER", | ||
"diseases" : "Pancreatitis", | "diseases" : "Pancreatitis", | ||
" | "abbreviation" : "PANTER", | ||
"title" : "A Step-up Approach or Open Necrosectomy for Necrotizing Pancreatitis", | "title" : "A Step-up Approach or Open Necrosectomy for Necrotizing Pancreatitis", | ||
"pmid" : "20410514" | |||
"pmid" : "20410514 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-05-21T21:38:41Z", | "timestamp" : "2013-05-21T21:38:41Z", | ||
"briefDesignDescription" : "Pentoxifylline in alcoholic hepatitis", | "briefDesignDescription" : "Pentoxifylline in alcoholic hepatitis", | ||
"fulltexturl" : "http://www.gastrojournal.org/article/S0016-5085(00)51183-4/fulltext", | "fulltexturl" : "http://www.gastrojournal.org/article/S0016-5085(00)51183-4/fulltext", | ||
"pageid" : 53, | "pageid" : 53, | ||
"pdfurl" : "http://download.journals.elsevierhealth.com/pdfs/journals/0016-5085/PIIS0016508500511834.pdf", | "pdfurl" : "http://download.journals.elsevierhealth.com/pdfs/journals/0016-5085/PIIS0016508500511834.pdf", | ||
"trainingLevel" : "Resident", | "trainingLevel" : "Resident", | ||
"citation" : "Akriviadis E, <i>et al</i>. \"Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial\". <i>Gastroenterology</i>. 2000. 119(6):1637-48." | "citation" : "Akriviadis E, <i>et al</i>. \"Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial\". <i>Gastroenterology</i>. 2000. 119(6):1637-48.", | ||
"subspecialties" : "Gastroenterology", | |||
"expansion" : "", | |||
"briefResultsDescription" : "Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis", | |||
"published" : "2000-12-20", | |||
"pageName" : "Pentoxifylline in Severe Alcoholic Hepatitis", | |||
"diseases" : "Alcoholic Hepatitis", | |||
"abbreviation" : "", | |||
"title" : "Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial", | |||
"pmid" : "11113085" | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-07-03T16:14:14Z", | |||
"briefDesignDescription" : "Accuracy of CT for PE", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa052367#t", | |||
"pageid" : 161, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa052367#t", | |||
"trainingLevel" : "MedicalStudent", | |||
"citation" : "Stein PD, <i>et al</i>. \"Multidetector Computed Tomography for Acute Pulmonary Embolism\". <i>The New England Journal of Medicine</i>. 2006. 354(22):2317-2327.", | |||
"subspecialties" : "Pulmonology;Hematology", | "subspecialties" : "Pulmonology;Hematology", | ||
"expansion" : "Prospective Investigation of Pulmonary Embolism Diagnosis II", | "expansion" : "Prospective Investigation of Pulmonary Embolism Diagnosis II", | ||
| Line 1,845: | Line 1,852: | ||
"published" : "2006-06-01", | "published" : "2006-06-01", | ||
"pageName" : "PIOPED II", | "pageName" : "PIOPED II", | ||
"diseases" : "Pulmonary Embolism;Venous Thromboembolism", | "diseases" : "Pulmonary Embolism;Venous Thromboembolism", | ||
" | "abbreviation" : "PIOPED II", | ||
"title" : "Multidetector Computed Tomography for Acute Pulmonary Embolism", | "title" : "Multidetector Computed Tomography for Acute Pulmonary Embolism", | ||
"pmid" : "16738268" | |||
"pmid" : "16738268 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-09-04T23:02:53Z", | |||
"briefDesignDescription" : "Ticagrelor vs. clopidogrel in ACS", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa0904327", | |||
"pageid" : 1629, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa0904327", | |||
"trainingLevel" : "Resident\n}}", | |||
"citation" : "Wallentin L, <i>et al</i>. \"Ticagrelor versus clopidogrel in patients with acute coronary syndromes\". <i>The New England Journal of Medicine</i>. 2009. 361(11):1045-1057.", | |||
"subspecialties" : "Cardiology", | "subspecialties" : "Cardiology", | ||
"expansion" : "Platelet Inhibition and Patient Outcomes", | "expansion" : "Platelet Inhibition and Patient Outcomes", | ||
| Line 1,863: | Line 1,870: | ||
"published" : "2009-09-10", | "published" : "2009-09-10", | ||
"pageName" : "PLATO", | "pageName" : "PLATO", | ||
"diseases" : "Acute Coronary Syndrome;Coronary Artery Disease", | "diseases" : "Acute Coronary Syndrome;Coronary Artery Disease", | ||
" | "abbreviation" : "PLATO", | ||
"title" : "Ticagrelor versus clopidogrel in patients with acute coronary syndromes", | "title" : "Ticagrelor versus clopidogrel in patients with acute coronary syndromes", | ||
"pmid" : "19717846" | |||
"pmid" : "19717846 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2012-05-07T02:36:42Z", | |||
"briefDesignDescription" : "8 vs. 15 days of antibiotics in VAP", | |||
"fulltexturl" : "http://jama.ama-assn.org/content/290/19/2588.long", | |||
"pageid" : 118, | |||
"pdfurl" : "http://jama.ama-assn.org/content/290/19/2588.full.pdf", | |||
"trainingLevel" : "Intern", | |||
"citation" : "Chastre J. \"Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial\". <i>Journal of the American Medical Association</i>. 2003. 290(19):2588-98.", | |||
"subspecialties" : "Critical Care;Infectious Disease;Pulmonology", | "subspecialties" : "Critical Care;Infectious Disease;Pulmonology", | ||
"expansion" : "", | "expansion" : "", | ||
| Line 1,881: | Line 1,888: | ||
"published" : "2003-11-19", | "published" : "2003-11-19", | ||
"pageName" : "PneumA", | "pageName" : "PneumA", | ||
"diseases" : "Pneumonia", | "diseases" : "Pneumonia", | ||
" | "abbreviation" : "PneumA", | ||
"title" : "Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial", | "title" : "Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial", | ||
"pmid" : "14625336" | |||
"pmid" : "14625336 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-06-04T02:34:52Z", | |||
"briefDesignDescription" : "Perioperative metoprolol", | |||
"fulltexturl" : "http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(08)60601-7/fulltext", | |||
"pageid" : 173, | |||
"pdfurl" : "http://download.thelancet.com/pdfs/journals/lancet/PIIS0140673608606017.pdf", | |||
"trainingLevel" : "Intern", | |||
"citation" : "Devereaux PJ, <i>et al</i>. \"Effects of Extended-Release Metoprolol Succinate in Patients Undergoing Non-Cardiac Surgery: a Randomised Controlled Trial\". <i>The Lancet</i>. 2008. 371(9627):1839-1847.", | |||
"subspecialties" : "Surgery;Cardiology", | "subspecialties" : "Surgery;Cardiology", | ||
"expansion" : "PeriOperative ISchemic Evaluation", | "expansion" : "PeriOperative ISchemic Evaluation", | ||
| Line 1,899: | Line 1,906: | ||
"published" : "2008-05-31", | "published" : "2008-05-31", | ||
"pageName" : "POISE", | "pageName" : "POISE", | ||
"diseases" : "Cardiac Risk Assessment;Coronary Artery Disease", | "diseases" : "Cardiac Risk Assessment;Coronary Artery Disease", | ||
" | "abbreviation" : "POISE", | ||
"title" : "Effects of Extended-Release Metoprolol Succinate in Patients Undergoing Non-Cardiac Surgery: a Randomised Controlled Trial", | "title" : "Effects of Extended-Release Metoprolol Succinate in Patients Undergoing Non-Cardiac Surgery: a Randomised Controlled Trial", | ||
"pmid" : "18479744" | |||
}, | |||
"pmid" : "18479744 | |||
}, | |||
{ | { | ||
"timestamp" : "2013-11-26T10:47:19Z", | |||
"briefDesignDescription" : "PCI to high-risk non-infarct arteries in STEMI", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa1305520", | |||
"pageid" : 1748, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa1305520", | |||
"trainingLevel" : "Resident\n}}", | |||
"citation" : "Wald DS, <i>et al</i>. \"Randomized trial of preventative angioplasty in myocardial infarction\". <i>The New England Journal of Medicine</i>. 2013. 369(12):1115-1123.", | |||
"subspecialties" : "Cardiology", | "subspecialties" : "Cardiology", | ||
"expansion" : "Preventative Angioplasty in Acute Myocardial Infarction", | "expansion" : "Preventative Angioplasty in Acute Myocardial Infarction", | ||
| Line 1,917: | Line 1,924: | ||
"published" : "2013-09-19", | "published" : "2013-09-19", | ||
"pageName" : "PRAMI", | "pageName" : "PRAMI", | ||
"diseases" : "Myocardial Infarction", | "diseases" : "Myocardial Infarction", | ||
" | "abbreviation" : "PRAMI", | ||
"title" : "Randomized trial of preventative angioplasty in myocardial infarction", | "title" : "Randomized trial of preventative angioplasty in myocardial infarction", | ||
"pmid" : "23991625" | |||
"pmid" : "23991625 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-08-22T00:58:12Z", | |||
"briefDesignDescription" : "Mediterranean diet in CVD prevention", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa1200303", | |||
"pageid" : 1247, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa1200303", | |||
"trainingLevel" : "Student", | |||
"citation" : "Estruch R, <i>et al</i>. \"Primary prevention of cardiovascular disease with a mediterranean diet\". <i>The New England Journal of Medicine</i>. 2013. 368(14):1279-1290.", | |||
"subspecialties" : "Cardiology", | "subspecialties" : "Cardiology", | ||
"expansion" : "Prevención con Dieta Mediterránea", | "expansion" : "Prevención con Dieta Mediterránea", | ||
| Line 1,935: | Line 1,942: | ||
"published" : "2013-02-25", | "published" : "2013-02-25", | ||
"pageName" : "PREDIMED", | "pageName" : "PREDIMED", | ||
"diseases" : "Coronary Artery Disease;Stroke;Transient Ischemic Attack", | "diseases" : "Coronary Artery Disease;Stroke;Transient Ischemic Attack", | ||
" | "abbreviation" : "PREDIMED", | ||
"title" : "Primary prevention of cardiovascular disease with a mediterranean diet", | "title" : "Primary prevention of cardiovascular disease with a mediterranean diet", | ||
"pmid" : "23432189" | |||
"pmid" : "23432189 | |||
}, | }, | ||
{ | { | ||
"subspecialties" : "Gastroenterology", | "timestamp" : "2013-03-13T05:33:06Z", | ||
"briefDesignDescription" : "Prednisolone vs. placebo in alcoholic hepatitis", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJM199202203260802", | |||
"pageid" : 1113, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJM199202203260802", | |||
"trainingLevel" : "Intern", | |||
"citation" : "Ramond MJ, <i>et al</i>. \"A randomized trial of prednisolone in patients with severe alcoholic hepatitis\". <i>The New England Journal of Medicine</i>. 1992. 362(8):507-512.", | |||
"subspecialties" : "Gastroenterology", | |||
"expansion" : "", | "expansion" : "", | ||
"briefResultsDescription" : "Prednisolone improves short-term survival", | "briefResultsDescription" : "Prednisolone improves short-term survival", | ||
"published" : "1992-02-20", | "published" : "1992-02-20", | ||
"pageName" : "Prednisolone in Severe Alcoholic Hepatitis", | "pageName" : "Prednisolone in Severe Alcoholic Hepatitis", | ||
"diseases" : "Alcoholic Hepatitis", | "diseases" : "Alcoholic Hepatitis", | ||
" | "abbreviation" : "", | ||
"title" : "A randomized trial of prednisolone in patients with severe alcoholic hepatitis", | "title" : "A randomized trial of prednisolone in patients with severe alcoholic hepatitis", | ||
"pmid" : "1531090" | |||
"pmid" : "1531090 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-03-21T00:59:25Z", | |||
"briefDesignDescription" : "Rifapentine/isoniazid in latent TB", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa1104875", | |||
"pageid" : 928, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa1104875", | |||
"trainingLevel" : "fellow", | |||
"citation" : "Sterling TR, <i>et al</i>. \"Three months of rifapentine and isoniazid for latent tuberculosis infection.\". <i>The New England Journal of Medicine</i>. 2011. 365(23):2155-66.", | |||
"subspecialties" : "Infectious Disease", | "subspecialties" : "Infectious Disease", | ||
"expansion" : null, | "expansion" : null, | ||
| Line 1,971: | Line 1,978: | ||
"published" : "2011-12-08", | "published" : "2011-12-08", | ||
"pageName" : "PREVENT TB", | "pageName" : "PREVENT TB", | ||
"diseases" : "Tuberculosis", | "diseases" : "Tuberculosis", | ||
" | "abbreviation" : "PREVENT TB", | ||
"title" : "Three months of rifapentine and isoniazid for latent tuberculosis infection.", | "title" : "Three months of rifapentine and isoniazid for latent tuberculosis infection.", | ||
"pmid" : "22150035" | |||
"pmid" : "22150035 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-03-25T00:56:44Z", | "timestamp" : "2013-03-25T00:56:44Z", | ||
"briefDesignDescription" : "ASA-dipyridamole vs. clopidogrel in stroke", | "briefDesignDescription" : "ASA-dipyridamole vs. clopidogrel in stroke", | ||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa0805002", | "fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa0805002", | ||
"pageid" : 1082, | "pageid" : 1082, | ||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa0805002", | "pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa0805002", | ||
"trainingLevel" : "Resident", | "trainingLevel" : "Resident", | ||
"citation" : "Sacco RL, <i>et al</i>. \"Aspirin and Extended-Release Dipyridamole versus Clopidogrel for Recurrent Stroke\". <i>The New England Journal of Medicine</i>. 2008. 359(12):1238-1251." | "citation" : "Sacco RL, <i>et al</i>. \"Aspirin and Extended-Release Dipyridamole versus Clopidogrel for Recurrent Stroke\". <i>The New England Journal of Medicine</i>. 2008. 359(12):1238-1251.", | ||
"subspecialties" : "Neurology", | |||
"expansion" : "Prevention Regimen for Effectively Avoiding Second Strokes", | |||
"briefResultsDescription" : "Similar efficacy but less bleeding with clopidogrel", | |||
"published" : "2008-09-18", | |||
"pageName" : "PRoFESS", | |||
"diseases" : "Stroke", | |||
"abbreviation" : "PROFESS", | |||
"title" : "Aspirin and Extended-Release Dipyridamole versus Clopidogrel for Recurrent Stroke", | |||
"pmid" : "18753638" | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2012-05-21T16:01:07Z", | |||
"briefDesignDescription" : "Procalcitonin-guided antibiotics", | |||
"fulltexturl" : "http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(09)61879-1/fulltext", | |||
"pageid" : 434, | |||
"pdfurl" : "http://download.thelancet.com/pdfs/journals/lancet/PIIS0140673609618791.pdf", | |||
"trainingLevel" : "resident", | |||
"citation" : "Bouadma L, <i>et al</i>. \"Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units\". <i>The Lancet</i>. 2010. 375(9713):463-74.", | |||
"subspecialties" : "Critical Care;Infectious Disease", | "subspecialties" : "Critical Care;Infectious Disease", | ||
"expansion" : "Procalcitonin to Reduce Antibiotic Treatments in Acutely ill patients", | "expansion" : "Procalcitonin to Reduce Antibiotic Treatments in Acutely ill patients", | ||
| Line 2,007: | Line 2,014: | ||
"published" : "2010-02-06", | "published" : "2010-02-06", | ||
"pageName" : "PRORATA", | "pageName" : "PRORATA", | ||
"diseases" : "Critical Illness", | "diseases" : "Critical Illness", | ||
" | "abbreviation" : "PRORATA", | ||
"title" : "Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units", | "title" : "Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units", | ||
"pmid" : "20097417" | |||
"pmid" : "20097417 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-06-21T20:27:16Z", | |||
"briefDesignDescription" : "Prone ventilation in ARDS", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa1214103", | |||
"pageid" : 1479, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa1214103", | |||
"trainingLevel" : "fellow\n}}", | |||
"citation" : "Guérin C, <i>et al</i>. \"Prone positioning in severe acute respiratory distress syndrome\". <i>The New England Journal of Medicine</i>. 2013. 368(23):2159-2168.", | |||
"subspecialties" : "Critical Care", | "subspecialties" : "Critical Care", | ||
"expansion" : "Proning Severe ARDS Patients", | "expansion" : "Proning Severe ARDS Patients", | ||
| Line 2,025: | Line 2,032: | ||
"published" : "2013-06-06", | "published" : "2013-06-06", | ||
"pageName" : "PROSEVA", | "pageName" : "PROSEVA", | ||
"diseases" : "Acute Respiratory Distress Syndrome", | "diseases" : "Acute Respiratory Distress Syndrome", | ||
" | "abbreviation" : "PROSEVA", | ||
"title" : "Prone positioning in severe acute respiratory distress syndrome", | "title" : "Prone positioning in severe acute respiratory distress syndrome", | ||
"pmid" : "23688302" | |||
"pmid" : "23688302 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-08-04T12:33:27Z", | |||
"briefDesignDescription" : "Pravastatin vs. atorvastatin after ACS", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa040583", | |||
"pageid" : 1338, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa040583", | |||
"trainingLevel" : "Intern", | |||
"citation" : "Cannon CP, <i>et al</i>. \"Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes\". <i>The New England Journal of Medicine</i>. 2004. 350(15):1495-1504.", | |||
"subspecialties" : "Cardiology", | "subspecialties" : "Cardiology", | ||
"expansion" : "Pravastatin or Atorvastatin Evaluation and Infection Therapy–Thrombolysis in Myocardial Infarction 22", | "expansion" : "Pravastatin or Atorvastatin Evaluation and Infection Therapy–Thrombolysis in Myocardial Infarction 22", | ||
| Line 2,043: | Line 2,050: | ||
"published" : "2004-04-08", | "published" : "2004-04-08", | ||
"pageName" : "PROVE IT-TIMI 22", | "pageName" : "PROVE IT-TIMI 22", | ||
"diseases" : "Acute Coronary Syndrome;Hyperlipidemia", | "diseases" : "Acute Coronary Syndrome;Hyperlipidemia", | ||
" | "abbreviation" : "PROVE IT-TIMI 22", | ||
"title" : "Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes", | "title" : "Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes", | ||
"pmid" : "15007110" | |||
"pmid" : "15007110 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-03-05T21:38:21Z", | |||
"briefDesignDescription" : "Activated protein C in severe sepsis", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJM200103083441001", | |||
"pageid" : 983, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJM200103083441001", | |||
"trainingLevel" : "Resident", | |||
"citation" : "Bernard GR, <i>et al</i>. \"Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis\". <i>The New England Journal of Medicine</i>. 2001. 344(10):699-709.", | |||
"subspecialties" : "Critical Care", | "subspecialties" : "Critical Care", | ||
"expansion" : "Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis", | "expansion" : "Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis", | ||
| Line 2,061: | Line 2,068: | ||
"published" : "2001-03-08", | "published" : "2001-03-08", | ||
"pageName" : "PROWESS", | "pageName" : "PROWESS", | ||
"diseases" : "Sepsis;Shock", | "diseases" : "Sepsis;Shock", | ||
"abbreviation" : "PROWESS", | "abbreviation" : "PROWESS", | ||
" | "title" : "Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis", | ||
"pmid" : "11236773" | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-03-05T21:38:37Z", | |||
"briefDesignDescription" : "Activated protein C in septic shock", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa1202290", | |||
"pageid" : 977, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa1202290", | |||
"trainingLevel" : "Resident", | |||
"citation" : "Ranieri VM, <i>et al</i>. \"Drotrecogin Alfa (Activated) in Adults with Septic Shock\". <i>The New England Journal of Medicine</i>. 2012. 366(22):2055-2064.", | |||
"subspecialties" : "Critical Care", | "subspecialties" : "Critical Care", | ||
"expansion" : "Prospective Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis and Septic Shock", | "expansion" : "Prospective Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis and Septic Shock", | ||
| Line 2,079: | Line 2,086: | ||
"published" : "2012-05-31", | "published" : "2012-05-31", | ||
"pageName" : "PROWESS-SHOCK", | "pageName" : "PROWESS-SHOCK", | ||
"diseases" : "Sepsis;Shock", | "diseases" : "Sepsis;Shock", | ||
" | "abbreviation" : "PROWESS-SHOCK", | ||
"title" : "Drotrecogin Alfa (Activated) in Adults with Septic Shock", | "title" : "Drotrecogin Alfa (Activated) in Adults with Septic Shock", | ||
"pmid" : "22616830" | |||
"pmid" : "22616830 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-10-30T11:31:37Z", | |||
"briefDesignDescription" : "Lenient vs. strict rate control in AF", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa1001337", | |||
"pageid" : 181, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa1001337", | |||
"trainingLevel" : "Resident", | |||
"citation" : "Van Gelder IC, <i>et al</i>. \"Lenient versus Strict Rate Control in Patients with Atrial Fibrillation\". <i>The New England Journal of Medicine</i>. 2010. 362(15):1363-73.", | |||
"subspecialties" : "Cardiology", | "subspecialties" : "Cardiology", | ||
"expansion" : "Rate Control Efficacy in Permanent Atrial Fibrillation: a Comparison between Lenient versus Strict Rate Control II", | "expansion" : "Rate Control Efficacy in Permanent Atrial Fibrillation: a Comparison between Lenient versus Strict Rate Control II", | ||
| Line 2,097: | Line 2,104: | ||
"published" : "2010-04-15", | "published" : "2010-04-15", | ||
"pageName" : "RACE II", | "pageName" : "RACE II", | ||
"diseases" : "Atrial Fibrillation", | "diseases" : "Atrial Fibrillation", | ||
" | "abbreviation" : "RACE II", | ||
"title" : "Lenient versus Strict Rate Control in Patients with Atrial Fibrillation", | "title" : "Lenient versus Strict Rate Control in Patients with Atrial Fibrillation", | ||
"pmid" : "20231232" | |||
"pmid" : "20231232 | |||
}, | }, | ||
{ | { | ||
"subspecialties" : "Cardiology", | "timestamp" : "2013-10-23T02:29:32Z", | ||
"expansion" : "Randomized Aldactone Evaluation Study", | "briefDesignDescription" : "Spironolactone in HF", | ||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJM199909023411001", | |||
"pageid" : 11, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJM199909023411001", | |||
"trainingLevel" : "Intern", | |||
"citation" : "Pitt B, <i>et al</i>. \"The effect of spironolactone on morbidity and mortality in patients with severe heart failure\". <i>New England Journal of Medicine</i>. 1999. 341:709-717.", | |||
"subspecialties" : "Cardiology", | |||
"expansion" : "Randomized Aldactone Evaluation Study", | |||
"briefResultsDescription" : "Spironolactone reduces all-cause mortality by 30% in severe CHF.", | "briefResultsDescription" : "Spironolactone reduces all-cause mortality by 30% in severe CHF.", | ||
"published" : "1999-09-02", | "published" : "1999-09-02", | ||
"pageName" : "RALES", | "pageName" : "RALES", | ||
"diseases" : "Heart Failure", | "diseases" : "Heart Failure", | ||
" | "abbreviation" : "RALES", | ||
"title" : "The effect of spironolactone on morbidity and mortality in patients with severe heart failure", | "title" : "The effect of spironolactone on morbidity and mortality in patients with severe heart failure", | ||
"pmid" : "10471456" | |||
"pmid" : "10471456 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-03-05T21:39:54Z", | |||
"briefDesignDescription" : "Rituximab vs. cyclophosphamide in ANCA-associated vasculitis", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa0909905", | |||
"pageid" : 1214, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa0909905", | |||
"trainingLevel" : "Fellow", | |||
"citation" : "Stone JH, <i>et al</i>. \"Rituximab versus cyclophosphamide for ANCA-associated vasculitis\". <i>The New England Journal of Medicine</i>. 2010. 363(3):221-232.", | |||
"subspecialties" : "Rheumatology", | "subspecialties" : "Rheumatology", | ||
"expansion" : "Rituximab in ANCA-Associated Vasculitis", | "expansion" : "Rituximab in ANCA-Associated Vasculitis", | ||
| Line 2,133: | Line 2,140: | ||
"published" : "2010-07-15", | "published" : "2010-07-15", | ||
"pageName" : "RAVE", | "pageName" : "RAVE", | ||
"diseases" : "Vasculitis", | "diseases" : "Vasculitis", | ||
" | "abbreviation" : "RAVE", | ||
"title" : "Rituximab versus cyclophosphamide for ANCA-associated vasculitis", | "title" : "Rituximab versus cyclophosphamide for ANCA-associated vasculitis", | ||
"pmid" : "20647199" | |||
"pmid" : "20647199 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-10-22T10:35:20Z", | "timestamp" : "2013-10-22T10:35:20Z", | ||
"briefDesignDescription" : "Dabigatran in mechanical heart valves", | "briefDesignDescription" : "Dabigatran in mechanical heart valves", | ||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa1300615", | "fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa1300615", | ||
"pageid" : 1707, | "pageid" : 1707, | ||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa1300615", | "pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa1300615", | ||
"trainingLevel" : "Resident\n}}", | "trainingLevel" : "Resident\n}}", | ||
"citation" : "Eikelboom JW, <i>et al</i>. \"Dabigatran versus warfarin in patients with mechanical heart valves\". <i>The New England Journal of Medicine</i>. 2013. 369(13):1206-1214." | "citation" : "Eikelboom JW, <i>et al</i>. \"Dabigatran versus warfarin in patients with mechanical heart valves\". <i>The New England Journal of Medicine</i>. 2013. 369(13):1206-1214.", | ||
"subspecialties" : "Cardiology;Hematology", | |||
"expansion" : "Randomized, Phase II Study to Evaluate the Safety and Pharmacokinetics of Oral Dabigatran Etexilate in Patients after Heart Valve Replacement", | |||
"briefResultsDescription" : "Dabigatran has more thromboembolism and bleeding than warfarin", | |||
"published" : "2013-09-26", | |||
"pageName" : "RE-ALIGN", | |||
"diseases" : "Valvular Disease", | |||
"abbreviation" : "RE-ALIGN", | |||
"title" : "Dabigatran versus warfarin in patients with mechanical heart valves", | |||
"pmid" : "23991661" | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-08-13T15:11:42Z", | |||
"briefDesignDescription" : "Dabigatran vs. warfarin in VTE", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa0906598", | |||
"pageid" : 973, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa0906598", | |||
"trainingLevel" : "fellow", | |||
"citation" : "Schulman S, <i>et al</i>. \"Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism\". <i>New England Journal of Medicine</i>. 2009. 361(24):2342-52.", | |||
"subspecialties" : "Hematology;Pulmonology", | "subspecialties" : "Hematology;Pulmonology", | ||
"expansion" : "Efficacy and Safety of Dabigatran Compared to Warfarin for 6 Month Treatment of Acute Symptomatic Venous Thromboembolism", | "expansion" : "Efficacy and Safety of Dabigatran Compared to Warfarin for 6 Month Treatment of Acute Symptomatic Venous Thromboembolism", | ||
| Line 2,169: | Line 2,176: | ||
"published" : "2009-12-10", | "published" : "2009-12-10", | ||
"pageName" : "RE-COVER", | "pageName" : "RE-COVER", | ||
"diseases" : "Deep Vein Thrombosis;Pulmonary Embolism;Venous Thromboembolism", | "diseases" : "Deep Vein Thrombosis;Pulmonary Embolism;Venous Thromboembolism", | ||
" | "abbreviation" : "RE-COVER", | ||
"title" : "Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism", | "title" : "Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism", | ||
"pmid" : "19966341" | |||
"pmid" : "19966341 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-10-09T22:19:06Z", | |||
"briefDesignDescription" : "Dabigatran vs. warfarin in AF", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa0905561", | |||
"pageid" : 178, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa0905561", | |||
"trainingLevel" : "Resident\n}}", | |||
"citation" : "Connolly SJ, <i>et al</i>. \"Dabigatran versus warfarin in patients with atrial fibrillation\". <i>The New England Journal of Medicine</i>. 2009. 361(12):1139-51.", | |||
"subspecialties" : "Cardiology", | "subspecialties" : "Cardiology", | ||
"expansion" : "Randomized Evaluation of Long-Term Anticoagulation Therapy", | "expansion" : "Randomized Evaluation of Long-Term Anticoagulation Therapy", | ||
| Line 2,187: | Line 2,194: | ||
"published" : "2009-09-17", | "published" : "2009-09-17", | ||
"pageName" : "RE-LY", | "pageName" : "RE-LY", | ||
"diseases" : "Atrial Fibrillation;Stroke;Transient Ischemic Attack", | "diseases" : "Atrial Fibrillation;Stroke;Transient Ischemic Attack", | ||
" | "abbreviation" : "RE-LY", | ||
"title" : "Dabigatran versus warfarin in patients with atrial fibrillation", | "title" : "Dabigatran versus warfarin in patients with atrial fibrillation", | ||
"pmid" : "19717844" | |||
"pmid" : "19717844 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-10-09T13:16:45Z", | |||
"briefDesignDescription" : "5d vs. 14d steroids in acute COPD", | |||
"fulltexturl" : null, | |||
"pageid" : 1615, | |||
"pdfurl" : null, | |||
"trainingLevel" : "Intern", | |||
"citation" : "Leuppi JD, <i>et al</i>. \"Short-term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial\". <i>JAMA</i>. 2013. 309(21):2223-2231.", | |||
"subspecialties" : "Pulmonology", | "subspecialties" : "Pulmonology", | ||
"expansion" : "Reduction in the Use of Corticosteroids in Exacerbated COPD", | "expansion" : "Reduction in the Use of Corticosteroids in Exacerbated COPD", | ||
| Line 2,205: | Line 2,212: | ||
"published" : "2013-06-05", | "published" : "2013-06-05", | ||
"pageName" : "REDUCE", | "pageName" : "REDUCE", | ||
"diseases" : "Chronic Obstructive Pulmonary Disease", | "diseases" : "Chronic Obstructive Pulmonary Disease", | ||
" | "abbreviation" : "REDUCE", | ||
"title" : "Short-term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial", | "title" : "Short-term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial", | ||
"pmid" : "23695200" | |||
"pmid" : "23695200 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-08-05T15:03:59Z", | |||
"briefDesignDescription" : "ARBs in diabetic nephropathy", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa011161", | |||
"pageid" : 1030, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa011161", | |||
"trainingLevel" : "Intern", | |||
"citation" : "Brenner BM, <i>et al</i>. \"Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy\". <i>The New England Journal of Medicine</i>. 2001. 345(12):861-869.", | |||
"subspecialties" : "Endocrinology;Nephrology", | "subspecialties" : "Endocrinology;Nephrology", | ||
"expansion" : "Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan", | "expansion" : "Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan", | ||
| Line 2,223: | Line 2,230: | ||
"published" : "2001-09-20", | "published" : "2001-09-20", | ||
"pageName" : "RENAAL", | "pageName" : "RENAAL", | ||
"diseases" : "Diabetes Mellitus;Chronic Kidney Disease", | "diseases" : "Diabetes Mellitus;Chronic Kidney Disease", | ||
" | "abbreviation" : "RENAAL", | ||
"title" : "Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy", | "title" : "Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy", | ||
" | "pmid" : "11565518" | ||
" | }, | ||
" | { | ||
"timestamp" : "2013-08-15T18:48:57Z", | |||
"briefDesignDescription" : "PFO closure in cryptogenic stroke", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa1301440", | |||
"pageid" : 1334, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa1301440", | |||
"trainingLevel" : "Intern", | "trainingLevel" : "Intern", | ||
"citation" : " | "citation" : "Carroll JD, <i>et al</i>. \"Closure of patent foramen ovale versus medical therapy after cryptogenic stroke\". <i>The New England Journal of Medicine</i>. 2013. 368(12):1092-1100.", | ||
"subspecialties" : "Neurology;Cardiology", | "subspecialties" : "Neurology;Cardiology", | ||
"expansion" : "Randomized Evaluation of Recurrent Stroke Comparing PFO Closure to Established Current Standard of Care Treatment", | "expansion" : "Randomized Evaluation of Recurrent Stroke Comparing PFO Closure to Established Current Standard of Care Treatment", | ||
| Line 2,241: | Line 2,248: | ||
"published" : "2013-03-21", | "published" : "2013-03-21", | ||
"pageName" : "RESPECT", | "pageName" : "RESPECT", | ||
"diseases" : "Stroke;Patent Foramen Ovale;Transient Ischemic Attack", | "diseases" : "Stroke;Patent Foramen Ovale;Transient Ischemic Attack", | ||
" | "abbreviation" : "RESPECT", | ||
"title" : "Closure of patent foramen ovale versus medical therapy after cryptogenic stroke", | "title" : "Closure of patent foramen ovale versus medical therapy after cryptogenic stroke", | ||
"pmid" : "23514286" | |||
"pmid" : "23514286 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-05-31T12:20:36Z", | |||
"briefDesignDescription" : "Early goal-directed therapy in sepsis", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa010307", | |||
"pageid" : 60, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa010307", | |||
"trainingLevel" : "Student", | |||
"citation" : "Rivers E, <i>et al</i>. \"Early Goal Directed Therapy in the Treatment of Severe Sepsis and Septic Shock\". <i>The New England Journal of Medicine</i>. 2001. 345(19):1368-1377.", | |||
"subspecialties" : "Critical Care;Emergency Medicine", | "subspecialties" : "Critical Care;Emergency Medicine", | ||
"expansion" : "", | "expansion" : "", | ||
| Line 2,259: | Line 2,266: | ||
"published" : "2001-11-08", | "published" : "2001-11-08", | ||
"pageName" : "Rivers Trial", | "pageName" : "Rivers Trial", | ||
"diseases" : "Sepsis;Shock", | "diseases" : "Sepsis;Shock", | ||
" | "abbreviation" : "", | ||
"title" : "Early Goal Directed Therapy in the Treatment of Severe Sepsis and Septic Shock", | "title" : "Early Goal Directed Therapy in the Treatment of Severe Sepsis and Septic Shock", | ||
"pmid" : "11794169" | |||
"pmid" : "11794169 | |||
}, | }, | ||
{ | { | ||
"subspecialties" : "Cardiology;Neurology", | "timestamp" : "2013-08-20T14:18:59Z", | ||
"briefDesignDescription" : "Rivaroxaban vs. warfarin in AF", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa1009638", | |||
"pageid" : 1358, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa1009638", | |||
"trainingLevel" : "Student", | |||
"citation" : "Patel MR, <i>et al</i>. \"Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation\". <i>The New England Journal of Medicine</i>. 2011. 365(10):883-891.", | |||
"subspecialties" : "Cardiology;Neurology", | |||
"expansion" : "Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation", | "expansion" : "Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation", | ||
"briefResultsDescription" : "Rivaroxaban is noninferior to warfarin for stroke/embolization prevention in nonvalvular AF", | "briefResultsDescription" : "Rivaroxaban is noninferior to warfarin for stroke/embolization prevention in nonvalvular AF", | ||
"published" : "2011-09-08", | "published" : "2011-09-08", | ||
"pageName" : "ROCKET AF", | "pageName" : "ROCKET AF", | ||
"diseases" : "Atrial Fibrillation;Stroke;Transient Ischemic Attack", | "diseases" : "Atrial Fibrillation;Stroke;Transient Ischemic Attack", | ||
" | "abbreviation" : "ROCKET AF", | ||
"title" : "Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation", | "title" : "Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation", | ||
"pmid" : "21830957" | |||
"pmid" : "21830957 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-06-30T15:43:08Z", | |||
"briefDesignDescription" : "Sertraline for depression post-ACS", | |||
"fulltexturl" : "http://jama.ama-assn.org/content/288/6/701.full", | |||
"pageid" : 423, | |||
"pdfurl" : "http://jama.ama-assn.org/content/288/6/701.full.pdf", | |||
"trainingLevel" : "Resident", | |||
"citation" : "Glassman AH, <i>et al</i>. \"Sertraline treatment of major depression in patients with acute MI or unstable angina\". <i>Journal of the American Medical Association</i>. 2002. 288(6):701-709.", | |||
"subspecialties" : "Psychiatry;Cardiology", | "subspecialties" : "Psychiatry;Cardiology", | ||
"expansion" : "Sertraline Antidepressant Heart Attack Randomized Trial", | "expansion" : "Sertraline Antidepressant Heart Attack Randomized Trial", | ||
| Line 2,295: | Line 2,302: | ||
"published" : "2002-08-14", | "published" : "2002-08-14", | ||
"pageName" : "SADHART", | "pageName" : "SADHART", | ||
"diseases" : "Depression;Acute Coronary Syndrome", | "diseases" : "Depression;Acute Coronary Syndrome", | ||
" | "abbreviation" : "SADHAT", | ||
"title" : "Sertraline treatment of major depression in patients with acute MI or unstable angina", | "title" : "Sertraline treatment of major depression in patients with acute MI or unstable angina", | ||
"pmid" : "12169073" | |||
"pmid" : "12169073 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2012-04-23T15:41:28Z", | "timestamp" : "2012-04-23T15:41:28Z", | ||
"briefDesignDescription" : "Albumin vs. saline in ICU", | "briefDesignDescription" : "Albumin vs. saline in ICU", | ||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa040232", | "fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa040232", | ||
"pageid" : 285, | "pageid" : 285, | ||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa040232", | "pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa040232", | ||
"trainingLevel" : "Intern", | "trainingLevel" : "Intern", | ||
"citation" : "Finfer S, <i>et al</i>. \"A comparison of albumin and saline for fluid resuscitation in the intensive care unit\". <i>The New England Journal of Medicine</i>. 2004. 350(22):2247-2256." | "citation" : "Finfer S, <i>et al</i>. \"A comparison of albumin and saline for fluid resuscitation in the intensive care unit\". <i>The New England Journal of Medicine</i>. 2004. 350(22):2247-2256.", | ||
"subspecialties" : "Critical Care", | |||
"expansion" : "Saline versus Albumin Fluid Evaluation", | |||
"briefResultsDescription" : "No mortality difference (except worse mortality with albumin for TBI)", | |||
"published" : "2004-05-27", | |||
"pageName" : "SAFE", | |||
"diseases" : "Critical Illness", | |||
"abbreviation" : "SAFE", | |||
"title" : "A comparison of albumin and saline for fluid resuscitation in the intensive care unit", | |||
"pmid" : "15163774" | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-06-30T15:43:54Z", | |||
"briefDesignDescription" : "Captopril in MI with LV dysfunction", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJM199209033271001", | |||
"pageid" : 150, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJM199209033271001", | |||
"trainingLevel" : "Resident", | |||
"citation" : "Pfeffer MA, <i>et al</i>. \"Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial Infarction — Results of the Survival and Ventricular Enlargement Trial\". <i>The New England Journal of Medicine</i>. 1992. 327(10):669-677.", | |||
"subspecialties" : "Cardiology", | "subspecialties" : "Cardiology", | ||
"expansion" : "Survival and Ventricular Enlargement Trial", | "expansion" : "Survival and Ventricular Enlargement Trial", | ||
| Line 2,331: | Line 2,338: | ||
"published" : "1992-09-03", | "published" : "1992-09-03", | ||
"pageName" : "SAVE", | "pageName" : "SAVE", | ||
"diseases" : "Acute Coronary Syndrome;Myocardial Infarction;Heart Failure", | "diseases" : "Acute Coronary Syndrome;Myocardial Infarction;Heart Failure", | ||
" | "abbreviation" : "SAVE", | ||
"title" : "Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial Infarction — Results of the Survival and Ventricular Enlargement Trial", | "title" : "Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial Infarction — Results of the Survival and Ventricular Enlargement Trial", | ||
"pmid" : "1386652" | |||
"pmid" : "1386652 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-04-09T23:23:32Z", | |||
"briefDesignDescription" : "Amiodarone or ICD in severe HF", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa043399", | |||
"pageid" : 40, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa043399", | |||
"trainingLevel" : "Intern", | |||
"citation" : "Bardy GH, <i>et al</i>. \"Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure\". <i>The New England Journal of Medicine</i>. 2005. 252(3):225-37.", | |||
"subspecialties" : "Cardiology", | "subspecialties" : "Cardiology", | ||
"expansion" : "Sudden Cardiac Death in Heart Failure Trial", | "expansion" : "Sudden Cardiac Death in Heart Failure Trial", | ||
| Line 2,349: | Line 2,356: | ||
"published" : "2005-01-20", | "published" : "2005-01-20", | ||
"pageName" : "SCD-HeFT", | "pageName" : "SCD-HeFT", | ||
"diseases" : "Heart Failure", | "diseases" : "Heart Failure", | ||
" | "abbreviation" : "SCD-HeFT", | ||
"title" : "Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure", | "title" : "Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure", | ||
"pmid" : "15659722" | |||
"pmid" : "15659722 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2012-12-13T23:16:37Z", | |||
"briefDesignDescription" : "Dexmedetomidine vs. midazolam for sedation", | |||
"fulltexturl" : "http://jama.ama-assn.org.laneproxy.stanford.edu/content/301/5/489.long", | |||
"pageid" : 353, | |||
"pdfurl" : "http://jama.ama-assn.org.laneproxy.stanford.edu/content/301/5/489.full.pdf", | |||
"trainingLevel" : "Resident", | |||
"citation" : "Riker RR, <i>et al</i>. \"Dexmedetomidine vs. Midazolam for Sedation of Critically Ill Patients\". <i>Journal of American Medical Association</i>. 2009. 301(5):489-499.", | |||
"subspecialties" : "Critical Care", | "subspecialties" : "Critical Care", | ||
"expansion" : "Safety and Efficacy of Dexmedetomidine Compared with Midazolam", | "expansion" : "Safety and Efficacy of Dexmedetomidine Compared with Midazolam", | ||
| Line 2,367: | Line 2,374: | ||
"published" : "2009-02-04", | "published" : "2009-02-04", | ||
"pageName" : "SEDCOM", | "pageName" : "SEDCOM", | ||
"diseases" : "Critical Illness", | "diseases" : "Critical Illness", | ||
" | "abbreviation" : "SEDCOM", | ||
"title" : "Dexmedetomidine vs. Midazolam for Sedation of Critically Ill Patients", | "title" : "Dexmedetomidine vs. Midazolam for Sedation of Critically Ill Patients", | ||
"pmid" : "19188334" | |||
"pmid" : "19188334 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-06-30T15:44:44Z", | |||
"briefDesignDescription" : "Early PCI/CABG in MI + shock", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJM199908263410901", | |||
"pageid" : 388, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJM199908263410901", | |||
"trainingLevel" : "Resident", | |||
"citation" : "Hochman JS, <i>et al</i>. \"Early Revascularization in Acute Myocardial Infarction Complicated by Cardiogenic Shock\". <i>The New England Journal of Medicine</i>. 1999. 341(9):625-634.", | |||
"subspecialties" : "Cardiology;Critical Care", | "subspecialties" : "Cardiology;Critical Care", | ||
"expansion" : "SHould we emergently revascularize Occluded Coronaries for Cardiogenic shocK", | "expansion" : "SHould we emergently revascularize Occluded Coronaries for Cardiogenic shocK", | ||
| Line 2,385: | Line 2,392: | ||
"published" : "1999-08-26", | "published" : "1999-08-26", | ||
"pageName" : "SHOCK", | "pageName" : "SHOCK", | ||
"diseases" : "Acute Coronary Syndrome;Myocardial Infarction;Shock", | "diseases" : "Acute Coronary Syndrome;Myocardial Infarction;Shock", | ||
" | "abbreviation" : "SHOCK", | ||
"title" : "Early Revascularization in Acute Myocardial Infarction Complicated by Cardiogenic Shock", | "title" : "Early Revascularization in Acute Myocardial Infarction Complicated by Cardiogenic Shock", | ||
"pmid" : "10460813" | |||
}, | |||
"pmid" : "10460813 | |||
}, | |||
{ | { | ||
"timestamp" : "2012-08-28T16:50:41Z", | |||
"briefDesignDescription" : "Salmeterol in asthma", | |||
"fulltexturl" : "http://chestjournal.chestpubs.org/content/129/1/15.long", | |||
"pageid" : 512, | |||
"pdfurl" : "http://chestjournal.chestpubs.org/content/129/1/15.full.pdf", | |||
"trainingLevel" : "intern", | |||
"citation" : "Nelson HS, <i>et al</i>. \"The salmeterol multicenter asthma research trial\". <i>Chest</i>. 2006. 129(1):15-26.", | |||
"subspecialties" : "Pulmonology", | "subspecialties" : "Pulmonology", | ||
"expansion" : "Salmeterol Multicenter Asthma Research Trial", | "expansion" : "Salmeterol Multicenter Asthma Research Trial", | ||
| Line 2,403: | Line 2,410: | ||
"published" : "2006-01-01", | "published" : "2006-01-01", | ||
"pageName" : "SMART", | "pageName" : "SMART", | ||
"diseases" : "Asthma", | "diseases" : "Asthma", | ||
" | "abbreviation" : "SMART", | ||
"title" : "The salmeterol multicenter asthma research trial", | "title" : "The salmeterol multicenter asthma research trial", | ||
"pmid" : "16424409" | |||
"pmid" : "16424409 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-08-29T05:19:54Z", | |||
"briefDesignDescription" : "Dopamine vs. norepinephrine in shock", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa0907118", | |||
"pageid" : 113, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa0907118", | |||
"trainingLevel" : "Intern", | |||
"citation" : "De Backer D, <i>et al</i>. \"Comparison of dopamine and norepinephrine in the treatment of shock\". <i>The New England Journal of Medicine</i>. 2010. 362(9):779-89.", | |||
"subspecialties" : "Critical Care;Emergency Medicine", | "subspecialties" : "Critical Care;Emergency Medicine", | ||
"expansion" : "Sepsis Occurrence in Acutely Ill Patients II", | "expansion" : "Sepsis Occurrence in Acutely Ill Patients II", | ||
| Line 2,421: | Line 2,428: | ||
"published" : "2010-03-04", | "published" : "2010-03-04", | ||
"pageName" : "SOAP II", | "pageName" : "SOAP II", | ||
"diseases" : "Sepsis;Shock", | "diseases" : "Sepsis;Shock", | ||
" | "abbreviation" : "SOAP II", | ||
"title" : "Comparison of dopamine and norepinephrine in the treatment of shock", | "title" : "Comparison of dopamine and norepinephrine in the treatment of shock", | ||
"pmid" : "20200382" | |||
"pmid" : "20200382 | |||
}, | }, | ||
{ | { | ||
"subspecialties" : "Cardiology", | "timestamp" : "2013-03-13T05:25:09Z", | ||
"briefDesignDescription" : "Enalapril in moderate-severe HF", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJM199108013250501", | |||
"pageid" : 394, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJM199108013250501", | |||
"trainingLevel" : "Resident", | |||
"citation" : "Yusuf S, <i>et al</i>. \"Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart Failure\". <i>The New England Journal of Medicine</i>. 1991. 325(5):293-302.", | |||
"subspecialties" : "Cardiology", | |||
"expansion" : "Studies of Left Ventricular Dysfunction", | "expansion" : "Studies of Left Ventricular Dysfunction", | ||
"briefResultsDescription" : "Enalapril reduces mortality and HF hospitalizations in HF", | "briefResultsDescription" : "Enalapril reduces mortality and HF hospitalizations in HF", | ||
"published" : "1991-08-01", | "published" : "1991-08-01", | ||
"pageName" : "SOLVD", | "pageName" : "SOLVD", | ||
"diseases" : "Heart Failure", | "diseases" : "Heart Failure", | ||
" | "abbreviation" : "SOLVD", | ||
"title" : "Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart Failure", | "title" : "Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart Failure", | ||
"pmid" : "2057034" | |||
"pmid" : "2057034 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-08-15T10:32:54Z", | |||
"briefDesignDescription" : "Atorvastatin after stroke", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa061894", | |||
"pageid" : 461, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa061894", | |||
"trainingLevel" : "intern", | |||
"citation" : "Amarenco P, <i>et al</i>. \"High-dose atorvastatin after stroke or transient ischemic attack\". <i>The New England Journal of Medicine</i>. 2006. 355(6):549-559.", | |||
"subspecialties" : "Neurology", | "subspecialties" : "Neurology", | ||
"expansion" : "Stroke Prevention by Aggressive Reduction in Cholesterol Levels", | "expansion" : "Stroke Prevention by Aggressive Reduction in Cholesterol Levels", | ||
| Line 2,457: | Line 2,464: | ||
"published" : "2006-08-10", | "published" : "2006-08-10", | ||
"pageName" : "SPARCL", | "pageName" : "SPARCL", | ||
"diseases" : "Stroke;Hyperlipidemia;Transient Ischemic Attack", | "diseases" : "Stroke;Hyperlipidemia;Transient Ischemic Attack", | ||
" | "abbreviation" : "SPARCL", | ||
"title" : "High-dose atorvastatin after stroke or transient ischemic attack", | "title" : "High-dose atorvastatin after stroke or transient ischemic attack", | ||
"pmid" : "16899775" | |||
"pmid" : "16899775 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-06-20T19:29:27Z", | "timestamp" : "2013-06-20T19:29:27Z", | ||
"briefDesignDescription" : "Tamoxifen vs. raloxifene in breast cancer prevention", | "briefDesignDescription" : "Tamoxifen vs. raloxifene in breast cancer prevention", | ||
"fulltexturl" : "http://jama.jamanetwork.com/article.aspx?articleid", | "fulltexturl" : "http://jama.jamanetwork.com/article.aspx?articleid", | ||
"pageid" : 963, | "pageid" : 963, | ||
"pdfurl" : "http://jama.jamanetwork.com/data/Journals/JAMA/5028/JOC60074.pdf", | "pdfurl" : "http://jama.jamanetwork.com/data/Journals/JAMA/5028/JOC60074.pdf", | ||
"trainingLevel" : "Fellow", | "trainingLevel" : "Fellow", | ||
"citation" : "Vogel VG, <i>et al</i>. \"Effects of Tamoxifen vs Raloxifene on the Risk of Developing Invasive Breast Cancer and Other Disease Outcomes\". <i>Journal of the American Medical Association</i>. 2006. 295(23):2727-2741." | "citation" : "Vogel VG, <i>et al</i>. \"Effects of Tamoxifen vs Raloxifene on the Risk of Developing Invasive Breast Cancer and Other Disease Outcomes\". <i>Journal of the American Medical Association</i>. 2006. 295(23):2727-2741.", | ||
"subspecialties" : "Oncology", | |||
"expansion" : "Study of Tamoxifen and Raloxifene (NSABP P-2)", | |||
"briefResultsDescription" : "Similar reduction in breast cancer risk but fewer adverse effects with raloxifene", | |||
"published" : "2006-06-21", | |||
"pageName" : "STAR", | |||
"diseases" : "Breast Cancer", | |||
"abbreviation" : "STAR", | |||
"title" : "Effects of Tamoxifen vs Raloxifene on the Risk of Developing Invasive Breast Cancer and Other Disease Outcomes", | |||
"pmid" : "16754727" | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-09-04T17:04:52Z", | |||
"briefDesignDescription" : "Tiered approach for depression", | |||
"fulltexturl" : "", | |||
"pageid" : 1564, | |||
"pdfurl" : "http://ajp.psychiatryonline.org/data/Journals/AJP/3782/06aj1905.PDF", | |||
"trainingLevel" : "Resident", | |||
"citation" : "Rush AJ <i>et al</i>. \"Acute and longer-term outcomes in depressed outpatient requiring one or several treatment steps: A STAR*D report\". <i>The American Journal of Psychiatry</i>. 2006. 163(11):1905-1917.", | |||
"subspecialties" : "Psychiatry", | "subspecialties" : "Psychiatry", | ||
"expansion" : "Sequenced Treatment Alternatives to Relieve Depression", | "expansion" : "Sequenced Treatment Alternatives to Relieve Depression", | ||
| Line 2,493: | Line 2,500: | ||
"published" : "2006-11-01", | "published" : "2006-11-01", | ||
"pageName" : "STAR-D", | "pageName" : "STAR-D", | ||
"diseases" : "Depression", | "diseases" : "Depression", | ||
" | "abbreviation" : "STAR-D", | ||
"title" : "Acute and longer-term outcomes in depressed outpatient requiring one or several treatment steps: A STAR*D report", | "title" : "Acute and longer-term outcomes in depressed outpatient requiring one or several treatment steps: A STAR*D report", | ||
"pmid" : "17074942" | |||
"pmid" : "17074942 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-06-18T17:07:32Z", | |||
"briefDesignDescription" : "CABG in ischemic HF", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa1100356", | |||
"pageid" : 471, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa1100356", | |||
"trainingLevel" : "Resident", | |||
"citation" : "Velazquez EJ, <i>et al</i>. \"Coronary-Artery Bypass Surgery in Patients with Left Ventricular Dysfunction\". <i>The New England Journal of Medicine</i>. 2011. 354(17):1607-1616.", | |||
"subspecialties" : "Cardiology", | "subspecialties" : "Cardiology", | ||
"expansion" : "Surgical Treatment for Ischemic Heart Failure", | "expansion" : "Surgical Treatment for Ischemic Heart Failure", | ||
| Line 2,511: | Line 2,518: | ||
"published" : "2011-04-28", | "published" : "2011-04-28", | ||
"pageName" : "STICH", | "pageName" : "STICH", | ||
"diseases" : "Heart Failure;Coronary Artery Disease", | "diseases" : "Heart Failure;Coronary Artery Disease", | ||
" | "abbreviation" : "STICH", | ||
"title" : "Coronary-Artery Bypass Surgery in Patients with Left Ventricular Dysfunction", | "title" : "Coronary-Artery Bypass Surgery in Patients with Left Ventricular Dysfunction", | ||
"pmid" : "21463150" | |||
"pmid" : "21463150 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-11-26T02:02:32Z", | |||
"briefDesignDescription" : "PCI vs. CABG in severe CAD", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa0804626", | |||
"pageid" : 525, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa0804626", | |||
"trainingLevel" : "Resident", | |||
"citation" : "Serruys PW, <i>et al</i>. \"Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery Disease\". <i>The New England Journal of Medicine</i>. 2009. 360(10):961-972.", | |||
"subspecialties" : "Cardiology;Surgery", | "subspecialties" : "Cardiology;Surgery", | ||
"expansion" : "Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery", | "expansion" : "Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery", | ||
| Line 2,529: | Line 2,536: | ||
"published" : "2009-03-05", | "published" : "2009-03-05", | ||
"pageName" : "SYNTAX", | "pageName" : "SYNTAX", | ||
"diseases" : "Coronary Artery Disease", | "diseases" : "Coronary Artery Disease", | ||
" | "abbreviation" : "SYNTAX", | ||
"title" : "Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery Disease", | "title" : "Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery Disease", | ||
"pmid" : "19228612" | |||
"pmid" : "19228612 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2012-09-16T11:23:34Z", | |||
"briefDesignDescription" : "Salmeterol/fluticasone in COPD", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa063070", | |||
"pageid" : 124, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa063070", | |||
"trainingLevel" : "Student", | |||
"citation" : "Calverley PM, <i>et al</i>. \"Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease\". <i>The New England Journal of Medicine</i>. 2007. 356(8):775-789.", | |||
"subspecialties" : "Pulmonology", | "subspecialties" : "Pulmonology", | ||
"expansion" : "Towards a Revolution in COPD Health", | "expansion" : "Towards a Revolution in COPD Health", | ||
| Line 2,547: | Line 2,554: | ||
"published" : "2007-02-22", | "published" : "2007-02-22", | ||
"pageName" : "TORCH", | "pageName" : "TORCH", | ||
"diseases" : "Chronic Obstructive Pulmonary Disease", | "diseases" : "Chronic Obstructive Pulmonary Disease", | ||
" | "abbreviation" : "TORCH", | ||
"title" : "Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease", | "title" : "Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease", | ||
"pmid" : "17314337" | |||
}, | |||
"pmid" : "17314337 | |||
}, | |||
{ | { | ||
"timestamp" : "2012-06-15T06:06:07Z", | |||
"briefDesignDescription" : "Darbepoetin in CKD and T2DM", | |||
"fulltexturl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa0907845", | |||
"pageid" : 5, | |||
"pdfurl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa0907845", | |||
"trainingLevel" : "Resident", | |||
"citation" : "Pfeffer MA, <i>et al</i>. \"A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease\". <i>The New England Journal of Medicine</i>. 2009. 361(21):2019-32.", | |||
"subspecialties" : "Nephrology;Hematology;Endocrinology", | "subspecialties" : "Nephrology;Hematology;Endocrinology", | ||
"expansion" : "Trial to Reduce Cardiovascular Events With Aranesp Therapy", | "expansion" : "Trial to Reduce Cardiovascular Events With Aranesp Therapy", | ||
| Line 2,565: | Line 2,572: | ||
"published" : "2009-11-19", | "published" : "2009-11-19", | ||
"pageName" : "TREAT", | "pageName" : "TREAT", | ||
"diseases" : "Chronic Kidney Disease;Anemia;Diabetes Mellitus", | "diseases" : "Chronic Kidney Disease;Anemia;Diabetes Mellitus", | ||
" | "abbreviation" : "TREAT", | ||
"title" : "A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease", | "title" : "A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease", | ||
"pmid" : "19880844" | |||
"pmid" : "19880844 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-07-25T09:17:02Z", | |||
"briefDesignDescription" : "ICU transfusion threshold", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJM199902113400601", | |||
"pageid" : 104, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJM199902113400601", | |||
"trainingLevel" : "Intern", | |||
"citation" : "Hebert PC, <i>et al</i>. \"A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care\". <i>The New England Journal of Medicine</i>. 1999. 340(6):409-417.", | |||
"subspecialties" : "Critical Care;Hematology", | "subspecialties" : "Critical Care;Hematology", | ||
"expansion" : "Transfusion Requirements in Critical Care", | "expansion" : "Transfusion Requirements in Critical Care", | ||
| Line 2,583: | Line 2,590: | ||
"published" : "1999-02-11", | "published" : "1999-02-11", | ||
"pageName" : "TRICC", | "pageName" : "TRICC", | ||
"diseases" : "Anemia", | "diseases" : "Anemia", | ||
" | "abbreviation" : "TRICC", | ||
"title" : "A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care", | "title" : "A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care", | ||
"pmid" : "9971864" | |||
"pmid" : "9971864 | |||
}, | }, | ||
{ | { | ||
"subspecialties" : "Cardiology", | "timestamp" : "2013-08-16T04:33:00Z", | ||
"briefDesignDescription" : "Prasugrel vs. clopidogrel in ACS", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa0706482", | |||
"pageid" : 1398, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa0706482", | |||
"trainingLevel" : "Resident", | |||
"citation" : "Wiviott ST, <i>et al</i>. \"Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes\". <i>The New England Journal of Medicine</i>. 2007. 357(20):2001-2015.", | |||
"subspecialties" : "Cardiology", | |||
"expansion" : "Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel–Thrombolysis in Myocardial Infarction 38", | "expansion" : "Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel–Thrombolysis in Myocardial Infarction 38", | ||
"briefResultsDescription" : "Prasugrel decreases CV mortality/morbidity, increases bleeding", | "briefResultsDescription" : "Prasugrel decreases CV mortality/morbidity, increases bleeding", | ||
"published" : "2007-11-15", | "published" : "2007-11-15", | ||
"pageName" : "TRITON-TIMI 38", | "pageName" : "TRITON-TIMI 38", | ||
"diseases" : "Acute Coronary Syndrome", | "diseases" : "Acute Coronary Syndrome", | ||
" | "abbreviation" : "TRITON-TIMI 38", | ||
"title" : "Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes", | "title" : "Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes", | ||
"pmid" : "17982182" | |||
"pmid" : "17982182 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-11-02T15:38:25Z", | |||
"briefDesignDescription" : "Intensive glycemic therapy in T2DM", | |||
"fulltexturl" : "http://linkinghub.elsevier.com/retrieve/pii/S0140673698070196", | |||
"pageid" : 253, | |||
"pdfurl" : "", | |||
"trainingLevel" : "Intern", | |||
"citation" : "Turner R, <i>et al</i>. \"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes\". <i>The Lancet</i>. 1998. 352(9131):837-53.", | |||
"subspecialties" : "Endocrinology", | "subspecialties" : "Endocrinology", | ||
"expansion" : "United Kingdom Prospective Diabetes Study", | "expansion" : "United Kingdom Prospective Diabetes Study", | ||
| Line 2,619: | Line 2,626: | ||
"published" : "1998-09-12", | "published" : "1998-09-12", | ||
"pageName" : "UKPDS 33", | "pageName" : "UKPDS 33", | ||
"diseases" : "Diabetes Mellitus", | "diseases" : "Diabetes Mellitus", | ||
" | "abbreviation" : "UKPDS", | ||
"title" : "Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes", | "title" : "Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes", | ||
"pmid" : "9742976" | |||
"pmid" : "9742976 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2012-10-29T23:28:48Z", | "timestamp" : "2012-10-29T23:28:48Z", | ||
"briefDesignDescription" : "Tiotropium in COPD", | "briefDesignDescription" : "Tiotropium in COPD", | ||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa0805800", | "fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa0805800", | ||
"pageid" : 123, | "pageid" : 123, | ||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa0805800", | "pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa0805800", | ||
"trainingLevel" : "Resident", | "trainingLevel" : "Resident", | ||
"citation" : "Tashkin DP, <i>et al</i>. \"A 4-Year Trial of Tiotropium in Chronic Obstructive Pulmonary Disease\". <i>The New England Journal of Medicine</i>. 2008. 395(15):1543-1554." | "citation" : "Tashkin DP, <i>et al</i>. \"A 4-Year Trial of Tiotropium in Chronic Obstructive Pulmonary Disease\". <i>The New England Journal of Medicine</i>. 2008. 395(15):1543-1554.", | ||
"subspecialties" : "Pulmonology", | |||
"expansion" : "Understanding Potential Long-Term Impacts on Function with Tiotropium", | |||
"briefResultsDescription" : "Decreased exacerbations and mortality", | |||
"published" : "2008-10-09", | |||
"pageName" : "UPLIFT", | |||
"diseases" : "Chronic Obstructive Pulmonary Disease", | |||
"abbreviation" : "UPLIFT", | |||
"title" : "A 4-Year Trial of Tiotropium in Chronic Obstructive Pulmonary Disease", | |||
"pmid" : "18836213" | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-06-05T10:08:18Z", | |||
"briefDesignDescription" : "ISDN/hydralazine in HF", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJM198606123142404", | |||
"pageid" : 155, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJM198606123142404", | |||
"trainingLevel" : "student", | |||
"citation" : "Cohn JN, <i>et al</i>. \"Effect of vasodilator therapy on mortality in chronic congestive heart failure\". <i>The New England Journal of Medicine</i>. 1986. 314(24):1547-52.", | |||
"subspecialties" : "Cardiology", | "subspecialties" : "Cardiology", | ||
"expansion" : "Vasodilator Heart Failure Trial", | "expansion" : "Vasodilator Heart Failure Trial", | ||
| Line 2,655: | Line 2,662: | ||
"published" : "1986-06-12", | "published" : "1986-06-12", | ||
"pageName" : "V-HeFT", | "pageName" : "V-HeFT", | ||
"diseases" : "Heart Failure", | "diseases" : "Heart Failure", | ||
" | "abbreviation" : "V-HeFT", | ||
"title" : "Effect of vasodilator therapy on mortality in chronic congestive heart failure", | "title" : "Effect of vasodilator therapy on mortality in chronic congestive heart failure", | ||
"pmid" : "3520315" | |||
"pmid" : "3520315 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2012-04-16T22:52:08Z", | |||
"briefDesignDescription" : "Aspirin in unstable angina", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJM198308183090703", | |||
"pageid" : 261, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJM198308183090703", | |||
"trainingLevel" : "Resident", | |||
"citation" : "Lewis HD, <i>et al</i>. \"Protective Effects of Aspirin against Acute Myocardial Infarction and Death in Men with Unstable Angina -- Results of a Veterans Administration Cooperative Study\". <i>The New England Journal of Medicine</i>. 1983. 309(7):396-403.", | |||
"subspecialties" : "Cardiology", | "subspecialties" : "Cardiology", | ||
"expansion" : null, | "expansion" : null, | ||
| Line 2,673: | Line 2,680: | ||
"published" : "1983-08-18", | "published" : "1983-08-18", | ||
"pageName" : "VA Cooperative Study", | "pageName" : "VA Cooperative Study", | ||
"diseases" : "Acute Coronary Syndrome", | "diseases" : "Acute Coronary Syndrome", | ||
" | "abbreviation" : null, | ||
"title" : "Protective Effects of Aspirin against Acute Myocardial Infarction and Death in Men with Unstable Angina -- Results of a Veterans Administration Cooperative Study", | "title" : "Protective Effects of Aspirin against Acute Myocardial Infarction and Death in Men with Unstable Angina -- Results of a Veterans Administration Cooperative Study", | ||
"pmid" : "6135989" | |||
"pmid" : "6135989 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-11-02T15:39:29Z", | |||
"briefDesignDescription" : "Intensive glycemic therapy in T2DM", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa0808431", | |||
"pageid" : 254, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa0808431", | |||
"trainingLevel" : "Resident", | |||
"citation" : "Duckworth W, <i>et al</i>. \"Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes\". <i>The New England Journal of Medicine</i>. 2009. 360(2):129-39.", | |||
"subspecialties" : "Endocrinology", | "subspecialties" : "Endocrinology", | ||
"expansion" : "Veterans Affairs Diabetes Trial", | "expansion" : "Veterans Affairs Diabetes Trial", | ||
| Line 2,691: | Line 2,698: | ||
"published" : "2009-01-08", | "published" : "2009-01-08", | ||
"pageName" : "VADT", | "pageName" : "VADT", | ||
"diseases" : "Diabetes Mellitus", | "diseases" : "Diabetes Mellitus", | ||
" | "abbreviation" : "VADT", | ||
"title" : "Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes", | "title" : "Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes", | ||
"pmid" : "19092145" | |||
"pmid" : "19092145 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-03-13T05:28:05Z", | |||
"briefDesignDescription" : "Valsartan in HF", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa010713", | |||
"pageid" : 20, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa010713", | |||
"trainingLevel" : "Resident", | |||
"citation" : "Cohn JN, <i>et al</i>. \"A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure\". <i>New England Journal of Medicine</i>. 2001. 345(23):1667-75.", | |||
"subspecialties" : "Cardiology", | "subspecialties" : "Cardiology", | ||
"expansion" : "Valsartan Heart Failure Trial", | "expansion" : "Valsartan Heart Failure Trial", | ||
| Line 2,709: | Line 2,716: | ||
"published" : "2001-12-06", | "published" : "2001-12-06", | ||
"pageName" : "Val-HeFT", | "pageName" : "Val-HeFT", | ||
"diseases" : "Heart Failure", | "diseases" : "Heart Failure", | ||
"abbreviation" : "Val-HeFT", | "abbreviation" : "Val-HeFT", | ||
" | "title" : "A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure", | ||
"pmid" : "11759645" | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-07-01T13:20:27Z", | |||
"briefDesignDescription" : "Valsartan vs. captopril in MI with LV dysfunction", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa032292", | |||
"pageid" : 462, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa032292", | |||
"trainingLevel" : "Resident", | |||
"citation" : "Pfeffer, MA <i>et al</i>. \"Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both\". <i>The New England Journal of Medicine</i>. 2003. 349(20):1893-1903.", | |||
"subspecialties" : "Cardiology", | "subspecialties" : "Cardiology", | ||
"expansion" : "Valsartan in Acute Myocardial Infarction Trial", | "expansion" : "Valsartan in Acute Myocardial Infarction Trial", | ||
| Line 2,727: | Line 2,734: | ||
"published" : "2003-11-13", | "published" : "2003-11-13", | ||
"pageName" : "VALIANT", | "pageName" : "VALIANT", | ||
"diseases" : "Heart Failure;Acute Coronary Syndrome;Myocardial Infarction", | "diseases" : "Heart Failure;Acute Coronary Syndrome;Myocardial Infarction", | ||
" | "abbreviation" : "VALIANT", | ||
"title" : "Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both", | "title" : "Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both", | ||
"pmid" : "12921816" | |||
"pmid" : "12921816 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-08-13T14:15:36Z", | |||
"briefDesignDescription" : "Vancomycin vs. metronidazole in C. difficile", | |||
"fulltexturl" : "http://cid.oxfordjournals.org/content/45/3/302.long", | |||
"pageid" : 6, | |||
"pdfurl" : "http://cid.oxfordjournals.org/content/45/3/302.full.pdf", | |||
"trainingLevel" : "Intern", | |||
"citation" : "Zar FA, <i>et al</i>. \"A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity\". <i>Clinical Infectious Diseases</i>. 2007. 45(3):302-7.", | |||
"subspecialties" : "Infectious Disease;Gastroenterology", | "subspecialties" : "Infectious Disease;Gastroenterology", | ||
"expansion" : null, | "expansion" : null, | ||
| Line 2,745: | Line 2,752: | ||
"published" : "2007-08-01", | "published" : "2007-08-01", | ||
"pageName" : "Vancomycin vs. Metronidazole in C. difficile Diarrhea", | "pageName" : "Vancomycin vs. Metronidazole in C. difficile Diarrhea", | ||
"diseases" : "Clostridium difficile", | "diseases" : "Clostridium difficile", | ||
" | "abbreviation" : null, | ||
"title" : "A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity", | "title" : "A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity", | ||
"pmid" : "17599306" | |||
"pmid" : "17599306 | |||
}, | }, | ||
{ | { | ||
"subspecialties" : "Hematology", | "timestamp" : "2013-08-04T06:26:01Z", | ||
"expansion" : "Warfarin and Aspirin", | "briefDesignDescription" : "Aspirin after VTE treatment", | ||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa1114238", | |||
"pageid" : 1244, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa1114238", | |||
"trainingLevel" : "resident", | |||
"citation" : "Becattini C, <i>et al</i>. \"Aspirin for preventing the recurrence of venous thromboembolism\". <i>The New England Journal of Medicine</i>. 2012. 366(21):1959-1967.", | |||
"subspecialties" : "Hematology", | |||
"expansion" : "Warfarin and Aspirin", | |||
"briefResultsDescription" : "Aspirin reduces recurrent VTE", | "briefResultsDescription" : "Aspirin reduces recurrent VTE", | ||
"published" : "2012-05-24", | "published" : "2012-05-24", | ||
"pageName" : "WARFASA", | "pageName" : "WARFASA", | ||
"diseases" : "Deep Vein Thrombosis;Pulmonary Embolism;Venous Thromboembolism", | "diseases" : "Deep Vein Thrombosis;Pulmonary Embolism;Venous Thromboembolism", | ||
" | "abbreviation" : "WARFASA", | ||
"title" : "Aspirin for preventing the recurrence of venous thromboembolism", | "title" : "Aspirin for preventing the recurrence of venous thromboembolism", | ||
"pmid" : "22621626" | |||
"pmid" : "22621626 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-07-27T23:47:17Z", | |||
"briefDesignDescription" : "Postmenopausal estrogen/progesterone", | |||
"fulltexturl" : null, | |||
"pageid" : 1507, | |||
"pdfurl" : "http://jama.jamanetwork.com/data/Journals/JAMA/4840/JOC21036.pdf", | |||
"trainingLevel" : "Student", | |||
"citation" : "Rossouw JE, <i>et al</i>. \"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results From the Women's Health Initiative randomized controlled trial\". <i>The Journal of the American Medical Association</i>. 2002. 288(3):321-333.", | |||
"subspecialties" : "Gynecology;Endocrinology", | "subspecialties" : "Gynecology;Endocrinology", | ||
"expansion" : "Women's Health Initiative Estrogen and Progestin Trial", | "expansion" : "Women's Health Initiative Estrogen and Progestin Trial", | ||
| Line 2,781: | Line 2,788: | ||
"published" : "2002-07-17", | "published" : "2002-07-17", | ||
"pageName" : "WHI", | "pageName" : "WHI", | ||
"diseases" : "Coronary Artery Disease;Menopause", | "diseases" : "Coronary Artery Disease;Menopause", | ||
" | "abbreviation" : "WHI E+P", | ||
"title" : "Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results From the Women's Health Initiative randomized controlled trial", | "title" : "Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results From the Women's Health Initiative randomized controlled trial", | ||
"pmid" : "12117397" | |||
"pmid" : "12117397 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-08-27T20:25:03Z", | |||
"briefDesignDescription" : "Pravastatin in CAD", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJM199511163332001", | |||
"pageid" : 172, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJM199511163332001", | |||
"trainingLevel" : "Resident", | |||
"citation" : "Shepherd J, <i>et al</i>. \"Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia\". <i>The New England Journal of Medicine</i>. 1995. 333(20):1301-1308.", | |||
"subspecialties" : "Cardiology", | "subspecialties" : "Cardiology", | ||
"expansion" : "West of Scotland Coronary Prevention Study", | "expansion" : "West of Scotland Coronary Prevention Study", | ||
| Line 2,799: | Line 2,806: | ||
"published" : "1995-11-16", | "published" : "1995-11-16", | ||
"pageName" : "WOSCOPS", | "pageName" : "WOSCOPS", | ||
"diseases" : "Hyperlipidemia;Coronary Artery Disease", | "diseases" : "Hyperlipidemia;Coronary Artery Disease", | ||
" | "abbreviation" : "WOSCOPS", | ||
"title" : "Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia", | "title" : "Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia", | ||
"pmid" : "7566020" | |||
"pmid" : "7566020 | |||
}, | }, | ||
{ | { | ||
"timestamp" : "2013-08-25T02:33:05Z", | |||
"briefDesignDescription" : "RSBI for predicting weaning", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJM199105233242101", | |||
"pageid" : 75, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJM199105233242101", | |||
"trainingLevel" : "Resident", | |||
"citation" : "Yang KL, Tobin MJ. \"A Prospective Study of Indexes Predicting the Outcome of Trials of Weaning from Mechanical Ventilation\". <i>The New England Journal of Medicine</i>. 1991. 324(21):1445-1450.", | |||
"subspecialties" : "Pulmonology;Critical Care", | "subspecialties" : "Pulmonology;Critical Care", | ||
"expansion" : "", | "expansion" : "", | ||
| Line 2,817: | Line 2,824: | ||
"published" : "1991-05-23", | "published" : "1991-05-23", | ||
"pageName" : "Yang-Tobin Study", | "pageName" : "Yang-Tobin Study", | ||
"diseases" : "Critical Illness", | "diseases" : "Critical Illness", | ||
" | "abbreviation" : "", | ||
"title" : "A Prospective Study of Indexes Predicting the Outcome of Trials of Weaning from Mechanical Ventilation", | "title" : "A Prospective Study of Indexes Predicting the Outcome of Trials of Weaning from Mechanical Ventilation", | ||
"pmid" : "2023603" | |||
"pmid" : "2023603 | |||
} | } | ||
] | ] | ||
} | } | ||
} | } | ||